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PREFACE
The Occupational Safety and Health Act of 1970 emphasizes the need 
for standards to protect the health and provide for the safety of 
workers occupationally exposed to an ever-increasing number of potential 
hazards. The National Institute for Occupational Safety and Health 
(NIOSH) evaluates all available research data and criteria and 
recommends standards for occupational exposure. The Secretary of Labor 
will weigh these recommendations along with other considerations, such 
as feasibility and means of implementation, in promulgating regulatory 
standards.
NIOSH will periodically review the recommended standard^ to ensure 
continuing protection of workers and will make successive reports as new 
research and epidemiologic studies are completed and as sampling and 
analytical methods are developed.
The contributions to this document on ketones by NIOSH staff, other 
Federal agencies or departments, the review consultants, the revieWeirs 
selected by the American Academy of Industrial Hygiene, and Robert B. 
O'Connor, M.D., NIOSH consultant in occupational medicine, are 
gratefully acknowledged.
The views and conclusions expressed in this document, together with 
the recommendations for a standard, are those of NIOSH. They are not 
necessarily those of the consultants, the reviewers selected by 
professional societies, or other Federal agencies. However, all 
comments, whether or not incorporated, were considered carefully and 
were sent with the criteria document to the Occupational Safety and 
Health Administration for consideration in setting the standard. The 
review consultants and the Federal agencies which received the document 
for review appear on pages v and vi.
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I. RECOMMENDATIONS FOR A KETONES STANDARD
NIOSH recommends that employee exposure to ketones in the workplace 
be controlled by adherence to the following sections. The standard is 
designed to protect the health and provide for the safety of employees for 
up to a 10-hour workshift, AO-hour workweek, over a working lifetime. 
Compliance with all sections of the standard should prevent adverse effects 
of ketones on the health of employees and provide for their safety. The 
standard is measurable by techniques that are valid, reproducible, and 
available to industry and government agencies. Sufficient technology 
exists to permit compliance with the recommended standard. Although NIOSH 
considers the workplace environmental limits to be safe levels based on 
current information, the employer should regard them as the upper 
boundaries of exposure and make every effort to maintain the exposure as 
low as is technically feasible. The criteria and standard will be subject 
to review and revision as necessary.
These criteria and the recommended standard apply to exposure of 
employees in the workplace to acetone, (2-propanone), methyl ethyl ketone 
(2-butanone), methyl n-propyl ketone (2-pentanone), methyl n-butyl ketone 
(2-hexanone), methyl n-amyl ketone (2-heptanone), methyl isobutyl ketone 
(4-methyl-2-pentanone), methyl isoamyl ketone (5-methyl-2-hexanone), 
diisobutyl ketone (2,6-dimethyl-4-heptanone), cyclohexanone, mesityl oxide 
(4-methyl-3-penten-2-one), diacetone alcohol (4-hydroxy-4-methyl-2- 
pentanone), and isophorone (3,5,5-trimethyl-2-cyclohexan-l-one), referred 
to as "ketones" in this document.
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Ketones have many industrial uses as chemical intermediates, 
solvents, and components in formulations, including inks, adhesives, and 
dyes. Exposure to ketones can cause local effects (irritation of eyes, 
upper respiratory tract, and skin) and systemic effects, the most important 
of which is peripheral neuropathy from methyl n-butyl ketone.
The action level is defined as half the time-weighted average (TWA) 
concentration environmental limit of each ketone. "Occupational exposure 
to ketones" is defined as exposure to ketones at a TWA concentration 
greater than the action level. Exposure at lower concentrations will not 
require adherence to the following sections, except for Sections 3(a), 4, 
5, 6(b-e), 7, and 8(a).
Section 1 - Environmental (Workplace Air)
(a) Concentration
Occupational exposure to ketones shall be controlled so that
employees are not exposed at concentrations greater than the limits, in 
milligrams per cubic meter (mg/cu m) of air, in Table 1-1 as TWA 
concentrations for up to a 10-hour workshift, 40-hour workweek.
(b) Sampling and Analysis
Workroom air samples shall be collected and analyzed for ketones by 
the methods described in Appendix I or by methods that are at least
equivalent in precision, sensitivity, and accuracy.
Section 2 - Medical
Medical surveillance shall be made available as outlined below to all 
workers occupationally exposed to ketones.
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TABLE 1-1
RECOMMENDED EXPOSURE LIMITS FOR THE KETONES


































(a) Preplacement examinations shall include at least:
(1) Comprehensive medical and work histories with special 
emphasis directed toward disorders of the nervous system, the respiratory 
system, and the eyes.
(2) Physical examination giving particular attention to the 
central and peripheral nervous systems, the respiratory system, and the 
eyes.
(3) Urinalysis, as an indicator of kidney function. In
addition, appropriate tests for liver function should be considered by the 
responsible physician. For workers occupationally exposed to methyl n-
butyl ketone, an electrodiagnostic examination including electromyography 
and nerve conduction velocity measurements shall be provided.
(A) A judgment of the worker's ability to use positive and
negative pressure respirators.
(b) Periodic examinations shall be made available annually or more
frequently when considered necessary by the responsible physician. These 
examinations shall include at least:
(1) Interim medical and work histories.
(2) Physical examination as outlined in paragraphs (a)(2) 
and (a)(3) of this section.
(c) During examinations, applicants or employees found to have
medical conditions that might be directly or indirectly aggravated by 
exposure to ketones, for example, a case of preexisting neuropathy in the 
case of methyl n-butyl ketone, shall be counseled on the increased risk of 
impairment of their health by working with these substances.
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In addition, employees who are occupationally exposed to methyl n- 
butyl ketone shall be made aware that repeated exposure can produce adverse 
effects on the nervous system and that accompanying signs and symptoms are 
insidious. If indicated by the electrodiagnostic examinations on those 
workers with occupational exposure to methyl n-butyl ketone, a neurologic 
consultation should be obtained, particularly in the presence of suspected 
neurologic abnormalities on preemployment or interim examination.
(d) Appropriate medical management shall be made available to
those workers who suffer effects from exposure to ketones.
(e) Pertinent medical records shall be maintained for all 
employees occupationally exposed to ketones in the workplace. Records of 
environmental exposures applicable to an employee shall be included in that 
employee's medical records. Such records shall be kept for at least 30 
years after termination of employment. These records shall be made 
available to the designated medical representatives of the Secretary of 
Health, Education, and Welfare, of the Secretary of Labor, of the employer, 
and of the employee or former employee.
Section 3 - Labeling and Posting
All labels and warning signs shall be printed both in English and in
the predominant language of non-English-reading workers. Workers unable to
read the labels and signs provided shall receive information regarding 
hazardous areas and shall be informed of the instructions printed on labels 
and signs. Because acetone, methyl ethyl ketone, methyl n-propyl ketone, 
methyl n-butyl ketone, methyl isobutyl ketone, and mesityl oxide are 
flammable while methyl n-amyl ketone, diisobutyl ketone, methyl isoamyl
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ketone, cyclohexanone, diacetone alcohol, and isophorone are combustible, 
all labels and warning signs shall bear the appropriate designation.
(a) Containers
Shipping and storage Vessels containing ketones shall carry, in a 
readily visible location, the following pertinent label that bears the name 
of the specific ketones contained therein, the trade name of the product, 
if appropriate, and information on the effects of exposure to the compound 
on human health in addition to, or in combination with, labels required by 
other statutes, regulations, or ordinances. The information shall be 
arranged as in the following examples:
(1) Label for methyl n-butyl ketone:
METHYL N-BUTYL KETONE 
(TRADE NAME) 
FLAMMABLE 
MAY CAUSE NERVE DAMAGE 
IF INHALED, SWALLOWED, OR 
ABSORBED THROUGH SKIN
Keep away from heat, sparks, and open flames.
In case of fire, use foam, dry chemical, or carbon dioxide fire 
extinguisher.
Avoid breathing vapor.
Do not get on skin, in eyes or mouth, or on clothing.
Keep containers closed when not in use.
Use only with adequate ventilation.
First Aid: If substance contacts skin, immediately wash
affected area with soap and water. In case of eye contact, 
flush eye with copious amounts of running water. If 
overexposure should occur, consult a physician.
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(2) Label for the other 11 ketones:
NAME OF KETONE 
(TRADE NAME)
FLAMMABLE! (or: COMBUSTIBLE!)
HARMFUL IF INHALED, SWALLOWED, 
OR ABSORBED THROUGH SKIN
Keep away from heat, sparks, and open flames.
In case of fire, use foam, dry chemical, or carbon dioxide fire 
extinguisher.
Avoid breathing vapor.
Do not get on skin, in eyes or mouth, or on clothing.
Keep containers closed when not in use.
Use only with adequate ventilation.
First Aid: If substance contacts skin, immediately wash
affected area with soap and water. In case of eye contact, 
flush eye with copious amounts of running water. If 
overexposure should occur, consult a physician.
(b) Work Area
Warning placards shall be affixed in readily visible locations in or 
near areas of occupational exposure to ketones. The information shall be 
arranged as in the following examples:
(1) Warning placard for methyl n-butyl ketone:
HAZARDOUS AREA 
METHYL n-BUTYL KETONE 
(TRADE NAME) 
FLAMMABLE 
MAY CAUSE NERVE DAMAGE 
IF INHALED, SWALLOWED, OR 
ABSORBED THROUGH SKIN
Prevent sources of heat, sparks, or open flames.
No smoking permitted. In case of fire use fire 
extinguishers at (location). Avoid breathing vapor. 
Avoid contact with skin, eyes, and clothing.
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(2) Warning placard for the other 11 ketones:
HAZARDOUS AREA 
NAME OF KETONE 
(TRADE NAME) 
FLAMMABLE! (or: COMBUSTIBLE!) 
HARMFUL IF INHALED, SWALLOWED, 
OR ABSORBED THROUGH SKIN
Prevent sources of heat, sparks, or open flames. No smoking or 
eating. In case of fire, use fire extinguishers at (location).
Avoid breathing vapor. Avoid contact with skin, eyes, and 
clothing.
(3) Respiratory Protection 
If respiratory protection is required in accordance with Section 4, 
the following statement in large letters shall be added to the required 
sign:
RESPIRATORY PROTECTION REQUIRED IN THIS AREA
Section 4 - Personal Protective Equipment and Clothing
(a) Respiratory Protection
The employer shall use engineering controls when needed to keep 
concentrations of airborne ketones at or below the recommended 
environmental limits. Compliance with this standard by the use of 
respirators is permitted only during installation and testing of 
engineering controls, during performance of nonroutine maintenance or 
repair, or during emergencies. When use of a respirator is permitted, it 
shall be selected and used in accordance with the following requirements:
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(1) To determine the type of respirators to be used, the
employer shall measure the concentration of airborne ketones in the 
workplace initially and thereafter whenever control, process, operational, 
worksite, or climatic changes occur that are likely to increase the 
concentration of airborne ketones.
(2) The employer shall ensure that no employee is exposed
to ketones at concentrations above the recommended limits because of
improper respirator selection, fit, use, or maintenance.
(3) A respiratory protection program shall be established.
Requirements are found in 29 CFR 1910.134.
(4) The employer shall provide respirators in accordance
with Table 1-2 and shall ensure that the employees use the respirators
properly when they are required. Respiratory protective devices shall be 
those approved by NIOSH and the Mine Safety and Health Administration.
(5) Respirators specified for use in higher concentrations 
of a specific airborne ketone may be used in an atmosphere of the same 
ketone at lower concentrations.
(6) The employer shall ensure that employees are properly
instructed in the use of respirators assigned to them and in ways to test 
for leakage, proper fit, and proper operation.
(b) Protective Clothing
The employer shall provide appropriate protective clothing to 
employees who may have skin contact with liquid ketones. Protective 
clothing, including aprons, coats or coveralls, gloves, and boots, shall be 
made of material resistant to penetration by ketones. The employer shall 
ensure that personal protective clothing is regularly inspected for defects
TABLE 1-2
RESPIRATOR SELECTION GUIDE FOR KETONES*
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Code Respirator Type Approved under Provisions of 30 CFR 11
A Chemical cartridge respirator with half-mask facepiece and 
organic vapor cartridge
B Chemical cartridge respirator with full facepiece arid organic 
vapor cartridge
C Gas mask with full facepiece and chin-type organic vapor can­
ister
D Gas mask with full facepiece and back- or front-mounted 
organic vapor canister
E Type C supplied-air respirator, with half-mask facepiece, 
operated in demand (negative pressure) mode
F Type C supplied-air respirator, with full facepiece, opera*- 
ted in demand (negative pressure) mode
G Type C supplied-air respirator, with half-mask facepiece, 
operated in continuous-flow or pressure-demand mode
H Type C supplied-air respirator, with full facepiece, opeta-1- 
ted in continuous-flow or pressure-demand mode
I Type C supplied-air respirator with hood, helmet, or suit
J Self-contained breathing apparatus, with full facepiece, 
operated in demand (negative pressure) mode
K Self-contained breathing apparatus, with full facepiece, 
operated in pressure-demand or other positive pressure mode
L Combination Type C supplied-air respirator, with full face­
piece, operated in pressure-demand mode and equipped with 
auxiliary positive pressure self-contained air supply
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and that it is worn by employees when necessary to prevent skin contact 
with liquid ketones.
(c) Eye Protection
The employer shall provide chemical safety goggles or face shields 
(20-cm minimum) with goggles and ensure that they are worn by employees 
where efe contact with liquid ketones is likely. Regulations concerning 
the selection, use, design, cleaning, limitations, precautions, and 
maintenance of eye protection equipment appear in 29 CFR 1910.133.
Section 5 - Informing Employees of Hazards from Ketones
(a) All new and current employees working with ketones shall be 
informed of the hazards, relevant signs and symptoms of overexposure, 
appropriate emergency procedures, including first aid, and proper 
conditions and precautions concerning safe use and handling of these 
compounds. Employees shall be informed, preferably by medical personnel, 
that ketones can irritate the eyes, nose, and throat and may cause impaired 
judgment at unknown concentrations and narcosis at high concentrations.
(b) The employer shall institute a continuing education program, 
conducted by persons qualified by experience or training, to ensure that 
all employees have current knowledge of job hazards, proper maintenance and 
cleanup methods, and proper respirator use. The instructional program 
shall include a description of the general nature of the environmental and 
medical surveillance procedures and of the advantage to the employees of 
participating in these surveillance procedures. As a minimum, instruction 
shall include the information in Appendix II, which shall be kept on file
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and shall be readily accessible to employees at all places of employment 
where ketones are present.
(c) Required information shall be recorded on the "Material Safety
Data Sheet" shown in Appendix II or on a similar form approved by the 
Occupational Safety and Health Administration, US Department of Labor.
Section 6 - Work Practices
(a) Control of Airborne Ketones
Engineering controls, such as process enclosure or local exhaust 
ventilation, shall be used when needed to keep exposures to ketones at or 
below the permissible exposure limits. Ventilation systems, if used, shall 
be designed to limit accumulation or recirculation of ketones in the 
workplace environment. Exhaust ventilation systems discharging to outside 
air must conform to applicable local, state, and Federal air pollution 
regulations and must not constitute a hazard to employees or to the general 
population. Ventilation systems shall be subject to regular preventive 
maintenance and cleaning to ensure effectiveness, which shall be verified 
by airflow measurements taken at least every 3 months. Motors in the 
exhaust systems shall be explosion proof, and all moving parts Shall be 
made of nonsparking materials.
(b) Confined Spaces
Entry into and work in confined spaces, such as tanks, pits, vessels, 
or tank cars, that may contain ketones shall be controlled by adherence to 
the following requirements (or their equivalent).
(1) Before entering a confined space an employee shall 
obtain a permit. Permits shall be signed by an authorized representative
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of the employer and shall certify that proper preventive and protective 
measures have been followed.
(2) Confined spaces that have contained ketones shall be
cleaned with water and purged with air. Confined spaces should be isolated 
by locking out associated valves and switches to prevent accidental entry 
of ketones. They shall be tested to ensure that there is an adequate 
supply of oxygen and to ensure that ketones and other contaminants are not 
present in unsafe amounts and concentrations. Adequate ventilation shall 
be maintained while employees are in the confined space.
(3) An employee entering a confined space shall be
furnished with appropriate personal protective equipment and shall be 
connected by a lifeline harness to another worker outside, who shall also 
be equipped for entry with approved personal protective equipment and have 
contact with a third party. The standby person shall keep in communication 
with the person in the confined space. The third person, equipped to aid 
the other two if necessary, shall observe their activities.
(c) Storage and Handling
(1) Containers of ketones shall be kept tightly closed at
all times when not in use. They shall be of a type designed to contain 
flammable or combustible liquids and shall be stored safely to minimize the 
possibility of breaks, spills, or leaks. Ketones shall be kept away from 
excessive heat, sparks, and flames.
(2) Employers shall ensure that improperly informed,
trained, and equipped personnel are not involved in storing, loading, 
unloading, or processing ketones.
14
(3) Guidelines and regulations on the storage and handling
of flammable and combustible liquids are found in 29 CFR 1910.106.
(d) Cleanup and Waste Disposal
(1) Spills of liquid ketones shall be cleaned up promptly 
and in a manner that will minimize the inhalation of, skin contact with, 
and hazard of fire from the ketones.
(2) Rags, mops, and other materials contaminated with 
ketones shall be stored in closed metal containers.
(3) Waste material containing ketones shall be disposed of 
in a manner that is not hazardous to employees or to the general population 
and that conforms to applicable local, state, and Federal regulations.
(e) Emergency Procedures
(1) The employer shall formulate emergency evacuation, 
medical, and firefighting procedures and shall ensure that employees are 
instructed in these procedures and that the instructions are posted in all 
work areas where emergencies such as large spills involving ketones might 
occur. Emergency procedures shall include prearranged plans for immediate 
evacuation, transportation, and medical assistance for affected employees, 
including alerting designated medical facilities to the impending arrival 
of affected workers.
(2) Necessary emergency equipment, including respirators, 
shall be available in readily accessible locations, and employees shall be 
instructed in its use.
(3) Employees not essential to emergency operations shall 
be evacuated from hazardous areas during emergencies. The perimeters of 
these areas shall be delineated, posted, and secured. Employers shall
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ensure that personnel who are not trained in emergency procedures and 
protected against the attendant hazards do not shut off sources of ketones, 
clean up spills, control and repair leaks, and fight fires where ketones 
are present.
(4) Employers shall provide emergency drench showers, 
eyewash fountains, and washroom facilities that are readily accessible to 
workers in all areas where skin or eye contact with liquid ketones is 
likely. If liquid ketones are splashed on the clothing or skin, 
contaminated clothing and shoes shall be promptly removed and the skin 
washed thoroughly with soap and water. If liquid ketones get into the 
eyes, the affected area shall be irrigated immediately with copious 
quantities of running water.
(5) The employer shall ensure, through regularly scheduled 
inspection and maintenance, that all emergency equipment, including washing 
facilities, is in proper working order.
Section 7 - Sanitation
(a) Regulations concerning plant sanitation are found in 29 CFR 
1910.141.
(b) The employer shall provide appropriate changing and shower 
rooms. Requirements for such rooms are found in 29 CFR 1910.141(e).
(c) Clothing that has been contaminated by ketones shall be 
discarded or decontaminated by laundering or drying under an exhaust hood 
or by an equivalent method.
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(d) The employer shall inform persons involved in laundering or 
otherwise handling clothing or equipment contaminated with ketones of the 
potential hazards of exposure to ketones.
(e) Employers shall prohibit the use of ketones for handwashing 
and other personal cleaning purposes.
(f) Employees who handle ketones shall be instructed by their 
employer to wash their hands thoroughly with soap and water before using 
toilet facilities, eating, or smoking.
Section 8 - Monitoring and Recordkeeping Requirements
(a) Each employer with a place of employment where ketones are 
manufactured, processed, stored, used, handled, or otherwise present shall 
determine by an industrial hygiene survey if there is occupational exposure 
to ketones. Records of these surveys, including the basis for concluding 
that there is no occupational exposure to ketones, shall be maintained. 
Surveys shall be repeated at least annually and within 30 days of any 
change likely to alter concentrations of any of these compounds in the 
workplace air.
(b) If it is determined that there is occupational exposure to 
ketones, the employer shall fulfill the following requirements:
(1) A program of personal monitoring shall be instituted to 
identify and measure, or to permit calculation of, the exposure of each 
employee occupationally exposed to airborne ketones. Source and area 
monitoring may be used to supplement personal monitoring.
(2) In all personal monitoring, samples representative of 
the breathing zones of the employees shall be collected.
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(3) For each TWA concentration determination, a sufficient 
number of samples shall be taken to characterize the employees' exposures 
during each workshift. Variations in work and production schedules and in 
employees' locations and job functions shall be considered in choosing 
sampling times, locations, and frequencies.
(4) Each operation in each work area shall be evaluated at 
least every 3 months if it is determined that there is occupational 
exposure.
(5) If an employee is found to be exposed to ketones in 
excess of any of the TWA concentration limits specified in Section la, the 
exposure of that employee shall be measured at least once a week, control 
measures shall be initiated, and the employee shall be notified of the 
extent of the exposure and of the control measures being implemented. Such 
monitoring shall continue until two consecutive determinations, 1 week 
apart, indicate that the employee's exposure no longer exceeds the 
appropriate limits. Routine monitoring may then be resumed.
(c) Recordkeeping
Records of workplace environmental monitoring shall be kept for at 
least 30 years after the employee's last occupational exposure to ketones. 
These records shall include the dates and times of measurements, job 
function and location of the employee within the worksite, methods of 
sampling and analysis used, types of respiratory protection in use at the 
time of sampling, TWA concentrations found, and identification of the 
exposed employee. Employees shall be able to obtain information on their 
own workplace environmental exposures. Workplace environmental monitoring
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records shall be made available to designated representatives of the 
Secretary of Labor and of the Secretary of Health, Education, and Welfare.
Pertinent medical records shall be retained by the employer for 30 
years after termination of employment. Records of environmental exposures 
applicable to an employee should be included in medical records. These 
medical records shall be made available to the designated medical 
representatives of the Secretary of Labor, of the Secretary of Health, 




This report presents the criteria and the recommended standard based 
thereon which were prepared to meet the need for preventing impairment of 
health from workplace exposure to ketones. The criteria document fulfills 
the responsibility of the Secretary of Health, Education, and Welfare under 
Section 20(a)(3) of the Occupational Safety and Health Act of 1970 to 
"...develop criteria dealing with toxic materials and harmful physical 
agents and substances which will describe...exposure levels at which no 
employee will suffer impaired health or functional capacities or diminished 
life expectancy as a result of his work experience."
After reviewing data and consulting with others, NIOSH formalized a 
system for the development of criteria upon which standards can be 
established to protect the health and to provide for the safety of 
employees exposed to hazardous chemical and physical agents. Criteria for 
a recommended standard should enable management and labor to develop better 
engineering controls resulting in more healthful work environments, and 
simply complying with the recommended standard should not be regarded as 
the final goal.
These criteria for a standard for ketones are part of a continuing 
series of criteria developed by NIOSH. The proposed standard applies only 
to workplace exposure to ketones arising from the processing, manufacture, 
and use of these ketones. The standard is not designed for the population- 
at-large, and any extrapolation beyond the occupational environment is not 
warranted. It is intended to (1) protect against injury from ketones, (2)
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be measurable by techniques that are valid, reproducible, and available to 
industry and official agencies, and (3) be attainable with existing 
technology.
There are a number of areas that need further research with respect 
to ketones. The possibilities of carcinogenic, mutagenic, teratogenic, and 
reproductive effects from ketones have not been thoroughly investigated. 
Epidemiologic studies on all of the ketones are also needed. Furthermore, 
toxicologic information from repeated exposures of experimental animals is 
deficient for most of the ketones. Animal experiments are needed to 
determine if ketones other than methyl n-butyl ketone produce peripheral 
neuropathy. The effects of various mixtures of the ketones and 
interactions that may occur have not been studied. Research in this 
complex area is needed. Pharmacokinetic studies (absorption, distribution, 
metabolism, and excretion) are also needed to help investigators understand 
the mechanism of action of ketones on the nervous system.
Exposure to ketones in the workplace is a major concern because one 
of these compounds has caused a neurologic disorder, and all of them may 
cause irritation of the eyes, nose, and throat, impaired judgment, and 
narcosis in humans. Exposure occurs primarily when ketones are inhaled or 
absorbed through the skin.
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III. BIOLOGIC EFFECTS OF EXPOSURE
Extent of Exposure
Ketones are compounds with a carbonyl group, C=0, which is attached 
to two carbon atoms. They are represented by the general formula RCOR' 
[1]. The 12 ketones discussed in this document are acetone, methyl ethyl 
ketone, methyl n-propyl ketone, methyl n-butyl ketone, methyl n-amyl 
ketone, methyl isobutyl ketone, methyl isoamyl ketone, diisobutyl ketone, 
cyclohexanone, mesityl oxide, diacetone alcohol, and isophorone. These 
ketones are known by a number of synonyms, some of which are listed, along 
with chemical and structural formulas of the compounds, in Table XI-1. 
Important physical and chemical properties are presented in Table XI-2.
Some of the applications of these ketones in industry are determined 
by the solvent properties, rate of evaporation, boiling point, viscosity, 
and availability [2]. Ketones are used as chemical intermediates in 
chemical manufacturing industries; as solvents for natural and synthetic 
resins in coating industries; as components in formulations such as inks, 
adhesives, and dyes; as extraction agents for lubricating oil; in wax 
refining; and for rare metal flotation in refining processes [1,3]. A list 
of occupations in which there is potential exposure to these ketones is 
presented in Table XI-3.
(a) Acetone
Acetone, CH3COCH3, is a colorless, highly volatile, flammable liquid 
with a burning taste and aromatic odor [4]. It is the simplest but most 
commercially important ketone [5]. Acetone occurs normally in small 
amounts in human blood and urine [6].
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Commercially, acetone is produced by catalytic dehydrogenation of 
isopropyl alcohol or by oxidation of cumene [5]. Before World War I, small 
amounts of acetone were produced from the dry distillation of wood. In the 
mid-1920's, most acetone was manufactured by the dehydrogenation of 
isopropyl alcohol.
In 1976, about 1,922 million pounds of acetone were produced in the 
United States [7]. About 58% of the acetone produced in the United States 
and Puerto Rico was manufactured by oxidizing cumene, and the remaining 42% 
was made by dehydrogenating isopropyl alcohol [8]. About 25% of the 
acetone produced was used to make methyl methacrylate, 13% to make methyl 
isobutyl ketone, 10% as a solvent for protective coatings, and the rest was 
used in manufacturing diacetone alcohol, methyl isobutyl carbinol, 
isophorone, mesityl oxide, higher methacrylates, bisphenol A, and other 
chemicals [8].
In addition to being used as a chemical intermediate, acetone is an 
excellent solvent for many natural gums and resins, for cellulose 
derivatives such as nitrocellulose, cellulose esters, and ethyl cellulose, 
and for synthetic resins such as vinyl and modified phenolic types, alkyds, 
and methacrylates [5]. Acetone is also used as a solvent in manufacturing 
smokeless powder, cements, and artificial leather.
NIOSH estimates that 2,816,000 workers are potentially exposed to 
acetone in the United States.
(b) Methyl Ethyl Ketone
Methyl ethyl ketone, CH3COCH2CH3, is a colorless liquid with an 
acetone-like odor and is produced commercially either by dehydrogenation or 
selective oxidation of sec-butyl alcohol [1], In 1976, about 524 million
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pounds of methyl ethyl ketone were produced in the United States [7].
Methyl ethyl ketone is mainly used as a solvent for formulations of 
nitrocellulose [1]. It is also used in the manufacture of synthetic
surface coatings made from acrylic resins, vinyl acetates, cellulose
acetate-butyrate, ethyl cellulose, and vinyl chloride-vinyl acetate 
copolymers. Methyl ethyl ketone is used as a dewaxing solvent in the 
refining of lubricating oils. It is used to manufacture methyl isopropenyl 
ketone, sec-butyl amine, and 1,3-diketones.
NIOSH estimates that 3,031,000 workers are potentially exposed to
methyl ethyl ketone in the United States.
(c) Methyl n-Propyl Ketone
Methyl n-propyl ketone, CH3(CH2)2C0CH3, is a clear liquid with a
strong odor resembling that of acetone but having a more ethereal character 
[9]. It is made primarily by the oxidation of 2-pentanol. Methyl n-propyl 
ketone is used as a solvent, either alone or in combination with other 
solvents.
NIOSH estimates that fewer than 500 workers are potentially exposed
to methyl n-propyl ketone in the United States.
(d) Methyl n-Butyl Ketone
Methyl n-butyl ketone, CH3CO(CH2)3CH3, is a colorless liquid with a 
strong odor resembling that of acetone but more pungent [9]. Commercially,
it is produced by the catalyzed reaction of acetic acid and ethylene under
pressure.
Methyl n-butyl ketone is used in the lacquer industry as a solvent 
for lacquers and in lacquer and varnish removers [9]. It is a useful 
solvent for nitrocellulose, resins, oils, fats, and waxes.
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NIOSH estimates that 222,000 workers are potentially exposed to 
methyl n-butyl ketone in the United States.
(e) Methyl n-Amyl Ketone
Methyl n-amyl ketone, CH3CO(CH2)4CH3, is a liquid with marked fruity 
odor [9]. It occurs naturally in oil of cloves and in Ceylon cinnamon oil 
[1]. Commercially, it is produced primarily by the catalytic 
dehydrogenation of 2-heptanol [9]. It is a useful solvent in synthetic 
resin finishes, particularly for metal roll coating [1],
NIOSH estimates that 67,000 workers are potentially exposed to methyl 
n-amyl ketone in the United States.
(f) Methyl Isobutyl Ketone
Methyl isobutyl ketone, CH3COCH2CH(CH3)2, is a colorless liquid with 
a pleasant odor [9]. It is manufactured commercially by the selective 
catalytic hydrogenation of the double bond in mesityl oxide.
Methyl isobutyl ketone is used as a solvent in synthetic resinous 
paints, lacquers, and varnishes [10]. It is also used as a solvent for 
adhesives, rubber cements, aircraft dopes with cellulose acetate-butyrate 
bases, 2,4-D, and DDT [1]. As an extractant, methyl isobutyl ketone is 
used in dewaxing mineral oils, refining tall oil, and cleaning metals [1]. 
In the recovery of uranium from fission products, methyl isobutyl ketone is 
used in the solvent extraction process [3].
NIOSH estimates that 1,853,000 workers are potentially exposed to 
methyl isobutyl ketone.
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(g) Methyl Isoamyl Ketone
Methyl isoamyl ketone, CH3C0(CH2)2CH(CH3)2, is a colorless, stable 
liquid with a pleasant odor. It is used as a solvent for nitrocellulose, 
cellulose acetate, and acrylic and vinyl copolymers [11]. NIOSH estimates 
that 19,000 workers in the United States are potentially exposed to methyl 
isoamyl ketone.
(h) Diisobutyl Ketone
Diisobutyl ketone, (CH3)2CHCH2COCH2CH(CH3)2, is an oily liquid of low 
volatility with a peppermint odor [1]. Commercially, diisobutyl ketone is 
produced by the reduction of phorone or as a byproduct in the manufacture 
of methyl isobutyl ketone from acetone. [1].
It is used as a solvent for nitrocellulose, milled crepe rubber, 
vinylite, and synthetic coatings [9] and as a dispersant for organosol-type 
resins. It is also used in the synthesis of inhibitors, dyes, 
pharmaceuticals, and insecticides [9]. It is useful as a dewaxing agent 
for lubricating oils [1].
An estimate of the number of workers who are potentially exposed to 
diisobutyl ketone in the United States is not available.
(i) Cyclohexanone
Cyclohexanone, C6H100, is a colorless liquid with an odor suggestive
of peppermint [12]. Cyclohexanone can be produced by the catalytic air 
oxidation of cyclohexane, by the catalytic dehydrogenation of cyclohexanol, 
or by the oxidation of cyclohexanol. The most common method probably is 
catalytic air oxidation of cyclohexane, which produces a mixture of 
cyclohexanol and cyclohexanone.
In 1975, about 554 million pounds of cyclohexanone were produced in 
the United States [13]. Its most commercially important use is as a 
chemical intermediate in the manufacture of adipic acid [3]. In lacquer 
industries, cyclohexanone is used as a solvent and thinner for lacquers 
that contain nitrocellulose or vinyl chloride polymers and copolymers [12]. 
It is used as a solvent for many resins, including vinyls, cellulose 
esters, ethyl cellulose, polystyrene, acrylics, and crude rubber [3], It 
is also used in stain, spot, and paint removers, metal degreasers, 
adhesives, polishes, and lube oil [3].
NIOSH estimates that in the United States there are 1,190,000 workers 
potentially exposed to cyclohexanone.
(j) Mesityl Oxide
Mesityl oxide, CH3COCH=C(CH3)2, is a colorless liquid with a strong 
odor of peppermint [9]. It is produced commercially by dehydration of 
diacetone alcohol or by autoxidation of acetone [1].
In 1975, approximately 46 million pounds of mesityl oxide were 
produced in the United States [14]. Mesityl oxide is used as a solvent for 
nitrocellulose, vinyl chloride-vinyl acetate copolymers, synthetic rubbers, 
gums, resins, and ink pastes [1]. It is found in paint and varnish 
removers, carburetor cleaners, stain removers, and flotation agents. It is 
also used to produce lubricating oil additives, plasticizers, and methyl 
isobutyl ketone [1].
NIOSH estimates that in the United States fewer than 500 workers are 
potentially exposed to mesityl oxide.
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(k) Diacetone Alcohol
Diacetone alcohol, CH3COCH2C(CH3)20H, is a colorless liquid with a 
pleasant, minty odor [1,2]. It is usually prepared by the aldol 
condensation of acetone with an alkaline catalyst [1].
Diacetone alcohol is an excellent solvent for cellulose acetate, 
nitrocellulose, vinyl chloride-vinyl acetate resins, and epoxy resins [1]. 
The pure (acetone-free) form is a component of castor oil-based hydraulic 
brake fluids. It also has numerous applications in the tanning industry 
[ 2 ] .
NIOSH estimates that 1,350,000 workers are potentially exposed to 
diacetone alcohol in the United States.
(1) Isophorone
Isophorone, C9H140, is a high-boiling (215.2 C), colorless liquid of 
low volatility with an odor resembling peppermint [9]. It is produced 
commercially by either of two methods, both of which require acetone as an 
intermediate. Acetone is passed over calcium oxide, hydroxide, carbide, or 
a mixture of these at 350 C, or it is heated at 200-250 C under pressure. 
Isophorone is used as a solvent for oils, fats, gums, and natural and 
synthetic resins and as a chemical intermediate.
NIOSH estimates that 1,507,000 workers are potentially exposed to 
isophorone in the United States.
Effects on Humans
(a) Sensory Effects
A number of investigators have studied the irritating effects of 
ketones in humans. In 1943, Nelson et al [15] reported on the sensory
28
thresholds of ACETONE, METHYL ETHYL KETONE, and CYCLOHEXANONE in a study 
designed to determine comfortable working concentrations for these ketones. 
Concentrations were nominal, ie, they were calculated from weight loss in a 
bubbler or from dropping the ketone at a known rate onto a hot plate. An 
average of 10 men and women were exposed to each ketone at various 
concentrations for 3-5 minutes. In some studies, the experimenters
themselves served as subjects. Each individual classified the effects on 
the eyes, nose, and throat as very irritating, slightly irritating, or 
causing no reaction. The odor was classified as absent, definite,
moderate, strong, or overpowering. Finally, the subjects were asked to 
estimate if they could work for 8 hours in an atmosphere of the ketone at 
each given concentration. The concentration of the ketone that most 
subjects rejected as a working atmosphere was termed objectionable, and the 
next lower concentration tested was proposed as a tentative practical 
limit. In a similar study from the same laboratory published in 1946,
Silverman et al [16] reported on the sensory thresholds for METHYL ISOBUTYL
KETONE, DIISOBUTYL KETONE, MESITYL OXIDE, DIACETONE ALCOHOL, and 
IS0PH0R0NE. The experimental design was the same as that used by Nelson et 
al [15], except that an average of 12 men and women were exposed to the 
ketones for 15 minutes [16]. The results of these two studies are 
summarized in Table III-l.
For acetone, some irritation was reported at 300 ppm (711 mg/cu m), 
and methyl ethyl ketone produced mild eye irritation in some subjects at 
200 ppm (588 mg/cu m) and slight nose and throat irritation at 100 ppm (294 
mg/cu m) [15]. Nelson et al noted that methyl ethyl ketone at 300 ppm (882 
mg/cu m) was objectionable, although this was below the concentration at
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TABLE III-l 












Acetone 200 500 500 500 15
Methyl ethyl ketone 200 350 350 350 15
Methyl isobutyl ketone 100 200 >200 >200 16
Diisobutyl ketone 25 50 >50 >50 16
Cyclohexanone 25 75 75 75 15
Mesityl oxide 25 25 50 >50 16
Diacetone alcohol 50 100 >100 100 16
Isophorone 10 25 25 25 16
♦Concentration judged by majority of exposed volunteers to be satisfactory 
for an 8-hr exposure
♦♦Concentration that caused irritation in the majority of subjects
which a majority of subjects experienced irritation. Most subjects 
considered methyl isobutyl ketone to have an objectionable odor at 200 ppm 
(820 mg/cu m), diisobutyl ketone above 25 ppm (145 mg/cu m), mesityl oxide 
above 50 ppm (201 mg/cu m), diacetone alcohol at 100 ppm (474 mg/cu m), and 
isophorone at 25 ppm (141 mg/cu m) [16]. After exposure to mesityl oxide, 
many subjects reported an unpleasant taste lasting 3-6 hours; subjects also 
noted an unpleasant taste from diacetone alcohol.
30
These sensory threshold studies [15,16] have certain shortcomings. 
The concentrations of ketones in the exposure chamber were calculated 
(nominal) rather than measured analytically, so the true concentration may 
have been lower than those reported. In the study by Nelson et al [15], 
the use of the experimenters as subjects was a possible source of bias, and 
the exposure periods of 3-5 minutes were not long enough to show if 
adaptation would occur. The 15-minute exposures used by Silverman et al 
[16] should have permitted a more accurate observation of olfactory fatigue 
and a better appraisal of increasing or decreasing irritation with 
continued exposure, but the authors did not discuss possible 
acclimatization. The fact that exposure duration did not approach that of 
a normal workshift is the major limitation of these studies. However, the 
data are useful as a guide to the relative irritating properties of ketones 
and the concentrations at which these appear.
Raleigh and McGee [17] investigated the effects on workers of 
exposure to acetone at high concentrations. Air samples from the workroom 
and the workers' breathing zones were collected in plastic bags at random 
times during the workshift. Breath samples from the workers were collected 
at end-expiration before, during, and after each workshift. All air 
samples were analyzed by gas-liquid chromatographic methods.
In July 1968 [17], nine workers were examined daily for 7 consecutive 
8-hour workdays. Air samples were collected, and symptoms, such as 
headache, drowsiness, dizziness, nausea, or irritation of the eyes, nose, 
or throat, were looked for. A brief physical examination paid particular 
attention to the eyes, nose, and throat and to central nervous system (CNS) 
effects (gait, finger to nose test, and Romberg's sign). Average 8-hour
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daily exposure concentrations for the workers were 1,006 ppm (2,386 
mg/cu m, range 950-1,060 ppm; 2,252-2,386 mg/cu m). Breath samples showed 
a range of 1-420 ppm (2-995 mg/cu m) during the day, with a morning average 
of 56 ppm (133 mg/cu m) and an afternoon average of 221 ppm (524 mg/cu m). 
Eye irritation was reported by seven of the nine employees, with three of 
them reporting eye irritation more than once. Four complained of throat 
irritation, three of headache, three of lightheadedness, and two of nasal 
irritation, with one reporting nasal irritation twice. The authors said 
that these symptoms were intermittent and transient and that they occurred 
when the concentrations of airborne acetone were considerably higher than
1,000 ppm (2,370 mg/cu m). However, four workers had slight to mild 
irritation at 800-1,000 ppm (1,896-2,370 mg/cu m). On physical 
examination, one worker had a slight redness of the nasal mucous membranes, 
and one had slight congestion of the mucosa of the nose and throat. The 
authors concluded that there was no indication of CNS disorders.
In 1972, Raleigh and McGee [17] conducted an additional study of two 
men for three 8-hour shifts and two men for two 8-hour shifts. Physical 
examinations similar to those in the 1968 study were performed and the 
workers were also given a psychomotor test, but this test was subsequently 
shown to be unreliable in measuring psychomotor impairment from alcohol 
intoxication. Environmental samples contained essentially the same 
concentration of acetone as those in the first part of this study. Breath 
samples also showed a similar range of acetone concentrations; however, the 
concentration was considerably lower (20 ppm; 474 mg/cu m) in the morning 
than those taken from workers examined previously. Two of the four workers 
complained of eye irritation, with one reporting the irritation on two
32
occasions. One of the workers complained of throat irritation, and three 
noted nasal irritation. On physical examination, one employee had a slight 
throat congestion.
A correlation of odor threshold and eye irritation with exposure 
concentration was reported [17]. Most reports of odor detection occurred 
when the concentration of acetone was near or above 1,000 ppm (2,370 
mg/cu m). Of 31 air samples in the 1968 study that were correlated with 
complaints of eye irritation, 10 were reported to contain acetone at 1,000- 
1,500 ppm, while the other incidents of eye irritation occurred above 1,500 
ppm (3,555 mg/cu m). One individual showed a variable response, noting
discomfort several times at concentrations between 1,042 and 6,053 ppm
(2,470 and 14,346 mg/cu m) but, on another occasion, he reported no eye 
irritation at a concentration of 6,596 ppm (15,632 mg/cu m), although he 
did experience some burning of the throat.
Raleigh and McGee [17] concluded from these experiments that 1,000 
ppm was a safe concentration for acetone since they did not consider the 
slight irritation at 800-1,000 ppm to be cause for concern. They also
indicated that the irritation seen at much higher concentrations was mild
and transient and that no objective evidence was available from the 
physical examinations to support the symptoms of eye irritation reported by 
the workers.
Matsushita et al [18] conducted a study to determine the maximum 
permissible concentration of acetone. Twenty-five healthy male students, 
about 22 years old, were divided into five groups. Four groups were 
exposed to acetone at concentrations of 100, 250, 500, or 1,000 ppm (237,
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592, 1,180, or 2,370 mg/cu m) for 6 hours, and the remaining group served
as a control. Methods of generating vapor-air mixtures or of measuring 
concentrations of airborne acetone were not presented.
The authors [18] reported that the subjects recognized the smell of 
acetone at all exposure concentrations, but that they seemed to get used to 
the smell. Most of the subjects exposed at 500 or 1,000 ppm had irritation 
of the nose, eyes, throat, and trachea. Only a few in the other groups had 
irritation.
In the groups exposed at 500 and 1,000 ppm, there were complaints of 
tension, general weakness, heavy eyes, or lack of energy the following 
morning. In the group exposed at 250 ppm, there were fewer complaints of 
the same nature. None of the volunteers exposed at 100 ppm had any 
complaints.
Although no sampling and analytical procedures were described, this 
study suggests that exposure to acetone at concentrations below 1,000 ppm 
can cause irritation of the eyes, nose, and throat.
In a 1935 report of an animal study, Patty et al [19] mentioned that 
men momentarily exposed to METHYL ETHYL KETONE at approximately 3.3 and 10% 
had intolerable irritation of the eyes and nose. Methyl ethyl ketone at 1% 
had a strong odor and was almost intolerable, while at 0.33% it had a 
moderate to strong odor and was moderately irritating to the eyes and nose.
In 1953, Carpenter et al [20] described the irritating effects of 
DIISOBUTYL KETONE in volunteers. Two men (25 and 32 years old) were 
exposed to diisobutyl ketone at 50 ppm (290 mg/cu m) for 3 hours in a 6.5- 
foot cube. Concentrations of airborne diisobutyl ketone were monitored by 
interferometry. The subjects recorded pulse rates and subjective symptoms
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during the exposure. Both men had a transitory, slight irritation of the 
eyes and nose at the beginning of exposure [20]. They could smell and 
taste diisobutyl ketone throughout the exposure, but they reported no 
change in the taste of cigarettes smoked at the end of exposure. 
(Carpenter et al apparently thought smoking was a sensitive indicator of a
nonspecific effect.) There was no significant change in pulse rate or
blood pressure, and urine sugar and albumin tests 1 hour and 24 hours after 
exposure were negative. The two subjects estimated that a workplace 
atmosphere of diisobutyl ketone at 50 ppm would be satisfactory for an 8- 
hour exposure.
Ten days later, the same two men and another man, 43 years old, were 
similarly exposed to diisobutyl ketone at a concentration of 100 ppm (581 
mg/cu m) for 3 hours [20]. Each subject drew six circles and six squares 
at the beginning, middle, and end of exposure. Initially, all three men 
experienced slight irritation of the eyes and nose. Diisobutyl ketone 
could be tasted by two subjects after 1 hour, and slight throat irritation 
was noted by one subject after 1.5 hours. Slight tearing occurred in one 
man, and the other two had slight headaches after 2 hours. After the 
exposure, two subjects felt slightly dizzy upon entering a fresh air 
atmosphere. The two men who smoked after the exposure complained of an 
unpleasant taste. Pulse rates, blood pressures, and the results of
urinalyses were normal. Performance on the coordination tests was not
affected by the vapor exposure. The subjects estimated that a workplace 
atmosphere of diisobutyl ketone at 100 ppm would be unsatisfactory. On the 
basis of comfort, the authors [20] recommended that workplace air should 
not contain diisobutyl ketone at concentrations higher than 50 ppm.
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Smyth et al [21], in a report of animal toxicity, commented that 
MESITYL OXIDE had an objectionable odor to the investigators; however, they 
also pointed out that their dislike of the odor diminished rapidly with 
familiarity. This finding might indicate olfactory fatigue or adaptation 
to the odor.
(b) Systemic Effects
General systemic effects resulting from exposure to ACETONE and to 
METHYL ISOBUTYL KETONE have been described by several investigators. A 
1903 report [22] described the death of a 12-year-old boy who lapsed into a 
state resembling a diabetic coma after a large celluloid dressing dampened 
with acetone had been applied.
In 1952, Harris and Jackson [23] described a case of acute ACETONE 
poisoning in a 10-year-old boy. He was exposed to acetone vapor at an 
unknown concentration in a warm room (about 82 F) while a lightweight hip 
cast was applied, reaching from nipple level to the right ankle, and 
including the left thigh. The cast consisted of glass and textile bandages 
set with a mixture of 90% acetone, 9% pentane, and 1% methyl salicylate.
About 8 hours after the cast was applied, the boy became restless, 
complained of a headache, and felt that the cast, although it fit loosely, 
was tight across his abdomen [23]. Approximately 4 hours later, he 
vomited, and persistent vomiting began 1.5 hours later. The patient became 
more restless, and, within 15 minutes, he collapsed. The cast was slit 
down the side but not removed. Eight hours after the original symptoms 
appeared, the boy was pale and almost stuporous. He continued to vomit, 
and his blood pressure was 80/60. His spontaneous speech was incoherent, 
although he could answer questions correctly. About 12 hours after the
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original symptoms were noted, the cast was removed. The inside of the cast
was wet and sticky and smelled of acetone. The skin that had been touching
the cast was apparently unchanged.
An hour after the cast was removed, the patient fell into a deep
sleep [23]. Three hours later, he was extremely ill and apathetic, and his
respiration was rapid, deep, and irregular. His pulse rate was 132 and his
blood pressure was 120/70. After taking a drink, he vomited a brownish 
material that gave a positive benzidine reaction, indicating that there was 
blood in the stomach. The urine contained acetone, diacetic acid, and
sugar. The concentration of acetone in the blood about 6 hours after the 
cast had been removed was 15 mg/100 ml. (Normal values for acetone range 
from 0.3 to 2.0 mg/100 ml blood according to a table in Stedman*s Medical 
Dictionary which probably lists values for adults [6]).
Supportive therapy consisting of intravenous (iv) administration of 
dextrose in saline was given following a presumptive diagnosis of acetone 
poisoning [23]. The patient’s condition returned to almost normal after 
about 16 hours of therapy, although the smell of acetone on his breath was
still noticeable. By the 4th day, his condition was normal, and no acetone
was detected on his breath or in his urine.
Harris and Jackson [23] pointed out that they could not distinguish 
the relative amount of acetone absorbed through the lungs from that 
absorbed percutaneously. They stated that this patient had a habit of 
sleeping with his head under the covers, which would have increased the 
respiratory exposure. The authors thought skin absorption might have 
occurred, and they stated that previous work to determine skin absorption 
of acetone had not provided contact as extensive or as intimate as that
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seen in this case. It is not clear whether the patient's illness was 
caused by skin absorption or inhalation of acetone or by both. One other 
study [24], however, described in detail a case where apparently less skin 
contact did not result in acetone absorption; this is discussed in more 
detail in Subsection (e) of this chapter. In addition, the possible 
contribution of pentane or methyl salicylate to this poisoning was not 
considered by the authors.
Ross [25] described adverse health effects in eight male workers, 
aged 30-57 years, who were exposed to acetone vapor. Four of them had been 
cleaning out a pit, 12 feet deep, in an enclosed building. Two 10-gallon 
tanks of acetone and two 10-gallon tanks of 1,1,1-trichloroethane were 
stored nearby. Draeger tube measurements in the pit, made 3 hours, 18 
hours, and 1 week after the exposure, revealed acetone concentrations in 
excess of 12,000 ppm (28,440 mg/cu m) and 1,1,1-trichloroethane levels up 
to 50 ppm.
The workers in the pit noticed a "sweet sickly smell" and complained 
of throat and eye irritation, weakness of the legs, and headache during the 
morning shift [25]. After returning to work from lunch, one worker 
fainted, and several of the workers felt dizzy and lightheaded and reported 
weakness in the legs. One of the workers noted the dizziness and weakness 
after an exposure of 2 minutes. Urine samples from five of the eight 
workers taken 90 minutes after the original exposures showed acetone levels 
of 4.6-7.15 mg/100 ml of urine. Urine specimens taken from two other 
workers 45 hours after the episode showed a trace of acetone in one and 2.4 
mg/100 ml in the other. Urine specimens collected from the eight workers 7 
days after the exposure showed acetone concentrations ranging from 0.39 to
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1.29 mg/100 ml. The diagnosis of "acute acetone intoxication" was made for 
these workers on the basis of their symptoms, urinary acetone 
concentrations, and environmental concentrations of airborne acetone. The 
authors did not consider the measured concentration of 1,1,1- 
trichloroethane (50 ppm) sufficient to cause adverse effects. Data 
presented by NIOSH in Criteria for a_ Recommended Standard....Occupational 
Exposure to 1,1,1-Trichloroethane (Methyl Chloroform) [26] are consistent 
with this conclusion. In that document NIOSH recommended an environmental 
limit of 350 ppm (1,910 mg/cu m) as a 15-minute ceiling. The effects 
observed in these workers indicate that acetone concentrations in excess of
12,000 ppm (28,440 mg/cu m) are an acute health hazard. The narcosis 
induced by acetone is cause for special concern, since it implies that 
exposure to acetone at lower concentrations may cause impaired judgment or 
other behavioral effects that could affect the health and safety of 
workers. These data, however, do not permit determination of a threshold 
value for judgmental impairment.
Parmeggiani and Sassi [27] investigated the effects of acetone in a 
collodion preparation department of a plant engaged in the production of 
cellulose acetate fibers. Eight workers had to dismantle a filter and 
replace the filter element, the two operations lasting about 3 hours. For 
the remainder of the day, these workers were not exposed to acetone. 
During removal, mounting, and changing of the filter, acetone
concentrations ranged from 307 to 918 ppm (730 to 2,180 mg/cu m). The
acetone concentration was determined following preliminary absorption in
distilled water, apparently with an impinger. The specific method of 
analysis was not described. The temperature in the filter rooms was
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maintained at 38-40 C (100-104 F). The authors examined the effects of 
acetone on seven of these workers, aged 19-53 years, who had been employed 
from 6 months to 13 years.
The first worker loaded the mixers, where acetone at a concentration 
of 25 ppm (60 mg/cu m) was found [27]. Examinations showed hyperemia of 
the conjunctiva and pharynx, rough breathing with some basal rhonchi, and 
slight choleduchol duodenal pain on palpation. He complained of asthenia, 
somnolence, occasional dizziness, and insomnia.
Of the other six workers who were exposed at 309-918 ppm, all 
complained of somnolence, four had eye and throat burning, two felt dizzy, 
and two felt inebriated, one had epigastric pain, one had a heavy head, and 
one complained of headaches [27]. The results of examination of one man 
were normal, but five had evidence of pharyngeal irritation, three had 
conjunctival irritation, and four had signs of lung irritation.
Although the authors [27] did not describe the method of analysis, 
and the temperature of the room may have contributed to the effects, this 
study does show that exposure to acetone at concentrations less than 1,000 
ppm can cause harmful effects.
Parmeggiani and Sassi [27] also studied the elimination of acetone in 
workers. Based on a study in which acetone was administered orally to 
volunteers and then determined in the blood and breath, they were able to 
calculate a theoretical distribution ratio. Thus, in workers exposed to 
acetone for 3 hours at 833 ppm (2,000 mg/cu m), twice each shift with a 1- 
hour rest between exposures, the authors found an average concentration of 
190 mg/liter at the end of work. They calculated that this corresponded to 
a blood acetone level of 85.5 mg/liter. Sixteen hours after the end of the
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workshift, the concentration of acetone in the expired air declined to 32 
jug/llter, which was equivalent to 14.5 mg/liter in the blood, according to 
the authors. In the opinion of the investigators, this was evidence that 
exposure to acetone at concentrations slightly less than the present 
Federal standard could lead to accumulation in the body. They added that, 
by the end of the weekend, ie, 48 hours after exposure, the acetone had 
disappeared.
Vigliani and Zurlo [28] discussed the health of factory workers who 
had been exposed to acetone at a concentration of 1,000 ppm (2,370 
mg/cu m), 3 hours/day, for 7-15 years. These workers appeared to have been 
the same as those studied by Parmeggiani and Sassi [27], although the two
reports differ in some details. All of the workers examined had 
inflammation of the respiratory tract, stomach, and duodenum and occasional 
dizziness and loss of strength. Similar effects were also reported in 
workers exposed at 700 ppm, (1,660 mg/cu m), but the authors did not 
specify whether this was a short- or long-term exposure. Exhaled air of 
workers exposed at 1,000 ppm for 3 hours/day at the end of the workshift 
contained 0.2 mg of acetone/liter and their urine contained 160 mg/liter. 
The next morning, acetone was detected at concentrations of 0.03 mg/liter 
in exhaled air and at 10 mg/liter in the urine. On Monday morning, no 
acetone was detected in exhaled air. The concentration of acetone in the
urine at this time was not reported.
Gitelson et al [29] examined the development of clinical signs in a
42-year-old man who had ingested about 200 ml of acetone. An hour later, 
he was stuporous, with flushed cheeks, shallow respiration, and a regular 
pulse rate of 108. His temperature and blood pressure were normal, and,
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although his abdominal reflexes were absent, he had normal tendon reflexes.
His throat was red and swollen, and erosions were observed on the soft
palate and around the entrance to the esophagus. His breath smelled 
strongly of acetone. His urine showed traces of albumin and a few hyaline 
casts and leukocytes but no sugar. It was strongly positive for acetone 
and acetoacetate.
The patient lapsed into a coma shortly after he was admitted to a 
hospital [29]. He was given supportive therapy and regained consciousness 
about 12 hours later. Six days later, he had pain when he moved his legs 
or hips, and he had hyperesthesia of the legs that gradually disappeared
over 2 months.
Four weeks after ingesting the acetone, the man noticed an increased 
fluid intake and urine output [29]. An oral glucose tolerance test 2.5
months after the ingestion gave values in the diabetic range, although no 
family history of diabetes was reported. Another glucose tolerance test 
2.5 months later gave values in the high normal range. During this test, 
the patient's urine contained a considerable amount of sugar.
Gitelson et al [29] stated that the cause of the persistent 
hyperglycemia in this patient was unknown, but, in referring to published 
case reports, they mentioned that this effect had also been seen in other 
patients with acetone poisoning. They speculated that the hyperglycemia 
might have resulted from an increase in acetoacetate caused by a metabolite 
of acetone.
In 1964, Linari et al [30] reported on a study of 19 employees who 
worked with METHYL ISOBUTYL KETONE for 20-30 minutes daily during an 8-hour 
shift. The ketone was mixed with other substances, including acetone [31],
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and the workers centrifuged the resulting suspension. Analysis of the 
workplace air showed methyl isobutyl ketone at 500 ppm (2,050 mg/cu m) near 
the centrifuge while it was operating and at 80 ppm (328 mg/cu m) at the 
far sides of the room [30]. The authors noted that the concentration of 
methyl isobutyl ketone was either minimal or undetectable at the end of the 
centrifuging operation and that the workplace was naturally aerated and had 
forced ventilation. The workers were required to wear appropriate masks 
during the operation.
Weakness, loss of appetite, headache, burning in the eyes, stomach 
ache, nausea, vomiting, and sore throat were reported by more than half of 
the workers [30]. Insomnia, somnolence, heartburn, and intestinal pain 
were less frequent. Four workers had slightly enlarged livers, and six 
workers had a nonspecific form of colitis. Skin lesions, found in three 
workers, varied from erythema to small areas of peeling after an initial 
dry dermatitis. The results of the clinical chemistry tests were 
essentially normal, with only slight variation. Skin lesions disappeared 
after workers used protective gloves and creams, suggesting that contact 
with liquid ketone was largely responsible for the dermal effects.
Linari et al [30] concluded that methyl isobutyl ketone irritated the 
conjunctiva and respiratory tract and produced disturbances of the 
gastrointestinal tract and CNS. While this conclusion is probably correct 
(ie, it seems likely that methyl isobutyl ketone could produce the effects 
noted), the possible role of other contaminants, such as acetone, seems not 
to have been evaluated.
In a followup study, Armeli et al [31] reexamined 14 of the original 
19 workers studied by Linari et al [30]. As in the first study, clinical
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chemistry tests were performed and work histories were taken. The authors 
[31] noted that, in the 5 years since the first study, work practices had 
been greatly improved. In addition, all workers were required to wear air 
masks and gloves and to use barrier creams in operations where methyl 
isobutyl ketone was used. Analysis of the workplace air showed methyl 
isobutyl ketone at 100-105 ppm (410-431 mg/cu m) near the centrifuge and 50 
ppm (205 mg/cu m) at the sides of the room. The authors noted that 
exposures lasted for 15-30 minutes daily.
Armeli and coworkers [31] reported that the results of clinical 
chemistry tests (red blood cell count, urine sedimentation, liver function, 
serum protein electrophoresis, glycemia, cholesterolemia, and lipid 
fractions) were essentially normal. The symptoms reported in the earlier 
study had nearly disappeared. Dermal lesions were also markedly reduced, 
but slight liver enlargement persisted in two workers. A few workers still 
reported CNS and gastrointestinal disturbances. The authors concluded that 
the improvements in work practices and engineering controls had reduced the 
symptoms of adverse effects. However, this study suggests that exposure to 
methyl isobutyl ketone at 50-105 ppm may produce harmful effects on 
workers.
In a written communication to the ACGIH TLV committee (GD Ware, June 
1973), a copy of which was given to NIOSH during preparation of this 
document, it was reported that workers exposed to IS0PH0R0NE at 5-8 ppm 
complained of fatigue and malaise. After improvements in ventilation, 
isophorone concentrations were lowered to 1-4 ppm, and there were no 
further complaints.
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(c) Effects on Skin
Dermal effects resulting from topical application of ACETONE were 
investigated by Lupulescu and Birmingham [32]. Small glass tubes 
containing about 1 ml of acetone were inverted on the right forearms of 
seven volunteers and held in place with tape for 90 minutes. Acetone was 
similarly applied to a second site that had been covered with a protective 
gel containing 50% water, 25% glycerin, 10-15% cellulose-methasol gum, and 
2-3% unspecified preservative. Only the protective gel was applied to a 
third site on the same forearm. After 90 minutes, skin appearance was 
checked, and 4-mm skin samples were taken by punch biopsy from the treated 
areas of the forearm. The tissue samples were immediately fixed and 
prepared for light and electron microscopy. For scanning electron 
microscopy, similar biopsy experiments were performed using larger samples. 
Control specimens taken before exposure were similarly examined.
Gross examination of the skin showed only mild edema and hyperemia 
after contact with acetone [32]. No abnormal features were observed on 
skin protected with the gel. A reduction and desquamation of horny layers 
with intercellular edema were observed by light microscopy in the specimens 
exposed to acetone alone. Vacuoles surrounding the nuclei of the cells of 
the epidermis, particularly the stratum spinosum, were seen with the 
electron microscope. The scanning electron microscope showed that, after
exposure to acetone, the cells of the stratum corneum were edematous, 
intercellular spaces were enlarged, and the desmosomes, which connect the 
cells, were broken apart. The usually organized pattern of the surface 
cells of the skin was not seen. Skin that had been protected with gel 
showed less severe effects under the scanning electron microscope.
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The data from this study [32] show that dermal exposure to liquid 
acetone for 90 minutes can produce gross changes of the skin and 
ultrastructural damage to the upper layers of the contacted skin.
(d) Effects on the Nervous System
Smith and Mayers [33], in 1944, described working conditions and 
health effects in two factories where ACETONE and METHYL ETHYL KETONE were 
used as solvents in the waterproofing of raincoats. In one factory, 
workers applied vinylite resins dissolved in methyl ethyl ketone or acetone 
to the raincoats with brushes. They were probably exposed through skin 
contact and inhalation of vapor. Room air samples in this factory showed 
methyl ethyl ketone at 398-561 ppm (1,170-1,650 mg/cu m) and acetone at 
330-495 ppm (782-1,170 mg/cu m). The sampling and analytical methods were 
not mentioned.
The authors [33] described two cases of possible ketone intoxication 
in this factory. One woman, 18 years old, developed gastric problems and 
watery eyes while at work. A few hours later, she was found unconscious
and was taken to a hospital. Acetone was detected on her breath, her
reflexes were hyperactive, and her face and limbs had occasional twitches. 
She had an elevated pulse (112 beats/minute), but her blood pressure was 
nopnal (128/70). Less than an hour after she was hospitalized, the woman 
had responded to nikethamide treatment, and a severe headache was the only 
effect still apparent. She was released from the hospital 2 days later.
The second worker was a 19-year-old woman who fainted at work [33]. 
She had a convulsion while unconscious but regained consciousness before
she was taken to a hospital. She was confused at the time of admission and
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suffered from a headache, but she had recovered enough to be released 
within an hour.
Because the women were exposed to acetone, methyl ethyl ketone, and 
vinylite resins, it is unclear whether the signs and symptoms were produced 
by exposure to only one of the compounds or were additive or synergistic 
effects from a combination of compounds. The effects, primarily in the 
CNS, may have been produced by both ketones since both cause CNS depression 
in animals according to a Public Health Service investigation [34],
In the second factory studied by Smith and Mayers [33], methyl ethyl 
ketone was used as a solvent for the resin with which the raincoats were 
made. Workers immersed their unprotected hands in the solvent, and they 
were also exposed by inhalation. Concentrations of methyl ethyl ketone in 
the workroom air ranged from 300 to 600 ppm (882-1,760 mg/cu m). Several 
workers had adverse health effects as a result of exposure. Some had 
dermatitis so severely that they could not work. Two men had dermatitis on 
the face that was attributed to exposure to methyl ethyl ketone in the air. 
Several workers experienced numbness in the fingers and arms, and one had a 
similar effect in the legs, which weakened when he tried to walk. Another 
worker stated that his shoulder felt as though it was made of dough and did 
not belong to him.
In 1971, Berg [35] reported a case of retrobulbar neuritis in an 18- 
year-old seaman who had been exposed to METHYL ETHYL KETONE while removing 
paint from an airplane hangar. Two other men who also were exposed had 
only mild respiratory symptoms and conjunctival irritation. The seaman 
noted a dull headache, mild vertigo, and diminished vision in both eyes. 
Two hours after exposure, he was alert, but his vision in both eyes was
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"reduced to counting fingers." His vision, which had been 20/20 when he 
began military duty, was now 20/200. At this time, he had blurred vision, 
lightheadedness, and nausea. Although the conjunctivae were slightly
congested, the results of an ophthalmoscopic examination were normal.
Testing showed marked enlargement of the blind spots and superior arcuate- 
type defects in both eyes. The author noted that the man's clothing had an 
odor like that of acetone.
About 10 hours after exposure, the man's blood was analyzed for the 
first time, and unspecified amounts of methanol and formaldehyde were found
[35]. Thirty-six hours after exposure, his vision had returned to 20/20 
and his visual fields were normal. Daily analysis of blood serum showed no 
formaldehyde and steadily decreasing levels of methanol. Throughout his 6- 
day hospital stay, he noted a daily lessening of his dizziness and nausea.
Berg [35] postulated that the subject had optic nerve toxicity
induced by methanol formed from the metabolism of methyl ethyl ketone. 
Berg did not rule out the possibility that methanol itself was the cause of 
the illness, although he pointed out that methanol toxicity produced a 
different clinical picture.
In 1975, Viader et al [36] investigated a case of peripheral 
neuropathy in a 55-year-old worker exposed to methyl ethyl ketone and other 
compounds. The worker was hospitalized in January 1974 for a loss of
muscular strength in his hands, bilateral paresthesia of the fingers, and
fatigue when he walked. He had a moderate weakness in all muscles of both 
hands, predominantly in the extensors of the fingers and the dorsal
interosseal muscles, as well as weakness of the anterior tibial
compartments of the legs. Tendon reflexes were present and normal, and
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there was no amyotrophy or fasciculation. All signs of objective 
sensitivity were normal.
Viader et al [36] reported that an electromyogram showed peripheral 
neurogenic signs in all four limbs. Motor conduction velocities were 
slowed slightly in the external popliteal branch of the sciatic nerve. The 
man had no history of alcoholism, and his serum lead concentration (0.20 
mg/liter) was normal. The authors noted that, 2.5 months after the worker 
was hospitalized, he had only a moderate weakness of the extensors of the 
fingers and the interossei of both hands and that his condition was judged 
to be further improved 10 months after the initial examination.
For 2 years before he was hospitalized, the worker had used a special 
adhesive and solvent to set plastic pipes into trenches about 2 meters deep
[36]. Analysis of these products showed that the adhesive was 60%
tetrahydrofuran and 40% polyester-type polymer. The solvent used to
dissolve the adhesive was said to be 100% methyl ethyl ketone, but it is 
not clear if an analysis was performed. The author reported that the 
worker had manipulated the adhesive without gloves, cleaned his hands with 
the solvent, and inhaled the vapor at the bottom of the trench without a 
mask. Viader et al noted that the symptoms were similar to those of methyl 
n-butyl ketone poisoning (described in the study by Allen et al [37] 
discussed below). The authors concluded that the illness was caused by 
tetrahydrofuran, methyl ethyl ketone, or a combination of these agents.
Although there is little doubt that this worker had signs of neurotoxicity,
it is not clear what the causative agent was.
In August 1973, a case of severe peripheral neuropathy was diagnosed 
in a 22-year-old man who had worked for 2.5 years in the printing
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department of a coated-fabric plant in Ohio, where some 275 chemicals, 
including METHYL ETHYL KETONE and METHYL n-BUTYL KETONE were used [37,38]. 
Since he was otherwise healthy, the symptoms were thought to be associated 
with exposure to a toxic chemical. The worker indicated that several 
others in the printing department had similar symptoms. An investigation 
was begun to identify neuropathy in other workers at the coated-fabric 
plant and to determine the causative agent. The investigation was 
conducted and supervised by a team of consultants from the company, the 
union, a hospital, the state health department, NIOSH, and the Center for 
Disease Control. The results of the investigation, discussed in detail in 
Epidemiologic Studies, implicated methyl n-butyl ketone as the probable 
cause of the neuropathy.
Allen et al [37] described the symptoms of the 22-year-old worker, 
which they considered to represent a typical case of motor and sensory 
neuropathy. He first noticed intermittent tingling sensations in his arms 
and legs, as if his limbs were "asleep"; those sensations progressed to 
weakness of the left leg about 3 months later. The leg weakness became 
worse, footdrop developed, and he had impairment of grip. The man lost 15 
pounds over 8 months and was hospitalized after his condition was diagnosed 
as peripheral neuropathy. Physical examination showed prominent atrophy 
and occasional fasciculations of the intrinsic muscles of both hands. The 
man had severe weakness of the finger extensors and the dorsal and ventral 
interossei muscles and moderate weakness of the finger flexors and wrist 
pronators, supinators, extensors, and flexors. He also had moderate 
weakness of the iliopsoas, slight involvement of the quadriceps and hip 
adductors, bilateral footdrop, and severe weakness of the gastrocnemii, toe
50
extensors, and toe flexors. Except for absent finger jerks, reduced knee 
and hamstring reflexes on the right, and absent ankle jerks, the tendon 
reflexes were normal. Sensory testing showed a dense, bilateral loss of 
fast pricking pain over the toes, soles, and heels with a milder loss in 
the knees and similar defects in the hands up to the wrists. Temperature 
discrimination was impaired up to the knees, and light touch sensation was 
lost over the toes and fingers. Right peroneal nerve conduction velocity 
was slowed. Deep sensation was normal. Electromyography showed positive 
waves and fibrillations in many muscles. Other laboratory findings were 
essentially normal. Eight months after the man was hospitalized, his 
condition had markedly improved.
The authors [37] also described a case of motor neuropathy in a 43-
year-old man who had been a pan washer at the coated-fabric plant for 18
years. He first noted a tendency of his knees to give way; this was 
followed by difficulty in picking up his feet, lifting heavy objects, and 
gripping small objects with his fingers. He reported a recent 25-pound 
weight loss. He was hospitalized and was found to have moderate, distal 
weakness of the arms and legs and mild, proximal weakness of the legs. 
Tendon reflexes and the results of sensory examinations were normal. An 
electromyogram showed positive waves and fibrillations in the distal 
muscles of the hands and a slowing of peroneal conduction velocities. 
Other laboratory findings were essentially normal. The man's condition was 
diagnosed as peripheral neuropathy of an undetermined origin. The
condition of the man steadily improved, but he had slight weakness in the
left ventral interossei. Otherwise, his strength was normal, and there was 
no atrophy.
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Allen et al [37] next described a case of sensory neuropathy. A 55- 
year-old man, who had been a print operator for 27 years in the coated- 
fabric plant, first had a continuous sensation of his toes being "asleep," 
aching pain in the calf, and occasional momentary loss of balance or a 
feeling of lightheadedness. He also noted general fatigue, especially when 
carrying heavy loads. The man estimated that he had lost 50 pounds over 
the last 10 months. The results of a motor examination were entirely 
normal, showing completely normal strength and no atrophy or fasciculations 
in any muscle groups. All tendon reflexes were present and normal. 
Sensory examinations showed a decrease in temperature discrimination, in 
fast pricking pain, and in light touch over the entire right foot to the 
ankle and on the toes of the left foot. There was a similar sensory loss 
in all of the fingers of the right hand and in the fingertips of the left. 
Deep pain and position senses were normal. An electromyographic 
examination showed positive waves and fibrillations in extensor and flexor 
hallucis longus muscles. A followup examination, 7 months after the 
initial symptoms began, showed substantial improvements, but the man still 
had numbness of the toes and a loss of discrimination of superficial pain, 
temperature, and touch in both large toes. Electromyography showed only 
occasional positive waves without fibrillations in the left extensor 
hallucis longus.
In screening 1,157 employees by electrodiagnostic examinations, 
interviews, and a questionnaire, Allen et al [37] identified 194 suspected 
of having peripheral neuropathy or other neurologic disorders. These 
employees were examined by electromyography and laboratory studies and were 
later given followup examinations. Eighty-one were either normal or showed
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results that were of doubtful importance to the study. Twenty-seven had 
neurologic disorders other than toxic polyneuropathy, such as diabetic 
neuropathy. Toxic polyneuropathy was diagnosed in 86 workers. Eleven of 
these had characteristic, disabling, peripheral neuropathy that was rated 
moderate to severe, and 38 had signs of neuropathy and characteristic 
electrodiagnostic abnormalities that were rated mild. Of the 86, 37 had no 
objective clinical findings, but they did have characteristic 
electrodiagnostic abnormalities and were classified as having minimal motor 
involvement.
The authors [37] described the neurologic pattern as a distal, motor, 
and sensory disorder that had an insidious onset with minimal loss of 
reflexes. Initial symptoms in those workers with prominent motor 
involvement included slowly developing weakness of the hands or feet 
accompanied by slapping gait or by difficulty moving their fingers or 
grasping heavy objects. Others had intermittent tingling paresthesia of 
the hands or feet. Pain was minimal or absent. Of the 10 patients in the 
group moderately to severely affected, in which body weight was monitored, 
8 experienced weight losses ranging from 3-60 pounds. In the milder cases, 
no substantial weight changes were observed.
In the 11 moderate to severe cases, a combination of motor and 
sensory loss or of motor and reflex loss was observed [37], In the 38 mild 
cases, sensory loss predominated. Muscle weakness commonly involved the 
intrinsic muscles of the hands and feet and the long extensors and flexors 
of the digits. Sensory loss was roughly symmetrical and was usually 
confined to the feet or fingers. Loss of reflexes was minimal, and no 
evidence of autonomic dysfunction was seen. Cranial nerve abnormalities
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were noted in only one patient, who had unilateral sensory loss on the
face. The authors noted that about one-sixth of the affected subjects 
continued to show progressive dysfunction for 3-5 months after all 
possibility of exposure had been eliminated.
Summarizing their electrodiagnostic findings in these workers, the 
authors [37] stated that electromyographic abnormalities were approximately 
symmetrical and were either restricted to a distal distribution or greater 
in degree in distal muscles than in proximal ones. In the moderately to 
severely affected group, positive waves and fibrillations were found in all 
11 employees. Eight of these workers also had abnormal motor unit 
potentials. In the 38 mild cases, 31 had positive waves, 22 had
fibrillations, and 23 had motor unit potential abnormalities. In the 37
cases of minimal involvement, 29 had positive waves, 16 had fibrillations, 
and 16 had abnormalities in motor unit potential. After serial
examination, positive waves and fibrillations subsided, but polyphasic and 
abnormally large motor unit potentials became more abundant. The authors 
noted that, in general, electromyograms and nerve conduction velocities 
correlated with the clinical severity of neuropathy. The results of 
clinical chemistry tests were within normal ranges; however, significantly 
lower erythrocyte cholinesterase activities (P<0.001) and significantly 
higher plasma cholinesterase activities (P<0.001) as compared to volunteers 
and neurologically normal patients were found. Cholinesterase activities 
did not correlate with severity of the neuropathy. The significance of the 
lower erythrocyte cholinesterase activities and elevated plasma 
cholinesterase activities is not clear, though liver cell damage might 
explain the changes in plasma esterases.
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To determine the causative agent, Allen et al [37] and Billmaier et 
al [38] investigated the processes and chemicals used in the plant and 
correlated this information with the incidence of polyneuropathy in various 
departments. These findings are reported in Epidemiologic Studies.
In 1976, Mallov [39] reported on spray painters who had worked with
two formulations of paint on the Cannelton Dam and the Newburgh Dam. The
older formulation contained 22% methyl isobutyl ketone and 22% methyl 
isoamyl ketone. In the new formulation, these two solvents were replaced
by 44% methyl n-butyl ketone. Both formulations contained 3.1% of a
tricresyl phosphate plasticizer. Gas-liquid chromatographic analysis by 
NIOSH did not detect triorthocresyl phosphate in the paint. The limit of 
sensitivity of this method was 0.1% by weight. The new formulation,
containing methyl n-butyl ketone, was first used sometime after September 
15, 1972, at Cannelton, where over 22,900 liters were used; at Newburgh, it 
was first used sometime after July 1972. Because there were no handwashing 
facilities, some workers washed their hands with paint thinners, including
one containing methyl n-butyl ketone. Twenty-six men who worked at the two
sites were examined, and medical and occupational histories were taken
during the spring of 1974. Three men had clinical evidence of peripheral
neuropathy.
One of the men with peripheral neuropathy was a 42-year-old painter 
who had worked on the Cannelton Dam from September 1972 until August 1973 
[39]. In July 1973, he complained of weight loss, numbness and tingling in 
his feet, and a progressive weakness in both legs which progressed to his 
arms. His condition deteriorated so that he could not stand up without
help or even turn a key in a lock. Examination showed bilateral footdrop
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and an absence of ankle jerks, knee jerks, and brachioradialis reflexes. 
Sensation was mildly diminished or normal in the fingers and feet 
bilaterally. An electromyogram showed an increase in insertional activity, 
fibrillation potentials, positive sharp waves, and many polyphasic muscle 
potentials. The left median nerve latency was increased, while the 
conduction velocity was decreased. Alcoholism, diabetes, cancer, uremia, 
collagen diseases, and porphyria were ruled out as causative agents. Blood 
lead levels were mildy elevated (55 jug/100 ml), but a 24-hour urine sample 
contained normal lead levels (67 jug/liter). Normal and elevated levels 
were judged from statements taken from a chapter on metal poisoning in a 
medical text book [40]. An EDTA provocative test indicated a previous 
absorption of lead that was described as excessive. The worker had used 
lead paint extensively until 1.5 years before the onset of his illness. 
These blood and urine lead levels were probably not sufficiently high to 
have been associated with neuropathy, but a high body burden sufficient to 
have caused neuropathy may have existed.
The second case was that of a 35-year-old man who had been a painter 
at Cannelton from April to October 1973 [39]. His initial symptoms were 
tingling in his extremities, burning and freezing sensations in the soles 
of his feet, cramps in his calves, and weakness in his legs and hands. The 
worker eventually was unable to rise from a sitting position without help, 
and he could not push down the top of his shaving-cream can. Examination 
showed a bilateral footdrop and a left wristdrop. Muscle weakness was 
apparent in the distal muscles of the arms and legs and in the proximal 
muscles of the legs. Reflexes in both legs were said to be markedly 
diminished. His condition subsequently improved, but the absence of ankle
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jerks and weakness in the foot persisted. Sensation was mildly impaired 
distal to the midcalf and midforearm. Two 24-hour urine specimens 
contained normal levels of lead (5.1 and 8 /ng/liter). Nothing was found in 
the man's medical history to explain his condition.
The third case was that of a 43-year-old painter who had worked at 
the Cannelton Dam from September 1970 to April 1972 and from October 1972 
to April 1973 [39]. He had also worked at the Newburgh Dam from April 1972 
to October 1972 and from April 1973 to November 1, 1973. In October 1973, 
he noticed weakness in his feet, legs, and hands and numbness and tingling 
in his hands and feet. He noted in November that his feet were slapping 
down consistently when he walked, and he fell 25-30 times during the last 
few weeks of November and the 1st week of December. During this time, he 
had constant numbness in both feet and legs below the midcalf, and he 
experienced numbness in his hands and wrists for several hours two or three 
times each day from November 1 until the middle of December. He also had 
transient tingling on the backs of his hands, which was provoked by 
rubbing, and steady aches in his calves. When he was examined 3.5 months 
after the onset of his illness, he no longer had sensory symptoms but his 
lower extremities still felt weak. He also had an absent right ankle jerk, 
weakness in his right foot, and diminished pinprick, light touch, and 
vibratory sensation in his right foot. Blood lead levels were normal (25 
jug/100 ml). Mallov [39] stated that all three workers, according to their 
work histories, had ample opportunity for respiratory and skin absorption 
of methyl n-butyl ketone and that all had developed neuropathy within 4 
months of each other. The first patient had the greatest opportunity for 
skin absorption, since he did not wear gloves and changed his work clothes
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only once a week. Mallov stated that, although the first patient had a 
previous exposure to lead, lead probably did not play a role in his 
neuropathy, because sensory loss is not characteristic of lead neuropathy. 
Mallov also believed that the tricresyl phosphate present in the paint had 
no relationship to the onset of neuropathy, since none of the ortho-isomer 
was present and since tricresyl phosphate had been used by the Army Corps 
of Engineers for 24 years without incident.
Davenport et al [41] have also described a case of progressive 
polyneuropathy in a 35-year-old furniture finisher. Unlike his coworkers, 
the man sometimes did not use his face mask and he often used a thinner to 
clean his hands. Six months before the man became ill, the manufacturer of 
the lacquers and solvents used in this process had substituted methyl n- 
butyl ketone for methyl isobutyl ketone on a volume for volume basis.
Methyl n-butyl ketone was present in a concentration of 20% in the finish, 
12% in the thinner, and 7% in the sealer. Toluene, xylene, n-butyl
alcohol, and acetone were also present in various proportions, and the
thinner contained 5% methanol.
The man first noticed tingling in his feet and mild clumsiness while 
walking. Two weeks later, he was unable to walk. He also developed
paresthesia in his fingers. Three months later he was much stronger and 
was able to walk unassisted. A sural nerve biopsy taken at this time 
showed enlarged axons and axons packed with fine filaments measuring 10-15 
nm in thickness, which were very similar to those described by Allen et al
[37].
RL Barnes (written communication, January 1978) informed NIOSH of the 
occurrence of peripheral neuropathy in workers employed in a dewaxing unit
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of a Texas refinery. The dewaxing unit uses a conventional solvent
extraction method for removing high melting point hydrocarbons from 
petroleum to produce oils with adequate lubricating properties over a broad 
temperature range. This process involves mixing methyl ethyl ketone and 
toluene with various petroleum fractions. Airborne methyl ethyl ketone and 
toluene were found in the workroom.
NIOSH initiated a health hazard survey of this operation, but, until 
the investigation and data evaluation have been completed, no conclusions 
can be drawn at this time.
(e) Absorption and Excretion Studies
Cesaro and Pinerolo [24] studied the percutaneous absorption of 
ACETONE in volunteers. Eight healthy men with no evident physiologic 
disturbances were enclosed nude in a sealed box for 20-30 minutes with 
their heads protruding through a hole in the box. Cotton compresses were 
used in an attempt to saturate the chamber with acetone. Each subject 
breathed through a rubber mask with tubes leading to another room. Acetone 
was sprinkled on each subject's skin with a cotton compress during the 
exposure. Total ketone bodies in the blood, which included preformed 
acetone and acetone derived from diacetic acid or beta-oxybutyric acid, was 
determined before and immediately after exposure. The average value before 
exposure was 0.89 mg%, while after exposure it was 0.90 mg%. They 
concluded that acetone was not absorbed through healthy human skin.
Using the apparatus of Cesaro and Pinerolo [24], Parmeggiani and 
Sassi [27] studied the percutaneous absorption of acetone. The method was 
the same except the subject lightly applied acetone to his skin with a 
saturated cotton pad for 30 minutes. A total of 15 g of acetone was used.
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The subject was then kept in the chamber for 1.5 hours. After the 
exposure, blood acetone levels were 40 mg/liter as compared with only a 
trace before exposure. Acetone concentrations in the urine were 10 
mg/liter before exposure and 70 mg/liter at the end of exposure. These 
data indicate that acetone was absorbed through the skin. The apparent 
contradiction between these results and those obtained by Cesaro and 
Pinerolo are most likely attributed to the longer period of exposure. 
Also, there was a greater chance in this study for liquid acetone to 
contact the skin. From these studies, it appears that percutaneous 
absorption of acetone is dependent on the extent of exposure.
DiVincenzo et al [42], in 1973, reported acetone excretion and blood 
chemistry changes in humans exposed to acetone vapor. Nine male employees, 
aged 22-62 years, volunteered to participate in the experiment, but 
participation was contingent on medical approval. It is unclear whether 
all nine participated in the experiments. Those that did participate 
fasted for 8 hours before they were exposed to acetone at 100 or 500 ppm
(237 or 1,185 mg/cu m), followed by 2 hours at rest, 2 hours with exercise,
or 4 hours at rest. They avoided using toothpaste and mouthwash because 
they might contain contaminants that could interfere with the analysis.
Those who exercised either remained seated or jogged for 5 minutes and
rested for 10 minutes. Before exposure and 24 hours later, blood samples 
were collected for hematologic and clinical chemistry testing. Exhaled 
breath, venous blood, and urine samples were also collected at regular 
intervals during and after exposure. These samples were analyzed for 
acetone by gas-liquid chromatography. The authors [42] concluded that 
there was no appreciable change in the blood chemistry of any of the
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subjects exposed to acetone at 100 or 500 ppm for 2 or 4 hours. However, 
for those exposed for 4 hours, no clinical data (blood chemistry) were 
reported. It is unclear, in addition, whether or not the clinical data 
presented were those for men who exercised; since the authors reported a 
twofold increase in acetone absorption during exercise, which was not 
reflected in an increase in the urine acetone concentration, the clinical 
data for men who exercised might have differed from those who did not 
exercise.
Analysis of the subjects' expired air during the 2-hour exposures and 
up to 7 hours afterwards showed that, after the first 15 minutes,
approximately 75-80% of the inspired vapor was absorbed by the blood and 
20-25% remained in the dead space volume [42], The ratio of acetone 
absorbed to that eliminated remained constant during exposure, indicating 
that body compartment saturation did not occur. The exposure concentration 
of acetone and the concentration in the expired air were directly
proportional both during and after exposures. The wash-out curves of the 
vapor showed that, up to 7 hours after exposure ended, acetone was not 
entirely eliminated from the body. However, data on the normal 
concentration of acetone in expired air were not given. The character of 
these curves suggested to the authors that repeated daily exposures at 
higher concentrations would allow acetone to accumulate in the body.
The concentrations of acetone vapor in the breath also depended on 
length of exposure and intensity of exercise during exposure at 100 ppm for 
2 hours [42]. Increasing the exposure from 2 to 4 hours caused an increase 
in postexposure respiratory excretion of acetone, but the excretion was
less than twice that measured for the 2-hour exposure. The significance of
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these findings is uncertain because of the small number of subjects used in 
the study and the wide variation in concentrations. Assuming the uptake to 
be directly dependent on time and concentration, this decrement indicated 
that excretion was carried out through other routes, such as urinary or 
percutaneous, or that metabolic breakdown of the acetone was occurring. 
The increased excretion in the exercising subjects indicated that the 
increase in minute volume resulting from the exposure was responsible for 
an increased uptake of the acetone vapor.
Analysis of whole blood samples for acetone showed that a 2-hour 
exposure was not sufficient to produce steady-state conditions [42] . This 
exposure duration was too short to allow saturation of the body water 
compartment. The half-life of the acetone in the blood was calculated to 
be about 3 hours for subjects at rest who were exposed at 100 ppm for 2 
hours, and the authors concluded that their postexposure results indicated 
that acetone disappeared from the blood at a constant rate that was 
independent of the initial concentration (zero-order kinetics).
Analysis of urine for acetone did not show a relationship that was 
directly proportional to the exposure concentration [42]. However, no 
attempt was made to regulate urinary volume during the collection period, 
so this relationship might be directly proportional under rigorously 
controlled conditions.
DiVincenzo et al [42] concluded that the absorption of acetone by 
humans was directly proportional to the magnitude of exposure. They also 
pointed out that physical activity increased absorption and that absorption 
was related to the minute volume of air breathed. They suggested that, 
since the concentrations of acetone in expired air and blood were directly
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proportional to the extent of exposure, these indices might be used for 
biologic monitoring. The authors' finding that acetone can accumulate in 
the body is significant because it suggests that longer periods of exposure 
may produce toxicity.
Munies and Wurster [43] investigated the percutaneous absorption of 
METHYL ETHYL KETONE in volunteers. Absorption was studied using hydrous, 
anhydrous, and normal skin. An absorption cell that was previously 
described by Wurster and Kramer [44] was used to keep the ketone in contact 
with the forearm of the subject. For hydrous conditions, water was mixed 
with methyl ethyl ketone in the cell. For anhydrous conditions, the cell 
was first filled with magnesium perchlorate. Expired air was analyzed by 
gas chromatography. Exposures lasted 8 hours.
The authors [43] reported that methyl ethyl ketone was found in the 
expired air 2.5-3 minutes after contacting normal skin. A plot of the 
concentration of the ketone in expired air showed that a plateau value for 
elimination was reached in 2-3 hours. In anhydrous skin, the plateau value 
was reached in 4-5 hours. Under hydrated skin conditions, methyl ethyl 
ketone was found in the expired air within 30 seconds; the concentration 
rose to a maximum in a few minutes and then declined to a plateau in about 
2 hours.
The authors [43] supplied data on the analysis of one sample of 
expired air which showed chromatographic peaks corresponding to those for 
methyl ethyl ketone, acetone, acetaldehyde, methanol, and ethanol. Munies 
and Wurster did not discuss these results, but the data may indicate that 
these compounds represent biotransformation products of the methyl ethyl 
ketone used in this study. However, the data might also represent
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contamination of the methyl ethyl ketone used in this study inasmuch as the 
authors did not present any information on the source or purity of their 
sample. This investigation demonstrated that methyl ethyl ketone is 
rapidly absorbed through the skin and is rapidly excreted in the expired 
air.
In 1978, DiVincenzo et al [45] reported on the respiratory uptake, 
excretion, and skin absorption of METHYL n-BUTYL KETONE in humans. Three 
men, aged 22-53 years, were exposed to air containing methyl n-butyl ketone 
at 100 ppm (410 mg/cu m) for 4 hours and at 10 or 50 ppm (41 or 205 
mg/cu m) for 7.5 hours with a half-hour lunch break after 4 hours of 
exposure. For skin exposures, the absorption cell method of Munies and 
Wurster [43] was used to determine the absorption of liquid 14C-methyl n- 
butyl ketone and the influence of methyl ethyl ketone on the absorption of 
methyl n-butyl ketone in a 9:1 mixture (by volume). Fifteen milliliters of 
methyl n-butyl ketone or the ketone mixture, each containing 20 microcuries 
of l-14C-methyl n-butyl ketone, was placed in contact with a shaved area on 
the inner forearm for 60 minutes. Precautions were taken to ensure that 
the ketones were not inhaled. Skin absorption was calculated from the 12- 
hour cumulative excretion of radiolabeled methyl n-butyl ketone in breath 
and urine. Two volunteers also ingested 2 microcuries of l-14C-methyl n- 
butyl ketone in a dose of 0.1 mg/kg. The 12-hour cumulative excretion of 
radioactivity in breath and urine was compared with the 12-hour excretion 
from volunteers exposed by skin contact.
In humans exposed to methyl n-butyl ketone at 10 and 50 ppm for 7.5 
hours, the mean breath concentration was 1.4 and 9.3 ppm (5.7 and 38.1 
mg/cu m), respectively [45]. Fifteen minutes after exposure at 10 and 50
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ppm, the expired air contained 0.1 and 0.5 ppm (0.4 and 2.0 mg/cu m), 
respectively, and, 3 hours after exposure at 50 and 100 ppm, no methyl n- 
butyl ketone was found in the expired air. Exposure to methyl n-butyl 
ketone at 100 ppm for 4 hours produced an average breath concentration of 
22 ppm after 2 hours of exposure. The authors noted that between 75 and 
92% of the vapor inhaled was absorbed, with greater retention at lower 
concentrations.
During and after exposure at 10 or 50 ppm, no methyl n-butyl ketone
was found in the serum; however, it was detectable during exposure at 100
ppm [45]. Neither methyl n-butyl ketone nor its metabolites were detected 
in the urine during or after exposure. However, 2,5-hexanedione was found 
in the urine for 1-3 hours after exposure.
Two volunteers, given methyl n-butyl ketone orally, excreted a 
maximum amount of 14C-labeled carbon dioxide at 4 hours after exposure. 
Eight days after the subjects received methyl n-butyl ketone, 39.5% of the 
dose had been excreted in the breath, while 26.3% of the dose had been 
recovered in the urine.
Methyl n-butyl ketone was readily absorbed through the skin, both 
alone and in combination with methyl ethyl ketone. When only methyl n- 
butyl ketone was applied, two volunteers absorbed 16.0 and 26.8 mg, 
respectively, about 0.1% or more of the amount applied; when the mixture 
was applied, the amount of total solvent absorbed was reported as 14.0 and
18.7 mg. The authors reported that the absorption rates ranged from 4.2 to
8.0 /ng/minute/sq cm for pure methyl n-butyl ketone and the mixture with 
methyl ethyl ketone. However, it is not certain that the total solvent 
absorbed from the mixture contained methyl ethyl ketone and methyl n-butyl
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ketone in a 9:1 ratio, since radiolabeled methyl ethyl ketone was not used.
The authors [45] concluded that methyl n-butyl ketone was readily
absorbed through the lungs, gastrointestinal tract, and the skin and that 
it was metabolized by at least two pathways, one forming respired carbon 
dioxide and the other forming 2,5-hexanedione. The major metabolite was 
respiratory carbon dioxide.
DiVincenzo and colleagues [45] pointed out that the absorption of 
methyl n-butyl ketone through human skin can be substantial. Assuming that 
the surface area of the hands is about 0.074 sq m and that the rate of 
absorption of methyl n-butyl ketone was 5 jug/minute/sq cm, they calculated 
that 222 mg would be absorbed through the skin in 1 hour. By comparison, 
exposure to methyl n-butyl ketone at 25 ppm for 1 hour by inhalation would 
result in absorption of 92 mg, assuming a minute volume of 20 liters/minute 
and 75% absorption by the lungs. This study, then, demonstrates that
percutaneous absorption can be an important route of exposure to methyl n- 
butyl ketone.
Epidemiologic Studies
In 1973, NIOSH was involved in an intensive and concerted
occupational health investigation involving several state, Federal, and 
private organizations [46]. The purpose of this investigation was to 
determine the causative agent in an outbreak of peripheral neuropathy in 
workers employed in a coated-fabric plant. Allen et al [37] and Billmaier 
et al [38] reported their findings on this outbreak. Clinical findings 
from these workers and three typical cases of peripheral neuropathy, as 
reported by Allen et al [37], have been described in Effects on Humans.
Billmaier et al [38] also presented data on the same population, although 
they reported slightly different figures.
Additional cases of suspected neuropathy were initially identified in 
print department workers through clinical examination and a short 
neurologic history [38]. Workers suspected of having neuropathy received 
electrodiagnostic tests, including electromyogram and nerve conduction 
studies. Because these tests are objective and sensitive, the 
investigators then decided to use electromyograms and nerve conduction 
tests to screen all workers at the plant for evidence of subclinical 
peripheral neuropathy after slight abnormalities were found in the tests of 
selected workers not employed in the print department.
The electromyograms and nerve conduction tests of 192 of the 1,157 
workers examined (17%) had abnormalities that could be associated with 
peripheral neuropathy [38]. After the employees received clinical 
evaluations, the investigators classified findings on these 192 workers by 
using a rating scale based on signs, symptoms, and electrodiagnostic tests. 
They reported that findings from 72 workers were within normal limits, 24 
were not indicative of any definite abnormality, 28 were indicative of 
suspected abnormality, and 68 were indicative of peripheral neuropathy.
Using data from questionnaires or from company records, Billmaier et 
al [38] determined that, of those workers with definite evidence of 
peripheral neuropathy, 21.9% were from the print shop (38 of 173) and only 
3.0% were from other departments (30 of 984). The difference between the 
percentages is statistically significant (P<0.001, using a chi-square 
test). Twenty of the 68 workers had diabetes or other conditions that can 
cause or contribute to neuropathy; 2 worked in the printing department and
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18 worked in nonprinting departments. None of the workers in the 
nonprinting departments had severe peripheral neuropathy. Of the 38 
workers from the print department with peripheral neuropathy, 27 operated 
the printing machines, 10 were helpers, and 1 washed ink pans by hand with 
recovered solvent. Nine of these workers had severe peripheral neuropathy. 
Operators spent virtually all of their time, and the helpers spent about 
half their time, near the printing machines when they were running. The 
number of print-department workers developing neuropathy, by job category, 
is compared with data from other departments in Table III-2.
Neuropathy was more prevalent in those who ate on the job and in 
those who worked overtime [38]. Printing department workers who developed 
peripheral neuropathy ranged from 20 to 57 years of age and had worked in 
the area for 5 weeks to 27 years. However, printing department workers who 
developed peripheral neuropathies did not differ significantly in either 
age or length of employment from those who did not develop the condition 
(P>0.05). Workers with peripheral neuropathy from other departments tended 
to be older than affected workers from the printing department (P<0.05) and 
older than workers in the other departments who did not develop neuropathy 
(P<0.05).
Symptoms were first noticed by 89% of the workers (34 of 38) between 
December 1972 and September 1973 [38] . These symptoms started most
frequently in the summer months. In contrast, only 53% of the workers (16 
of 30) in the other departments first noticed symptoms of neuropathy 
between December 1972 and September 1973, and the onset of symptoms was 
distributed more evenly throughout the 10 months. The condition of all
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TABLE III-2
OCCURRENCE OF NEUROPATHY IN EMPLOYEES 





Nonprint departments 30^ 954 984
Print department (total) 38** 135 173
Operators^A 27 42 69
Helpers^^ 10 49 59
Foremen - 21 21
Service helpers 1 15 16
Not known - 8 8
Total, all departments 68 1,089 1,157
♦Includes 18 persons with diabetes or other 
conditions that can cause or contribute to 
neuropathy
♦♦Includes 1 person with diabetes and anoth­
er on isoniazid therapy 
♦♦♦Operators required to be close to the 
printing modules virtually 100% of their 
time had a significantly higher incidence 
of peripheral neuropathy (P<0.001) than 
helpers who spent about 50% of their time at 
the printing machines.
Adapted from reference 38
employees with peripheral neuropathy who worked in the print department 
improved after they were removed from exposure.
The investigators [38] tentatively concluded that the incidence of 
peripheral neuropathy in workers from other departments represented a
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background level in a working population. They cautioned, however, that 
these workers were not a true control group, since the condition of workers 
in other departments with peripheral neuropathies improved when they were 
away from work.
To identify the agents most likely associated with the development of 
neuropathy, the investigators [38] obtained information on work practices 
and production, including any changes that might have occurred. The inks 
used in the printing department contained resins, stabilizers, 
plasticizers, pigments, and solvents, but the investigators noted that 
mists were not formed from the inks. This statement was apparently based 
on visual observation. They concluded that the workers were exposed 
primarily to solvents by skin contact and to solvent vapors by inhalation. 
The investigation revealed that apparently there had been no recent 
increase in the concentration of any of the airborne compounds used in the 
printing process. The substitution of methyl n-butyl ketone for methyl 
isobutyl ketone was the only major process change that had occurred in the 
past 7 years. To comply with community air pollution requirements, plants 
in other states owned by the same company had begun to substitute methyl n- 
butyl ketone for methyl isobutyl ketone. (According to the authors, methyl 
isobutyl ketone is photochemically reactive and thus can be a factor in the 
formation of smog.) At this plant, substitution of methyl n-butyl ketone 
for methyl isobutyl ketone began in August 1972 and was completed in 
January 1973.
Five or 10-minute area samples were taken near 9 of the 17 printing 
machines and analyzed by gas chromatography for 9 solvents (methyl ethyl 
ketone, methyl n-butyl ketone, methyl isobutyl ketone, hexane, toluene,
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xylene, methyl alcohol, acetone, and mineral spirits) and for methyl 
methacrylate [38]. Average concentrations of airborne methyl ethyl ketone 
were 331 ppm (976 mg/cu m) in front of the printers (range 104-670 ppm; 
307-1,976 mg/cu m), 516 ppm (1,522 mg/cu m) in back of the printers (range 
85-763 ppm; 251-2,250 mg/cu m), and 147 ppm (434 mg/cu m) in the nearby 
"wind-up" area (range, 39-338 ppm; 115-997 mg/cu m). The average air 
concentrations of methyl n-butyl ketone were 9.2 ppm (37.7 mg/cu m) in 
front of the printers (range 2.3-21.7 ppm; 9.4-89.0 mg/cu m), 36.0 (147.6 
mg/cu m) ppm in back of the printers (range 2.5-156.0 ppm; 10.2-639.6 mg/cu 
m), and 6.1 ppm (25.2 mg/cu m) in the wind-up area (range 1.0-17.5 ppm;4.1-
71.8 mg/cu m). The concentrations of the other eight airborne compounds 
were stated by the authors to be very low [38]. The investigators also 
found that the workers had not worn respirators or gloves, had eaten in the 
work areas, had washed their hands with solvent, and had used rags soaked 
with solvent to clean equipment and machinery.
Another report [47] indicated that no cases of neuropathy were found 
at a similar plant that used methyl ethyl ketone but not methyl n-butyl 
ketone. The results of electrodiagnostic studies of 21 workers in that 
plant were essentially normal. However, tetrahydrofuran was also used on 
occasion at the plant where cases of neuropathy developed. It was not used 
at the other plant.
Billmaier et al [38] and Allen et al [37] concluded that the outbreak 
of peripheral neuropathy in printing department workers was probably 
associated with exposure to methyl n-butyl ketone. Most of the printing 
department workers with peripheral neuropathy first noticed symptoms during 
the summer of 1973, about 6 months after the substitution of methyl n-butyl
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ketone for methyl Isobutyl ketone was completed. Production had been very 
limited, but no new cases of peripheral neuropathy were identified after 
methyl n-butyl ketone had been removed from the printing process. The 
authors stressed that exposures to airborne methyl n-butyl ketone near the 





Studies conducted in the 1920's [48,49] indicated that single 
injections of acetone in a variety of experimental animals produced 
depression of the respiratory and vasomotor centers. In 1920, Sollmann 
[50] demonstrated that, when rats consumed 1.8 ml/kg of acetone/day, growth 
and food consumption were reduced. No rats died after 4 months of 
exposure. In 1927, Walton et al [51] compared the toxicities of diacetone 
alcohol and acetone. Diacetone alcohol was considered to be a polymer of 
acetone by the authors. Rats were injected iv with various amounts of the 
ketones. The authors concluded that diacetone alcohol was somewhat more 
toxic than acetone because narcosis developed more rapidly and there was a 
more constant depression of respiration. Both substances also decreased 
blood pressure.
DiVincenzo et al [42] exposed three male beagle dogs to acetone vapor 
at concentrations of 100, 500, and 1,000 ppm (237, 1,185, and 2,370 mg/cu 
m) for 2 hours [42]. A comparison of data from breath and blood samples 
from the dogs with the human data presented earlier showed that the dogs
72
absorbed about five times more acetone than did humans on a weight- 
corrected basis, but the breath concentrations were significantly higher in 
humans at similar intervals in the study. The postexposure blood acetone 
concentrations of the dogs were similar to those of humans, and the 
calculated half-life was also about 3 hours.
(2) Methyl Ethyl Ketone
In 1935, Patty and associates [19] described the effects of 
exposure to methyl ethyl ketone on guinea pigs. According to the 
manufacturer, the methyl ethyl ketone was 92.3% ketone as determined by 
acetylation. Information on impurities was not given.
Guinea pigs in groups of six were exposed to airborne methyl ethyl 
ketone at concentrations of approximately 10.0, 3.3, 1.0, and 0.33% by
volume, as determined by an iodometric method, for various durations up to 
810 minutes [19]. Twenty-four guinea pigs served as controls. The organs 
of animals that died during exposure and of some animals killed on the 4th 
and 8th days after exposure were examined macroscopically.
The authors [19] reported that the signs of toxicity exhibited by the 
animals were, in the order of occurrence, irritation of the nose and eyes, 
tearing, incoordination, narcosis, gasping, and death. The guinea pigs 
exposed to methyl ethyl ketone at 0.33% showed no abnormal signs during or 
after 810 minutes of exposure. Those exposed at approximately 1.0% showed 
irritation of the nose in 2 minutes and eyes in 4 minutes, tearing in 40 
minutes, incoordination in 90 minutes, and unconsciousness in 240-280 
minutes, but no gasping respiration or deaths occurred during or after 810 
minutes of exposure. At the two higher concentrations of methyl ethyl 
ketone, the exposure time before these signs of toxicity appeared was much
shorter, and deaths occurred in 200-260 minutes at 3.3% and in 45-55 
minutes at 10%. The authors did not specify the number of animals that 
died after each exposure.
The guinea pigs that died during exposure had emphysema, slight 
congestion in the brain, and marked congestion of the systemic organs, 
especially in the lungs [19]. All guinea pigs exposed at 10.0% for more 
than 30 minutes developed corneal opacities. These diminished, and they 
had nearly disappeared in most animals 8 days after exposure. The guinea 
pigs killed immediately after exposure of up to 180 minutes to methyl ethyl 
ketone at 3.3 and 10% had slight congestion in the brain and moderate 
congestion of the lungs, liver, and kidneys. These findings were absent in 
nearly all animals killed for necropsy 4-8 days after exposure. Whether 
this suggests reversibility of the morbid changes or differential 
susceptibility of test animals, eg, early deaths among animals with 
preexisting changes, is not clear.
These results show that methyl ethyl ketone at a concentration of 5- 
10% was dangerous to the life of guinea pigs in 30-60 minutes and that 0.3% 
was the maximum concentration that could be tolerated for several hours 
without serious disturbance [19]. It was not clear whether death was 
caused by irritation of the lungs or by narcosis. Methyl ethyl ketone has 
warning properties (eye and nose irritation) in concentrations that were 
apparently otherwise harmless to guinea pigs exposed for several hours.
(3) Methyl n-Propyl Ketone
In 1936, Yant et al [52] reported the effects of methyl n- 
iropyi ketone on guinea pigs. Groups of six guinea pigs of unspecified sex 
and weight were exposed to methyl n-propyl ketone at concentrations of
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1,500, 5,000, 13,000, and 50,000 ppm (5,250, 17,600, 45,760 and 176,000 
mg/cu m) as determined by an iodometric method for up to 810 minutes. 
Twenty-four guinea pigs served as controls. The organs of some guinea pigs 
were examined macroscopically. Since the saturation concentration of the 
compound at 25 C is 21,000 ppm (73,920 mg/cu m), some of the compounds may 
have been present in particulate form at the higher exposures, even though 
they were apparently produced at 30 C.
The guinea pigs exposed at 1,500 ppm had no abnormal signs during the 
810-minute exposure [52], At 5,000 ppm, nose and eye irritation occurred 
in 3 minutes, tearing in 5 minutes, incoordination in 270 minutes, 
unconsciousness in 460-710 minutes, and labored breathing in 570-710 
minutes, but no guinea pigs died during or after the exposure. The authors 
noted that the time of onset for these signs decreased rapidly with 
increases in concentration and that death occurred after 50 minutes of 
exposure at 50,000 ppm. The authors did not mention the number of animals 
in each group with these signs, but they did report that animals that did 
not die during exposure survived the 4- or 8-day observation period after 
exposure.
Animals that died during the exposure had slight congestion of the 
brain and marked congestion of the systemic organs, including lungs that 
were emphysematous, edematous, and markedly congested [52]. Animals with 
marked incoordination, narcosis, and a gasping-type respiration that were 
killed immediately after exposure had little or no congestion of the brain 
and slight to moderate congestion of the lungs, liver, and kidneys. These 
findings were absent in nearly all animals killed for necropsy 4-8 days 
after exposure. No gross abnormalities were found in animals exposed to
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methyl n-propyl ketone for 270 minutes at 5,000 ppm and for up to 810 
minutes at 1,500 ppm.
These results [52] show that exposure to methyl n-propyl ketone at a 
.oncentration of 50,000 ppm for 30-60 minutes was lethal to guinea pigs. 
The authors' findings show that methyl n-propyl ketone caused death by 
narcosis and that the principal gross abnormalities were congestion, edema, 
and hemorrhage of the lungs, liver, and kidneys of the guinea pigs. The 
authors noted that a concentration of 1,500 ppm of methyl n-propyl ketone 
could be tolerated by guinea pigs for several hours with only slight signs 
or no signs at all.
(4) Methyl Isobutyl Ketone
MacEwen et al [53] exposed rats, mice, dogs, and monkeys for 
24 hours/day to methyl isobutyl ketone at concentrations of 100 or 200 ppm 
(410 or 820 mg/cu m) for 2 weeks and, in an experiment designed to evaluate 
toxicity under spacecraft cabin conditions, exposed dogs, rats, and monkeys 
to methyl isobutyl ketone at approximately 100 ppm for 90 days. The 2-week 
preliminary range-finding experiments were conducted in an altitude chamber 
at normal atmospheric pressure with an airflow of 40 cu ft/minute and a 
temperature of 22 C. Gas-liquid chromatography was used to determine the 
concentrations every 5 minutes from samples collected near the breathing 
iione of dogs. Four monkeys, 8 dogs, 40 mice, and 50 rats were exposed to 
■-ethyl isobutyl ketone at each concentration and 3 monkeys, 4 dogs, 20 
mice, and 25 rats, used as controls in identical inhalation chambers, 
revived no ketone exposure. One monkey in each group was implanted with 
.rrticai electrodes for evaluation of CNS effects. Body weights and the 
results of clinical chemistry, hematologic, and electroencephalographic
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(EEG) tests were determined before and after exposure. Organ-to-body 
weight ratios, macroscopic and microscopic tissue examinations, and blood
pH and gas tests were performed. Spontaneous activity measurements were
taken, and adverse signs were noted during the exposure.
The only findings in which exposed animals differed significantly 
from controls were heavier kidneys and higher kidney-to-body weight ratios 
in the rats exposed at 100 ppm and the higher liver and kidney weights and 
correspondingly increased organ-to-body weight ratios in rats exposed at 
200 ppm [53] . Microscopic examination of the kidneys of exposed rats 
showed toxic nephrosis of the proximal tubules at both 100 and 200 ppm. 
The authors concluded that the kidney was the primary organ affected by 
methyl isobutyl ketone.
MacEwen et al [53] then conducted a 90-day exposure experiment. Two 
male Rhesus monkeys, 8 male beagle dogs, and 100 male Wistar rats were
exposed for 24 hours/day at 5 psia (about one-third of an atmosphere) to 
methyl isobutyl ketone at about 100 ppm (410 mg/cu m). Controls consisted 
of an identical number of unexposed male animals. Every other week,
starting 1 month before the exposure began, the dogs and monkeys were
weighed and blood samples were taken for various hematologic and clinical 
chemistry determinations. Liver function tests were performed before and 
immediately after exposure, and serum acid phosphatase and serum
glucuronidase determinations were made before exposure began and on the 
30th and 60th days of exposure. After the 90-day exposure, two dogs were 
observed for 60 days to determine if the effects were reversible. The 
other dogs were killed and examined grossly, and organ samples were
examined microscopically. Rats were weighed before exposure and every
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other week during the exposure. Two exposed rats and two control rats were 
killed at weekly intervals for 3 weeks and then every other week 
thereafter, and their organs were grossly examined. After the rats had 
been exposed for 2 weeks, 10 were removed from exposure, and 2 of them were 
killed every 2 weeks and examined to determine if the kidney lesions seen 
in the short-term studies were reversible. At the end of the 90-day study, 
10 rats were saved and were later killed serially for reversibility 
studies, 10 were killed for microscopic examination of tissues, and the 
remaining rats were killed and organ weights were determined.
The results of clinical chemistry and hematologic measurements in 
dogs and monkeys showed no significant differences between experimental and 
control animals [53]. Serum glucuronidase activity was much higher in 
exposed monkeys than in controls, but this condition also existed in 
baseline measurements. The authors did not relate this condition to methyl 
isobutyl ketone exposure. No differences between exposed and control dogs 
were found in sections of heart, lungs, brain, liver, spleen, kidneys, 
adrenal gland, or pituitary gland tissues. The only microscopic change 
found in monkeys was focal chronic inflammation of the kidneys in one 
exposed animal.
There was no statistically significant difference in the weight 
gained by exposed and control rats [53]. As in the 2-week exposure, the 
exposed rats had significantly heavier livers and kidneys (P<0.01) and 
corresponding increases in organ-to-body weight ratios for these two 
organs. All exposed rats showed hyaline droplet degeneration of the 
proximal tubules of the kidneys with occasional foci of tubular necrosis 
after the 90-day exposure. Rats removed from exposure after as few as 15
days also showed some kidney changes, although hyaline droplets grew larger 
with time. No adverse changes were observed in rat livers. Kidney tubular 
damage was reversible in those rats observed for 60 days after being 
exposed to methyl isobutyl ketone for 15 days. The rats exposed for 90 
days recovered but did so more slowly than those exposed for less time.
(5) Diisobutyl Ketone
In 1953, Carpenter et al [20] studied the effects of single 
and repeated exposures to diisobutyl ketone on rats and guinea pigs. For 
single exposures, groups of six Sherman rats were exposed to diisobutyl 
ketone at a concentration of 2,000 ppm (11,640 mg/cu m). Seven of 12 
female rats died after a single 8-hour exposure to diisobutyl ketone at
2,000 ppm, but all 6 exposed males survived [20], The experiment was 
repeated with Carworth Farms Wistar rats using an undescribed number of 
males and females. All survived a single 8-hour exposure to diisobutyl 
ketone at 2,000 ppm. The authors concluded that the effects noted were due 
to differences in susceptibility between strains of rats.
In repeated exposure studies, groups of 15 male Sherman rats weighing 
145-197 g and 15 females weighing 128-162 g were exposed for 7 hours/day, 5 
days/week, for 6 weeks to diisobutyl ketone at concentrations of 125, 250, 
530, 920, and 1,650 ppm (728, 1,455, 3,085, 5,354, and 9,603 mg/cu m),
measured 4 times/day with an interferometer. In addition, groups of 10 
male guinea pigs weighing 288-360 g were exposed at 125 or 250 ppm.
Exposed animals and unexposed controls were weighed weekly, and the liver
and kidneys were weighed at the termination of the study. The lungs,
liver, kidneys, spleen, and adrenals of animals exposed to diisobutyl
ketone at 250, 530, 920, and 1,650 ppm were examined microscopically,
except that only lungs, liver, and kidneys in animals exposed at 125 ppm 
were examined.
Exposure to diisobutyl ketone at 1,650 ppm killed all 15 female rats 
during the 1st day of exposure [20]. Only 2 of 15 male rats died, but all 
the males were prostrate at the end of the 1st day, and about half had poor 
coordination at the end of the 2nd day. These signs were not observed
during the other 28 days of exposure. The 13 males that survived the 30-
day exposure had reportedly significantly lower body weights and higher 
kidney and liver weights than did the controls (no P value given). No 
major microscopic changes were noted in the adrenals, kidneys, liver, 
lungs, and spleen of survivors, but five male rats had cloudy swelling of 
the liver, and eight had moderate lung congestion. The authors noted that 
5 of 15 control males had similar lung involvement. Major lung, kidney, 
and liver abnormalities were found in the male and female rats that died 
during the 1st day of exposure.
No rats died when they were exposed for 30 days to diisobutyl ketone 
at 125, 250, 530, or 920 ppm [20]. Liver and kidney weights were
significantly increased in male and female rats exposed to diisobutyl
ketone at 920 and 530 ppm (no P value given). Similar organ weight 
increases occurred in females exposed at 250 ppm. There were no 
abnormalities noted in rats exposed at 125 ppm. Male guinea pigs had 
significantly lower liver weights after exposure to diisobutyl ketone at 
250 ppm, but no P value was given [20]. No toxic effect in rats or guinea 
pigs was noted at 125 ppm.
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In 1943, Treon et al [54] reported on the effects of
cyclohexanone exposure on rabbits and monkeys. Groups of four rabbits of
unspecified sex, age, and weight were exposed to cyclohexanone at average 
concentrations of 190-1,414 ppm (762-5,670 mg/cu m) for 6 hours/day, 5 
days/week, for 10 weeks, and at 3,082 ppm (12,359 mg/cu m) for 6 hours/day, 
5 days/week, for 3 weeks. In addition, one rhesus monkey was exposed at an 
average concentration of 608 ppm for 6 hours/day, 5 days/week, for 10
weeks. Cyclohexanone concentrations were determined colorimetrically
throughout the exposures. Animal weights were determined daily, and 
microscopic examinations were performed 2 months after the termination of 
exposure.
Only the rabbits exposed at 3,082 ppm lost weight [54], The body 
temperatures in exposed animals were similar to those of control animals, 
except in animals exposed at 3,082 ppm. In this case, the mean daily 
decrease was more than five times that observed in controls. Two of the 
four rabbits died at 3,082 ppm. They had no convulsions or tremors, but 
narcosis and incoordination were observed. Rabbits exposed at 3,082 ppm 
and at 1,414 ppm had distended ear veins, excess salivation, and 
conjunctival irritation throughout the daily exposures. Although narcosis 
and incoordination were not seen at 1,414 ppm, there was some lethargy. 
Exposures at 309 and 773 ppm (1,239 and 3,100 mg/cu m) produced less ocular 
irritation than did the exposures at higher concentrations. Exposure at 
190 ppm produced no noticeable behavioral abnormalities. Cyclohexanone at 
190 ppm induced barely demonstrable degenerative changes in the liver and 
kidneys of rabbits exposed for 300 hours. The authors reported that the
(6) Cyclohexanone
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monkey exposed at 608 ppm for 300 hours had extensive injury to the heart 
muscle, lungs, liver, and kidneys.
The work of Treon et al [54], although it lacks experimental detail, 
does provide evidence that repeated exposure of rabbits to cyclohexanone at 
190 ppm produces slight liver and kidney damage. The effects in the one 
monkey may not be appropriately attributed to the exposure, because it was 
suffering from a chronic bronchopulmonary infection.
(7) Mesityl Oxide
Hart et al [55] exposed mice and rabbits to saturated 
atmospheres of mesityl oxide. Concentrations were varied by changing the 
atmospheric temperature. Mice were exposed at concentrations ranging from 
0.6 to 2.4%. Toxic signs included eye and nose irritation, gasping 
respiration, rocking convulsions, narcosis, vasodilatation, cyanosis, and 
death. Deaths occurred in 23 minutes after exposures at 2.4%, in 84 
minutes after exposure at 1.3%, and in 135 minutes after exposure at 0.6%. 
Rabbits showed only eye and nose irritation when they were exposed at 1.3% 
for 30 or 90 minutes.
Mice and rabbits were also repeatedly exposed to mesityl oxide at 
1.3% [55]. Ten mice weire exposed for 15 minutes daily. After 5 exposures, 
none had died, and, after 11 exposures, 3 had died. When the exposures 
were increased to 30 minutes/day, all of 10 mice died within 6 days. Six 
rabbits showed only slight eye and nose irritation when they were exposed 
for 30 minutes/day for 15 days; however, when the exposures were increased 
to 60 minutes/day, the six rabbits developed spastic paralysis within 10 
days and died 7-11 days after the paralysis was first observed.
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The authors [55] also investigated the effects of mesityl oxide 
applied to the skin. Only 1 of 10 mice died when 0.1 ml of mesityl oxide 
was applied to the intact skin in the lumbar region; however, when 0.5 ml 
was applied, narcosis developed within 15 minutes, and death occurred in 3- 
9 hours.
Hart et al [55] found no significant abnormal changes by gross 
examination of the organs of mice that died after single exposures to 
mesityl oxide; however, mice that died after repeated exposures had 
necrotic spots in the liver, lung hemorrhages, and alimentary tract 
distention. Microscopic examination revealed necrosis, parenchymatous 
atrophy, and immature polynuclear cells in the liver. Some tubular 
degeneration in the kidneys and edema and hemorrhage in the lungs were also 
noted. Similar microscopic changes were found in rabbits after repeated 
exposures to mesityl oxide. The authors concluded that a concentration of 
about 0.7% of mesityl oxide was the maximum that could be inhaled by mice 
for an hour without fatal results. In rabbits, however, no deaths were 
observed at a concentration of 1.3%.
In 1942, Smyth et al [21] reported the effect on rats and guinea pigs 
after 6 weeks of 8-hour daily exposures (5 days/week) to mesityl oxide at 
50, 100, 250, or 500 ppm (201, 402, 1,005, or 2,010 mg/cu m). Ten male
Wistar rats and 10 guinea pigs of both sexes were used at each exposure 
concentration. No distinction was made between species in reporting the 
results because, according to the authors, the results differed only 
slightly. Nose and eye irritation was noted at the two higher exposure 
concentrations but not at 50 or 100 ppm. Exposure at 500 ppm was stopped 
after 10 days because of high mortality (13/20, 65%). No deaths occurred
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in the groups exposed at 50, 100, or 250 ppm. Poor growth was noted in the 
survivors of the 250-ppm exposure but not in those exposed at 50 or 100 
ppm. Blood changes were not apparent at any exposure concentration. 
Albumin was noted in the urine at the two higher concentrations but not at 
the lower two. Adverse liver and kidney changes were noted in all but the 
lowest exposure group. These changes increased proportionally with the 
dose. Liver damage was confined to congestion, but kidneys had dilated 
Bowman's capsules and swollen convoluted tubular epithelium. The lungs 
were often congested. The authors also determined that, in animals that 
died from the 500-ppm mesityl oxide exposures, the cause of death was the 
anesthetic effect on the circulatory and respiratory systems.
Smyth et al [21] supplemented their repeated-exposure studies by 
exposing rats and guinea pigs to mesityl oxide at high concentrations for 
short periods. At 13,000 ppm (52,130 mg/cu m), all 20 animals died after 
an exposure of 1 hour; at 2,500 ppm (10,050 mg/cu m), all the animals died 
after an 8-hour exposure; at 1,000 ppm (4,020 mg/cu m), 68% of the exposed 
animals died after 8 hours; and at 500 ppm, 30% died after 8 hours. Deaths 
resulted from narcosis; dead animals had some evidence of lung irritation.
The authors [21] concluded that mesityl oxide acted primarily as a 
narcotic. They also observed that, in rats and guinea pigs, "no effect 
whatever" was seen after 30 exposures to mesityl oxide for 8 hours at a 
concentration of 50 ppm.
In 1949, Carpenter et al [56] reported the results of an experiment 
to determine the extent of the acute toxicity of industrial compounds, 
including mesityl oxide. Groups of six male or female albino Sherman rats 
were exposed for 4 hours to compounds at successively higher concentrations
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until two, three, or four of the animals died during a 14-day observation 
period. The investigators found that exposures to mesityl oxide at about
1,000 ppm (4,020 mg/cu m) killed two to four of the six rats in 14 days. 
They concluded that mesityl oxide should be considered a moderate hazard.
(8) Diacetone Alcohol
Lehmann and Flury [57] cited the results, but not the 
experimental details, of an unpublished study by E. Gross on the toxicity 
of diacetone alcohol. Repeated sc injections of 0.08 ml in rats caused 
exhaustion, but the animals recovered. Three rabbits given 2 ml of 
diacetone alcohol orally 12 times/day had kidney injury, slight narcosis, 
and albumin and sugar in the urine. One of the three rabbits died. 
Inhalation of diacetone alcohol at 2,100 ppm (9,975 mg/cu m) for 1-3 hours 
by mice, rats, rabbits, and cats caused restlessness, signs of irritation, 
head colds, and excitation followed by sleepiness. Rabbits also had kidney 
injury.
As was mentioned in the discussion of animal toxicity of acetone, 
there is evidence that diacetone alcohol caused earlier narcosis and a more 
constant depression of respiration in rats injected by vein than did 
acetone.
(9) Isophorone
Smyth et al [21], in 1942, described the toxicity of 
isophorone in rats and guinea pigs. Ten male Wistar albino rats (weighing 
90-120 g) and 10 guinea pigs (weighing 250-300 g) were exposed to 
isophorone at concentrations, as determined by an interferometer, ranging 
from 25 to 500 ppm for 8 hours/day, 5 days/week, for 6 weeks. Weights were 
recorded weekly, blood cell changes were analyzed, and nose and eye
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irritation was noted during exposures. Pooled urine samples were examined 
at least once, and microscopic examination was performed on selected 
animals.
The effects in the two species differed only slightly, with the rats 
being slightly more sensitive [21]. One animal exposed at an unknown but 
high concentration developed corneal necrosis. Chronic conjunctivitis and 
nasal irritation, sometimes followed by the appearance of a bloody exudate, 
were caused by repeated exposure to isophorone at a concentration of 500 
ppm (2,825 mg/cu m) but not at 200 ppm (1,130 mg/cu m). Lungs were
irritated by isophorone at unspecified concentrations. These 
concentrations produced congestion, capillary leakage, and desquamation of 
the epithelium that was not further described by the authors.
Growth was inhibited in all animals exposed to isophorone at 
concentrations of 100, 200, and 500 ppm (565, 1,130, and 2,825 mg/cu m)
[21]. No blood cell changes were observed in animals exposed to isophorone
at a concentration of 25, 50, 100, or 200 ppm (141, 282, 565, or 1,130
mg/cu m), although unspecified blood cell changes were noted in some 
animals exposed to isophorone at 500 ppm. Only animals exposed to
isophorone at a concentration of 500 ppm excreted albumin in the urine. In
addition, the urine of animals exposed to isophorone at a concentration of
500 or 200 ppm contained a substance that reduced Benedict's solution. The 
authors suggested that a detoxification product was responsible because 
isophorone alone did not reduce Benedict's solution.
Many animals exposed to isophorone had pale or brown kidneys, pale 
livers, congested spleens and lungs, and discolored bile [21]. However,
exposure at 25 ppm produced neither microscopic abnormalities nor deaths.
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Liver changes were reported in one of six animals exposed to isophorone at 
50 ppm, in none of seven at 100 ppm, in none of six at 200 ppm, and in one 
of eight at 500 ppm. Kidney changes were found in four of six animals 
exposed at 50 ppm, in six of eight at 100 ppm, in four of seven at 200 ppm,
and in six of nine at 500 ppm. No further information was provided on the
liver and kidney changes.
All 20 animals survived exposure to isophorone at a concentration of 
50 ppm, 2 of 16 died at 100 ppm, 3 of 18 died at 200 ppm, and 9 of 20 died 
at 500 ppm [21]. Animals that were killed by repeated exposure to
isophorone had severely injured kidneys, lungs, or both. The kidneys of 
survivors were congested, and had dilation of Bowman's capsule and cloudy 
swelling in the convoluted tubules. Lungs were congested and had
desquamation of bronchial epithelium sometimes followed by pneumonia. The 
liver was less affected than the lungs or kidneys, but it was congested 
with prominent Kupffer cells and cloudy swelling. The authors concluded 
that repeated exposure to isophorone had caused toxic effects, primarily on 
the kidneys and lungs, and that isophorone at 25 ppm caused no apparent 
adverse effects after exposures for up to 6 weeks. In an earlier study, 
Smyth and Seaton [58] found that single exposures to isophorone killed rats 
by narcosis, probably by paralysis of the respiratory center.
(b) Comparative Effects
In 1940, Specht et al [34] reported on an extensive study on the 
acute toxicity of a number of ketones in guinea pigs. In one series of 
experiments, five members of a homologous series— acetone, methyl ethyl 
ketone, methyl n-propyl ketone, methyl n-butyl ketone, and methyl n-amyl 
ketone— were compared. In another series of experiments, four six-carbon
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ketones— methyl isobutyl ketone, methyl n-butyl ketone, cyclohexanone, and 
mesityl oxide— were compared. Measurements included rectal temperature, 
respiratory rate, and heart rate during each experiment. The authors 
attempted to correlate clinical signs and narcotic effectiveness with such 
physical properties as the number of carbon atoms, oil-to-water partition 
coefficients, and surface tension. The concentration of each ketone was 
determined by iodine titration, except for cyclohexanone, which was 
determined by titration of hydrochloric acid liberated after oxime 
formation.
Ten female guinea pigs of mixed stock weighing 400-600 g were exposed 
to the ketones at various concentrations and duration as shown in Table 
III-3 [34]. Ten unexposed guinea pigs served as controls. The clinical 
signs were reported during the experiments at only one representative 
concentration. Squinting, tearing, and rubbing of the eyes were considered 
to represent irritation of the cornea and conjunctiva, whereas sneezing, 
coughing, salivation, retching, and rubbing of the nose and mouth 
represented irritation of the buccal, nasal, and pharyngeal passages. 
These results, given in Table III-3, together with some apparently similar 
data developed by Specht and coworkers [59,60], suggest that irritative 
potency increases as the carbon number increases.
Specht et al [34] also reported that acetone produced immediate 
irritation at 50,000 ppm (118,500 mg/cu m) but no irritation at 10,000 ppm 
(23,700 mg/cu m). Methyl n-propyl ketone produced immediately an 
irritating effect at 2,500 ppm (5,925 mg/cu m) as well as at 10,000 ppm. 
Methyl ethyl ketone, however, produced immediate effects only at much 
higher concentrations. Methyl n-butyl ketone was even more irritating
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TABLE I1I-3









Eyes Upper Respiratory Tract





Acetone** 20,000 25 1 I 0 0 -
Methyl ethyl 
ketone
25 ,000 10 2 3 3 2 -
Methyl n-propyl 
ketone
10,000 10 4 3 4 3 0 3
Methyl n-butyl 
ketone
6,000 15 4 4 4 2 4 1
Methyl n-amyl 
ketone
2,000 I O 4 4 2 1 2 -
Methyl Isobutyl 
ketone***
16,800 1 4 4 2 4 -
Cyclohexanone 4 ,000 10 4 4 4 0 2
Mesltyl oxide 5,000 5 4 4 4 4 4 -
Key: 0»negative, l*slight, 2»moderate, 3*marked, 4-extreme
♦Observed effects may have occurred at any time during exposure up to time Indicated.
**Adapted from reference 60 
***Adapted from reference 59
Data on ocher ketones adapted from reference 34
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than methyl n-propyl ketone, producing immediate irritation at 
concentrations as low as 1,200 ppm. Immediate, strong effects were also 
noted with methyl n-amyl ketone and mesityl oxide at all concentrations 
tested. Immediate irritation was not found below concentrations of 10,000 
ppm for methyl isobutyl ketone, but it occurred at all concentrations 
tested above 10,000 ppm. The authors also noted that methyl n-butyl ketone 
and cyclohexanone produced a clouding of the cornea that persisted beyond 
the exposure period, but they did not mention whether or not it abated.
In addition to the irritant effects noted above, Specht et al [34] 
reported that the ketones used in this study produced narcosis, CNS 
depression, and respiratory dysfunction. These data are summarized in 
Table III-4. The values depicted represent the product of the exposure 
concentration and the duration of exposure (Ct product) calculated from the 
data presented by Specht et al. The criterion for a particular effect's 
being significant was arbitrary. In this case, a decrease of 30 
breaths/minute, 50 heartbeats/minute, or body temperatures 4 C below 
controls was considered significant. The first reported time at which this 
decrease occurred was then multiplied by the concentration of the ketone.
The data in Tablé III-4 suggest that, as the number of carbon atoms 
in these ketones increases, there is generally a decrease in the Ct product 
to produce a particular toxic effect. Although there are Ct products that 
do not fit into this model, the general trends suggest that CNS depression 
increases with increasing carbon numbers. Methyl n-amyl ketone was 
aberrant in this respect, probably because it was not lethal at this 
concentration. The Ct of methyl n-amyl ketone for the first death at 5,000
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TABLE III-4















Acetone 20,000 3 26,800
(1)















780 360 780 34
Methyl n-anyl 
ketone
18,100 7 No deaths 90 
in 890 tain***
1,720 1 ,720 34
Cyclohexanone 4,000 6 No deaths 
in 355 tain





420 622 1,008 59
Mesityl oxide 5,000 6 1,950
(2)
300 1,200 1,200 34
*Cc product units in ppm-minutes
**Product unit at which first death occurred; number of deaths in parentheses 
***Product vas 1,400 at 5,000 ppm
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ppm (a concentration not described in detail by Specht et al [34]) was 
calculated as 1,400 x 10^ ppm-minutes, a value that agrees with the above 
observation that carbon number and mortality are directly related.
In Table III-4, there is evidence that the relationship of mortality, 
CNS effects, and respiratory dysfunctions with carbon number may also apply 
to those six-carbon ketones (mesityl oxide, cyclohexanone, methyl isobutyl 
ketone) that are not straight chain ketones. Although there appears to be 
little correlation between the type of rearrangement (cyclization, 
unsaturation, or branching) and the Ct product, the Ct products are 
generally less than those of the five-carbon ketone, methyl n-propyl 
ketone. However, when these Ct products are compared with those of methyl 
n-butyl ketone, there are many discrepancies.
Selected animals from each exposure group were killed and examined to 
determine macroscopic and microscopic adverse effects on organs and tissues 
[34]. Occasional scattered liver cells containing fat droplets were found 
in a few animals. Congested liver capillaries were found in animals 
exposed to each of the ketones except acetone. The authors concluded that, 
in general, few or no significant changes were fQund in the liver. Each of 
the ketones produced slight to marked congestion of the interalveolar 
capillaries in the lungs. Various degrees of congestion of the 
interstitial capillaries of the kidneys were found in all guinea pigs. 
Hemorrhaging was found in the pulp of the spleen of all animals, and it was 
usually perifollicular in those exposed to acetone. Hemosiderosis was 
frequently found. Congestion of the capsular capillaries of the adrenal 
glands occurred in all animals except those exposed to acetone. 
Extravasation of red blood cells into the adrenal gland occurred in animals
exposed to methyl n-butyl ketone and methyl n-propyl ketone at 40,000 ppm. 
Fat droplets were present in adrenocortical cells of all animals. 
Congestion of the pia-arachnoid vessels and capillaries of the cerebral 
cortex occurred in guinea pigs exposed to methyl n-butyl ketone. The 
brains of other animals were not examined. No microscopic changes were 
observed in the heart, stomach, or pancreas.
Specht et al [34] concluded that there was no marked variation among 
the animals exposed to various ketones. The most consistent observation 
was congestion, and the organs most affected, in decreasing order, were 
lungs, kidneys, spleen, adrenals, and brain. Distention of renal tubules 
was also common, but liver congestion was considered negligible. Specht et 
al concluded that all of the ketones studied produced a general, 
progressive narcosis that best correlated with the partition coefficient 
between olive oil and water. Mesityl oxide was somewhat aberrant in this 
respect. All of the ketones produced irritation of mucous membranes and a 
transient reflex depression of the respiratory and heart rate that 
furnished a limiting index for adequate warning properties during 
inhalation.
Specht et al [34] presented olive oil-to-water partition coefficients 
for eight of the ketones. A comparison of these partition coefficients 
with LD50's for the ketones is given in Table III-5. Since factors such as 
the sex and strain of the rats used sometimes differed for the compounds 
tested, a detailed comparison of the LD50's is not valid.
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TABLE III-5
COMPARISON OF PARTITION COEFFICIENTS 










Acetone 0.1 8.5 F 61
Methyl ethyl 
ketone
1.9 5.5 F 61
Methyl n-propyl 
ketone
16.6 3.7 M 61
Methyl n-butyl 
ketone
26.5 2.6 M 62
Methyl n-amyl 
ketone
42.2 1.7 F 61
Methyl Isobutyl 
ketone
20.6 2.1 M 63
Cyclohexanone 24.1 1.5 M 64
Mesityl oxide 4.6 1.1 - 65
♦Adapted from reference 34
It appears that lipophilicity and oral toxicity are directly related 
for the five homologous ketones. As the affinity of the ketone for the oil 
increases, the oral toxicity correspondingly increases. The correlation is 
not applicable to the nonlinear six-carbon ketones.
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(c) Effects on the Skin and Eyes
Smyth et al [61,62] studied primary skin irritation produced by a
number of ketones on rabbits. The authors scored the reactions produced on 
the clipped skin of five albino rabbits within 24 hours of application of 
0.01 ml of undiluted ketone or of dilutions in water, n-propylene glycol, 
or kerosene. Each ketone was graded according to its irritant effect. 
Grade 1 produced the least visible capillary congestion in undiluted form, 
grade 6 produced necrosis when undiluted, and grade 10 produced necrosis 
from a 0.01% solution.
The grades found for the ketones were acetone, 1; methyl ethyl 
ketone, 2; methyl n-propyl ketone, 1; methyl n-amyl ketone, 4; methyl 
isoamyl ketone, 1 [61]; and methyl n-butyl ketone, 1 [62] . Further
experimental details or results were not presented.
The effects of acetone and of cyclohexanone on the eyes have been 
studied by Rengstorff et al [66]. In one experiment, 0.5 ml of either 
ketone was applied to the clipped skin on the back of albino guinea pigs. 
Four additional guinea pigs were given sc injections of 0.05 ml of a 1:1 
mixture of either ketone in saline, and 12 more were injected sc with 0.05 
ml of 5% of either ketone in saline. Guinea pigs were injected with 
acetone or cyclohexanone three times/week for 3 weeks. Eyes were examined 
60 or 90 days after the initial application of the ketone and then every 30 
days for up to 6 months after the experiment began. As a control, the eyes 
of over 500 other guinea pigs from the same colony were examined.
Cataracts developed in guinea pigs given acetone or cyclohexanone
either by injection or dermal application [66]. Of the 12 guinea pigs 
given acetone cutaneously for 3 weeks, two developed cataracts by the 3rd
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month. Cutaneous administration of cyclohexanone produced cataracts, which 
were first seen in the 5th or 6th month in 3 of 12 guinea pigs. 
Subcutaneous administration of acetone and cyclohexanone caused cataracts 
to form in 7 of 16 and 2 of 16 exposed guinea pigs, respectively. 
Generally, the cataracts in these guinea pigs were first seen by the 3rd 
month and were still apparent in later examinations. However, lens damage 
was occasionally reversed within 3 months after being observed. No 
cataracts formed in the control guinea pigs. Microscopic examination of a 
guinea pig that developed cataracts after cutaneous exposure to acetone 
showed extensive lens damage. Eosinophilic deposits were found in the 
subcapsular areas of the lens, and the lens epithelium could not be 
distinguished from the capsule. The eyes of a control guinea pig showed no 
abnormal features.
In a second experiment, two guinea pigs of each sex and one rabbit 
were given 1 ml of acetone cutaneously two times/day, 5 days/week for 4 
weeks, and an equal number of animals were given acetone for 8 weeks [66]. 
Four guinea pigs and two rabbits were given saline cutaneously and four 
unexposed guinea pigs served as controls. The animals' eyes were examined 
once a week for 8 weeks and then every other week until 6 months after the 
initial exposure. Cutaneously applied acetone produced cataracts in guinea 
pigs but not in rabbits. Two of the eight exposed guinea pigs had 
bilateral cataracts, while none of the controls had lens defects. It 
cannot be determined whether the negative findings were caused by the small 
number of animals used or by the rabbit being less sensitive to the ocular 
effects of acetone. However, these studies demonstrated the ability of 
acetone and cyclohexanone to produce cataracts in albino guinea pigs.
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Carpenter and Smyth [67] studied the effects on the rabbit cornea of 
a large number of chemical agents, including acetone, diisobutyl ketone, 
cyclohexanone, mesityl oxide, diacetone alcohol, and isophorone. A ranking 
system from 1 to 10 was used by the authors to numerically score the extent 
of ocular damage. In a typical experiment, a variable amount of the 
substance was applied to the center of the corneas of normal albino 
rabbits. Eighteen to 24 hours later, the eye was examined in strong 
diffuse daylight, and damage to the corneas and irises was scored. The eye 
was then stained with fluorescein to determine the extent of necrosis. A 
score of 5 represented severe injury. This score corresponded to necrosis 
covering 75% of the cornea after staining or more severe necrosis covering 
a smaller area. The volume of the test substance also affected the score.
The authors [67] assigned an injury grade of 1 to diisobutyl ketone, 
a grade of 4 to isophorone, and a grade of 5 to acetone, cyclohexanone, 
mesityl oxide, and diacetone alcohol. Substances such as acetic anhydride 
and sulfuric acid (5% solution) had grades of 9, and sodium hydroxide (1% 
solution) had a grade of 10.
Truhaut et al [68] studied the effects of isophorone on the eyes of 
rabbits. The official procedure of the US Food and Drug Administration was 
used for this investigation (Federal Register 29:13009, September 16, 
1964), except that Bourgogne rabbits were used instead of albino rabbits. 
This procedure, described earlier by Draize and coworkers [69] , consists of 
instilling 0.1 ml of the test compound into the eyes of six rabbits. The 
eyes are then examined and the degree of injury is noted after 24, 48, and 
72 hours. Either ulceration, or opacity of the cornea, inflammation of the 
iris, and conjunctival swelling are considered positive reactions. A test
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is considered positive if four or more animals have a positive reaction. 
An acute ocular index rating with a maximum value of 110 is then derived
[69].
Truhaut and coworkers [68] reported that four rabbits had pronounced 
opacity of the cornea which extended over the entire surface. All rabbits 
had inflammation of the eyelids and conjunctiva accompanied by a pronounced 
purulent discharge. Microscopic examination showed that the corneal 
epithelium was frequently reduced or nonexistent and sometimes had signs of 
ulceration. Inflamed cells in the cornea were also observed. Accordingly, 
the authors judged isophorone to be a moderate eye irritant. They assigned 
an acute ocular irritation rating of 20/110 to isophorone.
(d) Effects on the Nervous System
Mendell et al [70] exposed rats, cats, and chickens to methyl n-butyl 
ketone to observe its effects on the peripheral nervous system. Four 
Sprague-Dawley rats and four domestic cats were initially exposed to methyl 
n-butyl ketone at 600 ppm (2,460 mg/cu m), 24 hours/day, 7 days/week, for 
up to 12 weeks. Chickens were initially exposed at 200 ppm (820 mg/cu m). 
Exposures were later adjusted to 100 ppm (410 mg/cu m) for chickens and to 
400 ppm (1,640 mg/cu m) for rats and cats to minimize complications from 
starvation and weight loss. Environmental conditions in the exposure 
chamber were maintained at a normal atmosphere. Methyl n-butyl ketone 
concentrations were monitored by gas chromatography. Pair-fed animals were 
used as the controls. Electromyographic studies were performed weekly on 
all cats exposed to methyl n-butyl ketone. The electromyograms were 
recorded from several muscles, eg, the supraspinatus, triceps, and extensor 
carpi, with monopolar electrodes. At the end of the experiment, exposed
98
animals and an equal number of control animals were killed, and selected 
muscles were examined by light microscopy. Thin sections of the sciatic 
nerve were examined by electron microscopy.
All the exposed animals developed peripheral neuropathy during the 
exposure [70]. The earliest sign of peripheral neuropathy in chickens was 
the inability to stand at 4-5 weeks. Cats dragged their limbs at 5-8 weeks 
and later had forelimb weakness. Rats dragged their hindlegs at 11-12 
weeks. Exposed rats greatly increased their water intake.
Between 4 and 6 weeks, electromyographic examination of all exposed 
cats showed abnormal insertional activities accompanied by positive waves
[70]. Fibrillation potentials appeared in their muscles while they were at 
rest and accompanied insertional activity during the 9th and 10th weeks. 
In all exposed cats, the ulnar nerve conduction velocity was decreased 
between 7 and 9 weeks to an average of 50 meters/second. (Normal velocity 
in that laboratory was 115.) The electromyographic changes occurred in all 
the muscles tested. Although a few polyphasic potentials were seen at 8-9 
weeks, the amplitude of motor unit action potentials did not differ 
significantly from that of controls.
The authors [70] concluded that peripheral neuropathy had been 
induced in all three species exposed to methyl n-butyl ketone at 100-600 
ppm (410-2,460 mg/cu m) for 1,440 hours (24 hours/day for 2 months). This 
conclusion correlated well with their earlier finding that peripheral 
neuropathy developed in workers exposed to methyl n-butyl ketone for 1,584 
hours (22 days/month, 8 hours/day, for 9 months). They also concluded that 
the neuropathy observed in the animals was similar, according to clinical 
criteria, to that seen in affected workers who used methyl n-butyl ketone.
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In both cases, the neuropathy involved predominantly motor or muscular 
weakness, and the nerve conduction velocity decreases noted in humans were 
also seen in the exposed animals.
Spencer et al [71] studied the effects of methyl n-butyl ketone and 
methyl isobutyl ketone on adult rats. Six rats were exposed to each ketone 
for 6 hours/day, 5 days/week, for 4 months. Three rats served as controls. 
The concentration of methyl n-butyl ketone in the exposure chamber was 
calculated as 2,000 ppm (8,200 mg/cu m) and determined to be 1,300 ppm 
(5,330 mg/cu m) when analyzed by gas-liquid chromatography. The 
concentration of methyl isobutyl ketone in the exposure chamber was 
measured at 1,500 ppm (6,150 mg/cu m) by gas-liquid chromatography; the 
authors noted that approximately 3% methyl n-butyl ketone was present as a 
contaminant. The rats were examined periodically for signs of neurologic
effects. After the 4-month exposure, the rats were killed, and various 
nerve tissues were examined microscopically.
Slight narcosis was observed after 4 hours of exposure to methyl n-
butyl ketone, and some loss of coordination was noted after 5.5 hours of
exposure [71]. Slow progressive weight loss was evident from the 73rd day 
of exposure to the end of the exposure period. Animals developed 
symmetrical hindleg footdrop between the 3rd and 4th months of exposure. 
Severely affected rats also exhibited proximal hindleg and foreleg 
weakness.
Microscopic examination showed a consistent distribution of 
peripheral and CNS damage [71]. Degeneration of the peripheral nerve 
fibers was most evident in the intramuscular and distal portions, although 
scattered changes were evident in the sciatic nerve up to the level of the
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dorsal root ganglia. The authors noted that the most prominent early nerve 
fiber abnormality was an axonal dilatation associated with localized fiber 
swelling. Longitudinal sections of nerve fibers and teased fibers showed 
focal, internodal, paranodal, or nodal axonal swellings. Neither 
internodal demyelination nor remyelination was observed.
Animals exposed to methyl isobutyl ketone for 4 months showed a 
normal rate of weight gain, a slight narcosis during exposure, and no signs 
of neurologic dysfunction [71] . Microscopic examination of CNS tissues and 
proximal parts of the peripheral nervous system was insignificant. Frank 
distal nerve fiber degeneration was not observed. However, the most distal 
sections of the ulnar and tibial nerves had many axons with dilated 
mitochondrial remnants, adaxonal Schwann cell invaginations, and case focal 
swellings. The authors concluded that methyl isobutyl ketone was 
relatively ineffective in producing neurologic dysfunction. They noted 
that the minimal neuropathic changes induced by methyl isobutyl ketone may 
be related to the presence of the 3% methyl n-butyl ketone as a contaminant 
of the methyl isobutyl ketone used in this study.
This study [71] showed that, at a methyl n-butyl ketone concentration 
of 2,000 ppm, there was a progressive, symmetrical, distal neuropathy that 
spread proximally with time. The minimal neuropathic changes induced by 
methyl isobutyl ketone were most probably related to methyl n-butyl ketone, 
which was a contaminant.
In 1975, Raleigh and coworkers [72] reported on the toxicity of 
methyl n-butyl ketone in cats. Cats were exposed to methyl n-butyl ketone 
at 100 or 330 ppm (410 or 1,353 mg/cu m) for 6 hours/day, 5 days/week for 
approximately 5 months. No evidence of clinical neuropathy was observed.
I
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However, minimal microscopic changes were observed in nerve fibers 
supplying the interosseous muscle of cats that were exposed at 330 ppm for 
about 4.5 months. No microscopic changes were found in cats exposed at 100
ppm.
In other studies, the authors [72] reported that neuropathy was 
produced in cats that were injected twice daily sc with 150 mg/kg of methyl 
n-butyl ketone, 5 days/week, for 2 months and in dogs that were injected 
twice daily sc with 150 mg/kg of methyl n-butyl ketone, 5 days/week, for 2- 
4 months. No clinical neuropathy was seen in guinea pigs that had 
unreported amounts of methyl n-butyl ketone applied to the skin repeatedly 
for about 8 months.
In 1976, Saida et al [73] studied the effects of methyl n-butyl 
ketone on the nervous system of rats and the effects of methyl ethyl ketone 
on methyl n-butyl ketone toxicity. The authors [73] studied two groups of 
Sprague-Dawley rats. In the first group, 12 rats weighing 190-210 g were 
exposed to methyl n-butyl ketone vapor at a concentration of 400 ppm 
continuously (24 hours/day, 7 days/week), the concentrations being 
monitored by the gas chromatographic method of Mendell and colleagues [70]. 
They were serially killed and examined microscopically for neurologic 
changes. In the second group, 12 rats each weighing 160-180 g were 
continuously exposed to methyl n-butyl ketone at a concentration of 225 ppm 
(922 mg/cu m), to methyl ethyl ketone at 1,125 ppm (3,319 mg/cu m), or to a 
combination of methyl n-butyl ketone at 225 ppm and methyl ethyl ketone at
1,125 ppm. These rats were also serially killed and examined 
microscopically for neurologic changes. Control animals held under similar 
conditions were not exposed. A number of rats exposed to methyl n-butyl
I
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ketone at 400 ppm (1,640 mg/cu m) were killed on the 16th, 28th, and 42nd 
days, and rats exposed at 225 ppm were killed on the 16th, 25th, 35th, 
55th, and 66th days.
Paralysis occurred 42 days after exposure to methyl n-butyl ketone at 
400 ppm and 66 days after exposure to methyl n-butyl ketone at 225 ppm
[73]. The authors reported that an increase in the number of 
neurofilaments and inpouching of the myelin sheath were apparent many weeks 
before the onset of paralysis. In animals exposed to methyl n-butyl ketone 
at 400 ppm for 16 days, the number of neurofilaments significantly 
increased and had increased further when measured after 42 days of 
exposure. In addition, after 42 days of exposure to methyl n-butyl ketone 
at 400 ppm, rats had significantly fewer neurotubules (P<0.01) than did 
controls.
The authors [73] reported that the number of inpouchings of myelin 
sheaths in individual teased nerve fibers was strongly correlated with the 
duration of exposure. In the late stages of neuropathy when the animals 
were paralyzed, the authors occasionally observed Wallerian degeneration of 
nerve fibers.
To determine the earliest site of damage, Saida et al [73] studied 
the anterior horn cells, nerve roots, nerve trunks, intramuscular nerves, 
and motor endplates. No abnormalities were found in the motor endplates or 
intramuscular nerves of the intrinsic foot muscles in rats exposed to 
methyl n-butyl ketone at 225 ppm for 16 days or to a combination of methyl 
n-butyl ketone and methyl ethyl ketone at 225:1,125 ppm for 16 days. 
However, rats exposed to the combination did have more neurofilaments and 
inpouchings of the myelin sheath of the sciatic nerve. After 25 days of
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exposure to the combination, similar changes in the nerve roots and 
intramuscular nerves were noted when clinical paralysis was present, but no 
abnormalities were observed in the axon terminals or postsynaptic membrane 
at the neuromuscular junction. After 66 days of exposure to methyl n-butyl 
ketone at 225 ppm, rats had denervation of motor endplates. No 
abnormalities were observed in anterior horn cells and dorsal root ganglion 
cells.
When the authors [73] compared the effects of methyl n-butyl ketone 
at 225 ppm, of methyl ethyl ketone at 1,125 ppm, and of the two substances 
combined at a ratio of 225:1,125 ppm, they noted striking differences in 
toxicity. With methyl ethyl ketone alone at 1,125 ppm, no peripheral 
neurotoxicity occurred in rats for up to 55 days; additional exposure for 
up to 5 months did not produce abnormalities. Rats exposed to methyl n- 
butyl ketone at 225 ppm did not develop paralysis until they had been 
exposed for 66 days. However, rats exposed to the combination developed 
paralysis after 25 days of exposure. The authors noted that the time of 
onset of inpouchings of myelin sheaths, axonal swelling, and denudation of 
axons was greatly shortened in rats exposed to the combination. The 
authors concluded that the earliest microscopic change produced by methyl 
n-butyl ketone was an increase in the number of neurofilaments in large 
myelinated nerve fibers. Axonal swelling and myelin thinning occurred with 
longer exposures. Inpouchings of the myelin sheath also occurred early in 
neuropathy and increased in number as exposure continued.
These studies show that methyl ethyl ketone alone at 1,125 ppm did 
not produce peripheral neuropathy in rats after repeated exposure.
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However, methyl ethyl ketone shortened the latency period of the onset of 
methyl n-butyl ketone-induced peripheral neuropathy.
Spencer and Schaumburg [74] studied the effects of repeated sc 
injections of three ketones individually and in combination. Each cat was 
injected twice daily with 150 mg/kg of the test substances. Eight cats 
were injected with undiluted methyl n-butyl ketone, six with methyl ethyl 
ketone, four with methyl isobutyl ketone, four with a 9:1 mixture of methyl 
ethyl ketone and methyl n-butyl ketone, and six with a 9:1 mixture of 
methyl ethyl ketone and methyl isobutyl ketone for 5 days/week for up to
8.5 months. Four cats received twice-daily injections of an equivalent 
volume of saline, and three other cats given no injections were used to 
study normal tissue.
Two series of 20 biopsies were performed on some cats [74]. Tissue 
samples were taken from the right hindfeet after 45 days and from the left 
hindfeet after 135 days. Tissues sampled at biopsy included pacinian
corpuscles, branches of the lateral plantar nerves, and portions of a 
superficial interosseous muscle.
Morphologic studies were conducted on three cats that received methyl 
n-butyl ketone for 2, 4, and 6 months [74]. The tissues sampled were the 
pacinian corpuscles in hindfeet, the sciatic, tibial, peroneal sural, and 
plantar nerves in the hindlegs,- the proximal and distal hindleg muscles, 
the lumbosacral dorsal root ganglia and corresponding dorsal and ventral 
roots, and multiple levels of the spinal cord and medulla oblongata.
The authors [74] reported that the cats often salivated excessively 
and showed signs of narcosis shortly after injections. Abscesses and skin 
ulcers appeared at the injection site in several animals. All 10 cats
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receiving injections of methyl ethyl ketone or a 9:1 mixture of methyl
ethyl ketone and methyl n-butyl ketone died after 31-93 days. Two cats 
receiving injections of methyl n-butyl ketone alone died after 7 and 93
days. The cats given methyl isobutyl ketone did not die.
Spencer and Schaumburg [74] detected neurologic dysfunction only in 
cats that were given methyl n-butyl ketone alone. The first sign of
peripheral neuropathy was a weakness of the hindquarters after 8-10 weeks 
of methyl n-butyl ketone injections. After 10-12 weeks, the cats had
severe hindleg footdrop and, by 16 weeks, they could not walk. Cats 
injected with methyl ethyl ketone, methyl isobutyl ketone, or 9:1 mixtures 
of methyl ethyl ketone with methyl n-butyl ketone or methyl isobutyl ketone 
had no neurologic dysfunction.
Cats given methyl n-butyl ketone and a 9:1 mixture of methyl ethyl 
ketone and methyl n-butyl ketone had nerve fiber damage [74]. Tissues from 
the cats given the other ketones appeared normal. Cats given methyl n- 
butyl ketone for 45 days had a proliferation of neurofilaments in pacinian 
corpuscles with subsequent degeneration of axoplasm. After 135 days, 
pacinian corpuscles were either denervated or had extensive axonal damage. 
Focal giant axonal swelling was seen in plantar nerves and interosseous 
muscles. No changes were apparent in hindleg tissues from cats that 
received a 9:1 mixture of methyl ethyl ketone and methyl n-butyl ketone for 
45 and 135 days; however, after 8.5 months, tibial nerve branches contained 
abnormal numbers of fibers that had segmental remyelination. Pacinian 
corpuscles appeared normal.
The peripheral and central nervous systems were studied in three cats 
that received methyl n-butyl ketone for 2, 4, and 6 months [74]. One cat
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given injections for an unspecified period had no signs of neurologic 
dysfunction, but parts of its peripheral nervous system showed changes 
characteristic of neuropathy induced by methyl n-butyl ketone. The other 
two cats had overt signs of neuropathy. There was microscopic evidence in 
the cat that was treated for 4 months, but the authors discussed both cats 
in general. The cats had nerve fiber degeneration, proximal muscle fiber 
atrophy, and axonal swellings in the sciatic nerve. Giant axonal 
swellings of myelinated fibers, enlargement of nerve terminals, and total 
fiber breakdown were found in the CNS.
Spencer and Schaumburg [74] concluded that methyl n-butyl ketone 
produced a primary axonal degeneration that affected the distal regions of 
nerves first and then progressed proximally. To describe this pattern, 
they referred to an earlier study [75] in which they proposed the term 
"central-peripheral distal axonopathy."
They [74] found microscopic evidence of neuropathy in cats that
received a 9:1 mixture of methyl ethyl ketone and methyl n-butyl ketone. 
They noted that this subclinical damage appeared to be caused by methyl n- 
butyl ketone in the amount given (15 mg/kg), but they also pointed out 
that, as reported by Saida et al [73], methyl ethyl ketone may have 
potentiated the toxicity of methyl n-butyl ketone.
This study [74] further confirmed that methyl n-butyl ketone is a
neurotoxic agent. It also showed that repeated administration of only 
methyl ethyl ketone produced no clinical or microscopic evidence of 
neuropathy. Repeated injections of methyl isobutyl ketone of 98.8% purity 
and of a 9:1 mixture of methyl ethyl ketone and methyl isobutyl ketone also
produced no clinical or microscopic evidence of neuropathy. These findings
107
confirm the suggestions of Spencer et al [71] that the subclinical plantar 
nerve damage in rats exposed to commercial grade methyl isobutyl ketone for 
up to 5 months was probably caused by 3% methyl n-butyl ketone in the
methyl isobutyl ketone used for this study.
Krasavage et al [76] also found neurotoxic effects of methyl n-butyl 
ketone. Two groups of 18 male Sprague-Dawley rats were exposed at vapor 
concentrations of 100 and 330 ppm for 6 hours/day, 5 days/week, for 72 
weeks. Beginning at 4 weeks and continuing at about 6-week intervals for 
the first 52 weeks, rats were killed and examined by light and electron 
microscopy.
Neuropathy (hindlimb weakness and microscopic evidence of nerve 
damage) was seen only in rats that were exposed at 330 ppm (1,353 mg/cu m) 
[76]. This first appeared in 1 rat after 149 exposures. Although weight 
gain was depressed in both groups, no evidence of neurotoxicity, either 
clinical or microscopic, was observed at 100 ppm.
DeJesus et al [77] studied the effects of methyl n-butyl ketone and
methyl ethyl ketone on peripheral nerves of Wistar rats. Animals were
exposed for 6 hours/day, 5 days/week to methyl n-butyl ketone vapor at 60
ppm (246 mg/cu m) for 6 weeks, and at 100 ppm (410 mg/cu m) for 4 weeks,
and at 1,050 and 1,450 ppm (4,305 and 5,945 mg/cu m) for 5 weeks. Rats
were also exposed to methyl ethyl ketone vapor at 2,150 ppm for 6 weeks and
at 4,740 ppm (13,983 mg/cu m) for 4 weeks.
Rats exposed to methyl n-butyl ketone at 1,050 and 1,450 ppm
developed typical signs of peripheral neuropathy. These signs were hindleg 
dragging, decreased motor conduction velocities in sciatic nerves, 
decreased evoked muscle action potentials, and weight loss. Rats exposed
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to methyl ethyl ketone at 2,150 and 4,740 ppm and rats exposed to methyl n- 
butyl ketone at 60 and 100 ppm had no signs of peripheral neuropathy.
Schaumburg and Spencer [78] studied the effects on the hypothalamus 
and optic nerve tract of cats given 2,5-hexanedione, a compound suggested 
to be a neurotoxic metabolite of methyl n-butyl ketone. Four young adult 
cats were given 0.5% 2,5-hexanedione in their drinking water for up to 136 
days and then were perfused with a fixative. Two untreated cats served as 
controls. After 60-75 days, cats had an unsteady gait and distal weakness 
in the lower extremities. Further treatment produced a progressive 
symmetrical weakness with footdrop. At the time of perfusion, cats were 
quadriparetic and unable to walk. Visual loss, abnormal pupillary 
reflexes, nystagmus, staggering, and hoarseness were not observed.
The authors [78] found evidence of giant axonal degeneration that was 
similar to the findings of other investigations [71,74]. They also found 
advanced distal fiber degeneration in the rostral gracile, dorsal 
spinocerebellar, and caudal corticospinal tracts. In contrast, early 
axonal swellings were found throughout the mammillary bodies, the lateral 
geniculate body and distal optic tract, and the superior colliculus that 
were not associated with necrosis, macrophage accumulation, or hemorrhage. 
The optic nerves, vestibular nuclei, dorsal medial thalamic nuclei, and 
inferior colliculi were normal. The authors suggested that these changes 
might be responsible for the alterations of memory and vision that have 
occasionally been reported in n-hexane neuropathy. They thought that CNS 
degeneration might be irreversible.
Goldberg et al [79] studied modifications to behavior in rats induced 
by inhalation of vapors from several industrial solvents, including
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acetone. Conditioned avoidance and escape in a modified pole-climbing test 
were the two behavioral patterns observed. Rats were trained to climb the 
pole within 2 seconds after receiving a stimulus. Any delay of response 
greater than 6 seconds was considered a significant change in behavior.
Female CFE rats, weighing 140-180 g, were selected for exposure 
according to their training performance in the behavioral testing apparatus 
before exposure [79]. The rats, in groups of 8-10, were exposed at nominal 
concentrations of 3,000, 6,000, 12,000, and 16,000 ppm (7,110, 14,220,
28,440, and 37,920 mg/cu m). The actual concentrations, as determined by 
an interferometer, were found to be within 10% of these concentrations. 
Rats were exposed for 4 hours/day, 5 days/week, for 2 weeks, and tested for 
performance before and after each exposure. Rats exposed to acetone at 
concentrations above 3,000 ppm showed some behavioral changes, but no 
alteration of avoidance or escape behavior was observed in rats exposed at
3.000 ppm [79]. At 6,000 ppm 38% of the rats showed an inhibition of 
avoidance behavior after the 1st day of exposure and 25% after the 2nd day, 
but no decrement was reported after the remaining exposures. None of the 
animals exposed at this concentration showed decreased escape behavior. 
After the first exposure at 12,000 ppm, 50% of the rats showed inhibited 
avoidance response and 12% showed inhibited escape response. After the 
second exposure, avoidance response was inhibited in 37%, but the escape 
response was no longer inhibited. After three exposures, the avoidance 
response was inhibited in 25% of the rats, and no further inhibition 
occurred after additional exposures. Several rats exposed at 12,000 or
16.000 ppm developed muscular incoordination after one exposure; however, 
no signs of muscular incoordination were noted after subsequent exposures.
Of the rats exposed at 16,000 ppm, 62% had an inhibition of the avoidance 
response after one exposure. The escape response was inhibited in 25% of 
these animals after one exposure; however, as in the previous group, no 
inhibition was observed on subsequent days. The avoidance response was 
inhibited in 37% of the rats after 2 exposures, in 37% after 3 exposures, 
and in 25% after 4, 5, and 10 exposures. The inhalation of acetone did not 
significantly affect the growth rate of exposed animals compared to control 
rates.
Goldberg and coworkers [79] showed that acetone at concentrations of
6,000 ppm or more modified avoidance and escape in rats. Many of the rats 
exposed at 12,000 and 16,000 ppm developed tolerance, and escape responses 
were less inhibited than avoidance responses by exposure to acetone. 
Inhalation of acetone at increasing concentrations produced modification of 
behavior in an increasing proportion of the experimental population.
Johnson et al [80] studied the effects of methyl n-butyl ketone on 
behavior and the nervous system. Groups of 10 albino male rats and 8 male 
monkeys were exposed to methyl n-butyl ketone at 97 or 976 ppm (398 or 400 
mg/cu m) for 6 hours/day, 5 days/week. Similiar but unexposed groups of 
rats and monkeys served as controls. For neurologic tests in rats and 
monkeys, maximum motor conduction velocities, absolute refractory period, 
and muscle action potentials were recorded. In addition, 
electroencephalograms and visually evoked potentials were recorded from 
monkeys.
For behavioral studies, 12 Sprague-Dawley albino rats were trained on 
a multiple fixed ratio 5, fixed interval 3-minute schedule (mult FR5FI3) 
[80]. Six standard operant test enclosures with a press bar, food cup, and
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feeder were used. A red light was associated with the fixed ratio and a 
yellow light with the fixed interval of the operant schedule. Inter­
response times were recorded separately from each component of the multiple 
schedule of reinforcement. Stability in responding was reached after 20-40 
days of training. For recovery studies, three monkeys from each exposed 
group were neurologically tested monthly until recovery was evident. Motor 
conduction velocity in the sciatic tibial nerve was the measurement used to 
evaluate neurologic recovery because, as the authors stated, it had given 
the earliest indication of methyl n-butyl ketone-induced neurotoxicity at 
both exposure levels.
After 25 weeks of exposure to methyl n-butyl ketone at 976 ppm the 
experiment was terminated because hindlimb drag was evident in both rats 
and monkeys [80]. The authors reported that exposure at 976 ppm reduced 
motor conduction velocities in ulnar and sciatic-tibial nerves, decreased 
the evoked muscle action potentials, lengthened implicit time of visually 
evoked potentials, impaired operant behavioral performance, and reduced 
body weight.
In monkeys, the first significant decrease in motor conduction 
velocity occurred after 4 months of exposure at 976 ppm [80]. At 97 ppm, 
the first significant decrease in motor conduction velocity occurred after 
9 months. In rats exposed at the higher concentration, a significant 
decrease in motor conduction velocity occurred after 13 weeks.
Operant behavior in rats exposed at 976 ppm first appeared to be 
significantly impaired after 2 weeks [80]. No effects on operant behavior 
were found after exposure at 97 ppm.
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The study of Johnson et al [80] is in agreement with the findings of 
other investigators [70-72,74] on the neurotoxicity of methyl n-butyl 
ketone. An interesting finding was the impaired operant behavior after 2 
weeks of exposure at 976 ppm because other measurements indicated that 21 
weeks of exposure was necessary to produce detectable nerve damage. These 
findings are consistent with a suggestion that modification of behavior 
might occur in humans exposed to methyl n-butyl ketone before the onset of 
peripheral neuropathy.
Anger and coworkers [81] described, in a report available only as an 
abstract, the effects of methyl n-amyl ketone by inhalation exposures and 
ip injections on multiple fixed ratio, fixed interval (MULT FRFI) response 
rates in rats. Twelve rats were injected intraperitoneally (ip) with
methyl n-amyl ketone at 18, 37, 74, and 175 mg/kg and were tested 15
minutes after treatment.
At 18 mg/kg, there was little effect on the fixed interval response 
rate, a moderate decrease in FI rate at 37 and 74 mg/kg, and a near 
cessation of responding at 175 mg/kg. Changes were statistically 
significant at 37, 74, and 174 mg/kg. Inhalation exposures to methyl n-
amyl ketone at concentrations in excess of 1,600 ppm (7,472 mg/cu m) had 
effects similar to those in animals that were injected with 175 mg/kg.
Johnson et al [82] described an electrodiagnostic study of the 
neurotoxicity of methyl n-amyl ketone. Rats and monkeys were exposed to 
methyl n-amyl ketone at 0, 131, and 1,025 ppm (612 and 4,787 mg/cu m) for 6 
hours/day, 5 days/week for 9 months. Conventional procedures were used
throughout the study. None of the animals showed any clinical signs of 
illness during the course of the study. No impairment in locomotion,
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grip, or gait was observed. Electrodiagnostic studies in the form of 
maximum motor conduction velocities in sciatic-tibial and ulnar nerves in 
all exposed animals did not differ significantly from those of controls. 
Microscopic examination revealed no tissue damage.
This study [82] provides evidence that methyl n-amyl ketone is not 
neurotoxic. Because methyl n-amyl ketone is one of the two closest 
homologs of methyl n-butyl ketone, methyl n-propyl ketone being the other, 
this evidence suggests that the straight-chain 6-carbon structure is 
essential for producing neurotoxic effects.
(e) Metabolism
The metabolic pathways for the degradation and biotransformation of 
the ketones are not completely understood. Several intermediates and 
endproducts have been identified for methyl n-butyl ketone, methyl ethyl 
ketone, methyl isobutyl ketone, and cyclohexanone, and, correspondingly, 
several steps in the pathway have been postulated for these ketones. In 
general, the proposed pathways include an oxidative hydroxylation to the 
corresponding hydroxy ketone, followed by a reduction to the secondary 
alcohol or further oxidation to the dione. Although data do not exist for 
the other ketones, it is reasonable to suggest that they also follow these 
metabolic steps.
DiVincenzo et al [83] reported that male guinea pigs metabolized 
methyl n-butyl ketone, methyl isobutyl ketone, or methyl ethyl ketone, 
after a single ip dose of 450 mg/kg, to their corresponding alcohols, with 
subsequent oxidation steps occurring as shown in Table III-6. In general, 
all three ketones were both oxidatively and reductively metabolized. 
Oxidation occurred by hydroxylation of the omega-1 carbon, ie, the next to
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the last carbon, to form the corresponding hydroxy ketone, and reduction 
occurred at the carbonyl group to form the corresponding secondary alcohol. 
Although the proportion of metabolites may differ, omega-1 oxidation and 
carbonyl reduction appear to be the initial steps in the metabolic pathways 
in guinea pigs.
TABLE III-6 






























Adapted from reference 83
DiVincenzo et al [83] concluded that the predominant metabolite of 
methyl n-butyl ketone was 2,5-hexanedione, which could be reduced to 5- 
hydroxy-2-hexanone but was probably not significantly converted to 2,5- 
hexanediol. Comparison of the metabolism of the hydroxy ketone and the 
dione showed that the formation of the dione was favored. Another 
metabolite, 2-hexanol, could be further metabolized to 2,5-hexanediol, 5-
hydroxy-2-hexanone, 2,5-hexanedione, and to methyl n-butyl ketone. When n-
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hexane was injected ip into guinea pigs at 250 mg/kg, 5-hydroxy-2-hexanone 
and 2,5-hexanedione were detected [83]. The authors noted the importance 
of finding 5-hydroxy-2-hexanone and 2,5-hexanedione as common metabolites 
of n-hexane and methyl n-butyl ketone because n-hexane also has been 
reported to cause peripheral neuropathy [84].
A later study by DiVincenzo and colleagues [85] in which 20 or 200 
mg/kg of 14C-methyl n-butyl ketone was given by gavage to rats showed that 
about 6% of the administered dose was excreted in the breath as unchanged 
methyl n-butyl ketone and 38% as carbon dioxide. An additional 40% of the 
dose was excreted in the urine, and 8% remained in the carcass after 6 
days. Serum metabolites were reported as 2-hexanol, 5-hydroxy-2-hexanone, 
and 2,5-hexanedione. Metabolites identified in urine were 2-hexanol, 5- 
hydroxy-2-hexanone, 2,5-hexanedione, 2,5-dimethyIfuran, gamma-
valerolactone, norleucine, and urea. Besides the reduction of the carbonyl 
group and oxidation of the omega-1 carbon atom, a major metabolic pathway 
was the oxidation of the alpha carbon to form an alpha-keto acid. 
Decarboxylation of this acid apparently accounted for most of the 
respiratory carbon dioxide produced. Transamination of the alpha-keto acid 
to form the amino acid, norleucine, was a minor metabolic pathway.
The authors [85] noted that pretreatment with SKF 525A produced an 
increase in respiratory carbon dioxide and a decrease in urinary 
radioactivity, suggesting that omega oxidation was mediated by a microsomal 
mixed-function oxidase system. Phénobarbital pretreatment increased the 
amount of labeled carbon dioxide in the first 4 hours but did not alter its 
subsequent output. A proposed metabolic pathway developed largely from 
information on guinea pigs is shown in Figure III-l.
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Krasavage et al [86] studied the neurotoxic effects of several methyl 
n-butyl ketone metabolites and n-hexane in rats. Equimolar doses of 6.6 
millimoles/kg were given by gavage to male Charles River rats 5 days/week 
for 90 days. Relative neurotoxicity was evaluated by comparing the time of 
onset of severe hindleg weakness. The compounds studied were methyl n- 
butyl ketone, n-hexane, 2,5-hexanedione, 2,5-hexanediol, 5 hydroxy-2- 
hexanone, and 2-hexanol.
Microscopic and clinical examination showed that each compound except 
n-hexane produced a typical giant axonal neuropathy and severe hindleg 
footdrop [86] . The relative order of the neurotoxicity of the hexacarbon 
compounds studied, in decreasing order, was 2,5-hexanedione, 5-hydroxy-2- 
hexanone, 2,5-hexanediol, methyl n-butyl ketone, and 2-hexanol. No 
evidence of neuropathy was found in n-hexane-treated animals or in 
controls.
Couri et al [87] reported that aniline hydroxylase activity was 
significantly increased in liver microsomal preparations from rats exposed 
continuously or intermittently (7 hours/day) for 7 days to a combination of 
methyl ethyl ketone and methyl n-butyl ketone (P<0.05). The continuous 
exposure significantly increased aminopyrine demethylase, para- 
nitrobenzoate reductase, and neoprontosil reductase activities in the 
microsomal preparations (P<0.01). Intermittent exposure caused a 
significant decrease in para-nitrobenzoate reductase activity (P<0.05), but 
it did not affect aminopyrine demethylase or neoprontosil reductase 
activities. The explanation for the discrepancy in the data on the effect 
of ketone exposure on the activity of para-nitrobenzoate reductase is not 
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methyl n-butyl ketone metabolism and thus increase the production of 2,5- 
hexanedione which is neurotoxic [72].
In 1943, Treon et al [88] found a decrease in the ratio of inorganic 
sulfates to total sulfates and an increase in the level of glucuronic acid 
in the urine of rabbits exposed to cyclohexanone. On the basis of a 
monomolecular conjugation, the investigators determined that approximately 
45-50% of the administered oral dose was excreted in conjugation with 
glucuronic acid. Elliott et al [89] also reported that rabbits given 248 
mg/kg of cyclohexanone by stomach tube eliminated 66% (51-86%) of the 
administered dose as cyclohexylglucuronide in the urine. Because 
cyclohexanol also was metabolized to cyclohexylglucuronide, it is possible 
that cyclohexanone is first reduced to cyclohexanol and then is conjugated 
with glucuronic acid. James and Waring [90] showed that rabbits and rats 
given oral doses of cyclohexanone excreted trace amounts of 
hydroxycyclohexylmercapturic acid and cis-2-hydroxycyclohexylmercapturic 
acid in the urine. From these data [88-90], it seems reasonable to 
conclude that the principal metabolic pathway of cyclohexanone in rats and 
rabbits is reduction to cyclohexanol and subsequent conjugation with 
glucuronic acid.
Abdel-Rahman et al [91] found a peak blood methyl n-butyl ketone 
concentration of 650 Mg/ml in male rats given a 160-mg ip dose of methyl n- 
butyl ketone. The half-life for the rapid elimination from the blood was 
about 10 minutes, followed by a slower phase of elimination with a 7-hour 
half-life. When male rats were continuously exposed to methyl n-butyl 
ketone at 400 ppm for either 6 or 60 days, the parent compound could not be 
detected in the blood.
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Guinea pigs receiving phenobarbital prior to methyl n-butyl ketone ip 
injections had increased 2-hexanol concentrations in the blood at 100 
minutes after exposure and substantially increased 2,5-hexanedione 
concentrations at 50, 100, and 180 minutes after exposure [91]. In rats, 
phenobarbital conditioning increased 2-hexanol concentrations 200 minutes 
after exposure and increased 2,5-hexanedione concentrations at 50, 100,
160, and 200 minutes after exposure. Phenobarbital also enhanced the 
urinary excretion of 2,5-hexanedione in rats and of methyl n-butyl ketone, 
2-hexanol, and 2,5-hexanedione in guinea pigs.
In another experiment, 61% of a total ip dose of tritiated methyl n- 
butyl ketone administered to rats was recovered in 72 hours [91]. In the 
first 24 hours, 12.7% was excreted in the expired air, 31.8% in the urine, 
and 2% in the feces; in the first 72 hours, these values were 12.8, 40.1,
and 7.9%, respectively.
Raleigh and coworkers [72] also reported that 2,5-hexanedione was a 
major metabolite of methyl n-butyl ketone in several species of animals. 
Peripheral neuropathy was produced in rats by a daily sc injection of an 
average of 340 mg/kg of 2,5-hexanedione, 5 days/week, for 19 weeks or by an 
average dose in drinking water of 520 mg/kg/day for about 2 months. 
Although many experimental details were omitted, these findings are in 
agreement with the results of other investigators [71,78,92].
(f) Carcinogenesis, Mutagenesis, Teratogenesis, and Effects 
on Reproduction
No studies implicating the ketones as possible carcinogens or 
mutagens were found in the literature. However, some studies that produced
1 2 0
negative results were found. McCann et al [93] found that acetone was not
mutagenic in the Ames test. Van Duuren et al [94] applied 0.1 ml of
acetone 3 times/week to the skin of mice for 1 year and found no evidence 
of tumors 208 days later. McLaughlin et al [95] injected 39 and 78 mg of
acetone into the yolks of fertile chick eggs prior to incubation and found
no evidence of teratogenicity. DiPaolo et al [96] used an acetone
concentration of 0.02% or less in the growth medium of cultures of 
embryonic cells of the Syrian hamster uterus and found no transformation to 
altered clones of diminished cloning efficiency. N10SH found no evidence 
of mutagenic activity in cyclohexanone by the Ames test (G Taylor, written 
communication, March 1978) .
Schwetz et al [97] exposed pregnant Sprague-Dawley rats to methyl 
ethyl ketone in a study of possible teratogenic effects. On days 6-15 of 
gestation, 23 rats were exposed to methyl ethyl ketone for 7 hours/day at 
an average concentration of 1,126 ppm, and 21 rats were exposed at an 
average concentration of 2,618 ppm. A control group of 43 pregnant rats 
was exposed to filtered room air. Observations and measurements included 
maternal and fetal mortality, gross appearance and body weight, maternal 
liver weight and behavior, number of resorptions, and serum glutamic- 
pyruvic transaminase (SGPT) activity on day 21 of gestation.
No gross anomalies were observed in the dams exposed at either 
concentration [97]. Exposure to methyl ethyl ketone did not appreciably 
affect the number of corpora lutea/dam, the number of implantation 
sites/litter, the number of live fetuses/litter, or the percentage of 
resorptions. Methyl ethyl ketone at 1,126 ppm significantly reduced the 
fetal body weights and fetal crown to rump length (P<0.05), but these
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changes were not apparent in rats exposed at the higher concentration. No 
gross anomalies were observed in the fetuses of rats exposed at 1,126 ppm, 
but four fetuses were affected at the higher concentration. Two of these 
had short lower jaws, and two had no tails with an imperforate anus. The 
authors stated that these anomalies had never been seen in over 400 control 
litters that had been examined in their laboratory. The total incidence of 
skeletal anomalies was significantly greater than the control incidence for 
the group exposed at 1,126 ppm but not in the rats exposed at 2,618 ppm. 
The most prevalent skeletal effects involved the sternum, and rats exposed 
at 2,618 ppm had a significantly greater number of sternal anomalies than 
did the controls. Total soft tissue effects, including subcutaneous edema 
and dilated ureters, were more frequent in the offspring of exposed rats 
than in the controls, but the difference was significant only at the higher 
concentration.
Exposure to methyl ethyl ketone did not affect maternal body weight, 
maternal liver weight, liver appearance, SGPT activity, or the general 
behavior of the rats [97] .
Rats exposed at the higher concentration occasionally ate less food
than did controls; while this difference was statistically significant 
during two 2-day measuring periods, the difference was only about 10-15%.
The authors concluded that methyl ethyl ketone, on the basis of these 
results in fetuses from dams exposed to the solvent, was embryotoxic, 
fetotoxic, and potentially teratogenic to rats. It is difficult to draw 
conclusions from this study with confidence because of the lack of a dose- 
response relationship from such effects as total skeletal anomalies and 
fetal size, ie, crown to rump length. On the other hand, the greater
1 2 2
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incidence of sternebral and soft tissue anomalies at the higher 
concentration lends some credence to the results. It is noted that the 
data were analyzed by litters rather than in terms of individual animals. 
An analysis of data on individual animals might also have been useful.
Because of the possible implications of this study in terms of 
hazards to unborn children of working mothers, it is important that this 
work be verified or refuted by additional research, both in terms of this 
specific ketone and in terms of other ketones.
Griggs et al [98] studied the effects of cyclohexanone on chick 
embryos. Fertile eggs were placed in a 37 C incubator containing 
cyclohexanone at an undescribed concentration. Two groups of eggs were 
exposed for 3 or 6 hours prior to incubation. Three other groups were 
similarly exposed for 3, 6, or 12 hours after being incubated for 96 hours. 
After exposure, eggs were kept in hatching incubators for 13 days, and then 
most embryos were examined for viability, gross appearance, and microscopic 
changes in the heart, liver, and brain [98]. In addition, blood serum 
tests, including determinations of serum cholesterol, bilirubin, albumin, 
uric acid, urea nitrogen, lactate dehydrogenase, lipids, alkaline 
phosphatase, calcium, inorganic phosphate, serum glutamic-oxaloacetic 
transaminase (SGOT), mean packed erythrocyte volume, and hemoglobin 
concentration, were performed on selected embryos.
The body weight of all exposed embryos without incubation before 
exposure were significantly less than those of their respective controls 
(P<0.01) [98], In contrast, the weights of the exposed embryos that had 96 
hours of incubation before exposure varied with respect to controls. The 
only changes in serum indices after exposure to cyclohexanone were a
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decreased calcium level and an increased inorganic phosphate concentration 
and SGOT activity. Gross inspection of the chicks showed no effects on the 
head, beak, toes, eyes, and feathers. No changes were found in the hearts 
and brains that were examined, but livers of exposed chicks appeared darker 
than those of the controls.
Chicks that hatched from eggs exposed to cyclohexanone for 3 hours 
after a 96-hour incubation could not stand and exhibited spastic motions 
when they tried to move [98]. Their only anatomical abnormality was a 
curling inwards of their toes. No changes were noticed in the chicks that
hatched from eggs exposed for 6 or 9 hours, but 20-50% of the exposed eggs
did not hatch compared to 10-20% of the control eggs. The authors did not
examine the nervous systems and therefore could not determine whether
cyclohexanone acted centrally or caused lesions in the peripheral nervous 
system. Interpretation of the implications of these results should, if 
possible, await confirmation in placental mammals.
Correlation of Exposure and Effect
All of the ketones except methyl isoamyl ketone have been reported to 
cause some degree of systemic organ damage [20,21,34,54,57,99] which 
generally occurred only at very high concentrations. Some of the ketones, 
however, have produced significant organ damage at lower concentrations. 
Cyclohexanone at 608 ppm for 300 hours produced extensive injury to heart 
muscle, lungs, liver, and kidneys in monkeys [54]. Mesityl oxide at 250 
ppm for 240 hours caused congestion in livers and lungs and dilated 
Bowman's capsules and swollen convoluted tubular epithelium in the kidneys
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of guinea pigs [21] . Isophorone at 500 ppm for 240 hours produced severely 
injured kidneys or lungs or both in rats and guinea pigs.
All of the ketones except methyl isoamyl ketone have been reported to 
produce irritation of the eyes, nose, or throat. Specht et al [34] gave 
evidence suggesting that the irritation produced by the homologous ketones 
increased in proportion to the number of carbon atoms. Acetone, for 
example, was only slightly irritating at 20,000 ppm, but methyl n-butyl 
ketone was extremely irritating at 6,000 ppm. The nonhomologous six-carbon 
ketones (methyl isobutyl ketone, cyclohexanone, and mesityl oxide) were 
also extremely irritating. Specht et al [34] found that methyl n-butyl 
ketone and cyclohexanone at 6,000 and 4,000 ppm, respectively, produced 
clouding of the corneas of guinea pigs that persisted after the exposure 
period. Rengstorff et al [66] found that cutaneous application of 0.5 ml 
of acetone or cyclohexanone and sc administration of 0.05 ml of acetone or 
cyclohexanone, three times/week for 3 weeks, produced cataracts in guinea 
pigs. Generally, the cataracts were first seen 3 months after treatment 
with the ketones. In some cases, lens damage was reversed within the first 
3 months.
The results of sensory threshold studies in humans [15,16] also 
indicate that the high molecular-weight ketones are, in general, more 
irritating. Isophorone, a ketone that contains nine carbon atoms, was 
perceived as being irritating by the subjects at significantly lower 
concentrations than those of acetone and methyl ethyl ketone that caused 
irritation [15] . Yant et al [52] reported that methyl n-propyl ketone at 
1,500 ppm produced moderate to marked irritation of the eyes and nose of 
humans after an unspecified exposure period. Raleigh and McGee [17] found
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eye, nose, and throat irritation in a small group of workers exposed to 
acetone for 8 hours at an average concentration of 1,000 ppm. Matsushita 
et al [18] reported that most subjects exposed to acetone at 500 and 1,000 
ppm had irritation of the eyes, nose, and throat.
Probably because of their excellent lipid solvent properties and, 
thus, their defatting action, the liquid ketones produce adverse effects on 
the skin. Lupulescu and Birmingham [32] found intercellular edema and
disruption of the cells of the keratin layer in volunteers exposed to
liquid acetone. Smith and Mayers [33] reported that methyl ethyl ketone at 
300-600 ppm produced dermatitis in exposed workers after an unspecified 
period of exposure. Linari et al [30] found skin lesions in 3 of 19 
workers exposed to methyl isobutyl ketone at 80-500 ppm for 20-30 minutes 
daily. These lesions were described as varying from erythema to small 
desquamative areas after an initial dry dermatitis. In a follow-up study, 
Armeli et al [31] reported that dermal lesions were markedly reduced. At 
that time, workers were required to wear gloves and barrier creams. The
workplace environment contained methyl isobutyl ketone at 50-105 ppm, and
exposures lasted for 15-30 minutes daily. These findings and the ability 
of ketones to dissolve lipids suggest that ketones in liquid form may cause 
dermatitis. The question of whether ketone vapor can cause dermatitis is 
not settled, but it seems unlikely; except for some exposures to methyl 
ethyl ketone vapor that appeared to be responsible for dermatitis of the 
face [33], liquid contact was the more likely cause.
Smyth et al [61,62] studied the primary skin irritation produced by 
ketones on rabbits. Methyl n-amyl ketone produced the most severe 
irritation of the ketones considered in this document and was assigned a
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grade of 4. (Grade 6 compounds produced necrosis when applied undiluted.) 
Methyl ethyl ketone was grade 2, and acetone, methyl n-propyl ketone, and 
methyl n-butyl ketone were grade 1, indicating minimal visible capillary 
injection.
Little information was available on percutaneous absorption, although 
the more lipid-soluble ketones would be expected to penetrate the skin more 
readily than the less lipid-soluble ketones. In this respect, Cesaro and 
Pinerolo [24] demonstrated that acetone concentrations in the blood were 
not increased after nude volunteers were exposed to acetone vapor at 
unspecified concentrations for 20-30 minutes. However, Parmeggiani and 
Sassi [27] showed that acetone was absorbed percutaneously when applied to 
the skin of a subject for 30 minutes and the subject remained in a chamber 
for an additional 1.5 hours. This was demonstrated by the levels of 
acetone found in the blood and urine. Munies and Wurster [43] showed that 
methyl ethyl ketone was excreted in the expired air in a few minutes after 
the ketone was placed on the forearm of volunteers. Billmaier et al [38] 
suggested that skin absorption was probably a contributing factor in the 
development of peripheral neuropathy in the workers exposed to methyl n- 
butyl ketone in a coated-fabric plant. Studies by DiVincenzo and 
colleagues [45] support this theory. They demonstrated that methyl n-butyl 
ketone was absorbed through the skin of volunteers at the rate of 4.2-8.0 
/¿g/minute/sq cm.
All of these ketones except methyl isoamyl ketone have been reported 
to cause narcosis or signs of CNS depression. However, had this compound 
been studied, it seems likely that it, like the related ketones, would also 
have been found to have caused CNS depression. Acute intoxication of a 10-
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year-old boy with- acetone resulted in collapse, stupor, and incoherence 
[23]. Eight workers exposed to acetone at a concentration greater than
12,000 ppm felt dizzy and lightheaded and reported weakness of the legs 
[25]. Raleigh and McGee [17] noted headache and lightheadedness in workers 
exposed to acetone for 8 hours at an average concentration of 1,000 ppm. 
Parmeggiani and Sassi [27] found irritation of the eyes, nose, throat, and 
lungs and CNS disturbances in workers exposed to acetone at 307-918 ppm. 
The authors attributed these effects to slight accumulations of acetone in 
the body resulting from repeated exposure to the compound. Vigliani and 
Zurlo [28] reported occasional dizziness and loss of strength in workers 
exposed to acetone at 1,000 ppm 3 hours/day for 7-15 years. DiVincenzo et 
al [42] exposed nine volunteers to acetone at 100 or 500 ppm for 8 hours 
with no symptoms reported except for an awareness of acetone at 500 ppm. 
He also presented evidence that acetone might accumulate in the body at 
these concentrations.
GD Ware (written communication, June 1973) reported to the ACGIH that 
isophorone at 5-8 ppm caused fatigue and malaise in workers. When 
concentrations were reduced to 1-4 ppm, no adverse effects were reported.
In animals, Specht et al [34] reported narcosis and decreased rectal 
temperature, respiratory rate, and pulse rate in guinea pigs exposed to 
acetone, methyl ethyl ketone, methyl n-propyl ketone, methyl n-butyl 
ketone, methyl n-amyl ketone, methyl isobutyl ketone, mesityl oxide, or 
cyclohexanone. Exposures lasted from 204 to 1,405 minutes. Their 
findings, as summarized in Table III-4, indicated that in general the high 
molecular weight ketones were stronger narcotic agents than the low 
molecular weight ketones. Carpenter et al [20] reported that male rats
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exposed to diisobutyl ketone for 7 hours at 1,650 ppm were prostrate at the 
end of the 1st day and had poor coordination at the end of the 2nd day. 
Lehmann and Flury [57] found that diacetone alcohol caused exhaustion in 
rats, mild narcosis in rabbits, and sleepiness in mice, rabbits, and cats. 
Smyth and Seaton [58] noted that single exposures to isophorone produced 
narcosis in rats and guinea pigs.
It is well established that the ketones can produce narcosis at high 
concentrations, so it seems reasonable to infer that modification of 
behavior or impairment of judgment could also occur. Exposure to acetone 
at concentrations that were less than those causing unconsciousness in 
humans did produce stupor, dizziness, and lightheadness, as might be 
expected [17,23,25]. Such effects could lead to serious consequences in 
the workplace. Goldberg et al [79] found that, in rats, acetone at 
concentrations of 6,000 ppm produced modification of behavior involving 
avoidance and escape patterns. Johnson and colleagues [80] demonstrated 
that the response rate in operant behavioral performance was decreased in 
rats that were exposed to methyl n-butyl ketone at 976 ppm for 6 hours/day, 
5 days/week, after 2 weeks of exposure. Anger and coworkers [81] studied 
rats trained on a multiple fixed-ratio, fixed-internal (FRFI) schedule of 
reinforcement. They found methyl n-amyl ketone at 175 mg/kg ip produced a 
near cessation in the fixed interval response rates. Similar effects that 
were not statistically significant were found in rats exposed at 1,600 ppm.
Peripheral neuropathy is the most serious occupational illness 
related to exposure to these ketones. Exposure to methyl n-butyl ketone 
has been associated with this neurologic disorder [37,38,47].
Allen et al [37] reported that 11 workers in a coated-fabric plant
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had a characteristic disabling peripheral neuropathy that was described as 
a distal, motor, and sensory disorder with an insidious onset and minimal 
reflex loss. Electromyographic abnormalities were approximately 
symmetrical and were either restricted to a distal distribution or greater 
in degree in distal muscles than proximal ones. Some of the affected 
workers had washed their hands with a solvent that contained methyl n-butyl 
ketone, although employees who operated the printing machines had ample 
opportunity to inhale the solvent vapors. Analysis of the area around the 
print machines showed methyl ethyl ketone at 331-516 ppm and methyl n-butyl 
ketone at 9.2-36 ppm. Other investigators [39,41] have found similar signs 
of neurologic disorders in workers exposed to methyl n-butyl ketone. These 
studies also indicated that skin contact with methyl n-butyl ketone 
contributed to the development of the peripheral neuropathy.
The incidence of peripheral neuropathy in the print department of the 
coated-fabric plant was 21.5%, which was highly significant (P<0.001) when 
compared to other departments [37,47]. Area atmospheric samples showed 
that printers were exposed to methyl n-butyl ketone at calculated TWA 
concentrations ranging from 2 to 50 ppm. However, because of the poor work 
practices at the coated-fabric plant, it was not certain whether the 
outbreak of peripheral neuropathy was caused by inhalation or skin 
absorption of methyl n-butyl ketone or by a combination of both routes of 
exposure. Questionnaire results showed that workers washed their hands 
with the solvent containing methyl n-butyl ketone, cleaned machines with 
rags dipped by hand in open containers of the solvent, and washed their 
work clothes with the solvent at the plant. Since methyl n-butyl ketone 
penetrates human skin [45], it is highly probable that skin absorption, as
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a result of the aforementioned poor work practices, played a significant 
part in the development of peripheral neuropathy in this case.
DiVincenzo et al [45] have shown that about 75-92% of inhaled methyl 
n-butyl ketone was absorbed by volunteers. When applied to the skin of 
volunteers, about 5 ¿ig/minute/sq cm was absorbed. From these data, it can 
be calculated that immersion of both hands in liquid methyl n-butyl ketone 
for 15 minutes results in the absorption of approximately 13% of the amount 
of ketone absorbed by a worker who is exposed to airborne methyl n-butyl 
ketone at the average TWA concentration of 13.1 ppm. If the immersion time 
had been as much as 30 minutes/day, the contribution of percutaneous ketone 
would have been about one fourth. There is no good information on the role 
of ingestion in these intoxications, but it is thought to have been minor 
or perhaps even negligible.
Several studies on animals have confirmed that methyl n-butyl ketone 
causes peripheral neuropathy [70,71,74,76,77,80,91]. Mendell et al [70] 
reported peripheral neuropathy in chickens, rats, and cats exposed to 
methyl n-butyl ketone at 200-600 ppm for 24 hours/day, 7 days/week. 
Krasavage et al [76] found that methyl n-butyl ketone vapor at 330 ppm, but 
not at 100 ppm, caused clinical and microscopic evidence of neuropathy in 
rats. DeJesus and coworkers [77] found no evidence of neuropathy in rats 
exposed to methyl n-butyl ketone vapor at 60 and 90 ppm. In contrast, 
Johnson et al [80] reported that decreased motor conduction velocities 
occurred in monkeys exposed at 97 ppm for 9 months.
Although most of the available evidence indicates that, of these 
ketones, only methyl n-butyl ketone can cause peripheral neuropathy, 
studies implicating other ketones have been found [33,36,71]. Viader et al
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[36] found evidence of peripheral neuropathy in a man who worked with an 
adhesive composed of 60% tetrahydrofuran and 40% of a polyester-type 
polymer. The man also worked with a solvent that was reported to be 100% 
methyl ethyl ketone. Viader postulated that the man's illness was caused 
by exposure to methyl ethyl ketone or by a combined exposure. Smith and 
Mayers [33] reported that workers exposed to methyl ethyl ketone at 
concentrations ranging from 300-600 ppm developed numbness of the fingers 
and arms. One worker complained of numbness in the legs. Spencer et al
[71] found minimal neuropathic changes in rats exposed to methyl isobutyl 
ketone, but they attributed this to the presence of methyl n-butyl ketone 
as a contaminant, a reasonable conclusion in the light of their later study
[74] showing that methyl isobutyl ketone of greater than 98.8% purity 
caused no neurotoxic effects.
In animals, several studies [73,74,77] have shown that methyl ethyl 
ketone alone did not produce neurotoxicity. However, methyl ethyl ketone 
did shorten the latency period for the onset of neurotoxic effects of 
methyl n-butyl ketone in cats. The reason for this effect is not 
understood. Couri et al [87] reported results that indicated that methyl 
ethyl ketone might have stimulated the metabolism of methyl n-butyl ketone, 
which might explain the enhancement of toxicity. Saida et al [73] found no 
evidence of neuropathy in rats exposed continuously to methyl ethyl ketone 
at 1,125 ppm for about 7 months. Spencer and Schaumburg [74] found no 
neuropathy in rats injected sc twice daily with 150 mg/kg for 5 days/week 
for 8.5 months. DeJesus et al [77] were unable to demonstrate any 
neuropathy in rats exposed to methyl ethyl ketone at 2,150 ppm for 6 weeks 
or at 4,740 ppm for 4 weeks.
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Johnson et al [82] exposed rats and monkeys to methyl n-amyl ketone 
at 131 and 1,025 ppm for 6 hours/day, 5 days/week for 9 months and found no 
evidence of neuropathy. This finding is particularly significant because 
methyl n-amyl ketone is one of the two closest homologs of methyl n-butyl 
ketone.
DiVincenzo et al [83] demonstrated that in guinea pigs methyl ethyl 
ketone, methyl n-butyl ketone, and methyl isobutyl ketone were metabolized 
by omega-1 oxidation to form the corresponding hydroxy ketone, and by 
carbonyl reduction to form the corresponding secondary alcohol. The 
hydroxy ketone underwent further transformation to the diol by reduction or 
to the dione by oxidation. They noted that 2,5-hexanedione and 5-hydroxy- 
2-hexanone were also metabolites of n-hexane, which has been shown to cause 
peripheral neuropathy.
Krasavage et al [86] found in a study with rats that the relative 
order of neurotoxicity for methyl n-butyl ketone and its metabolites was 
2,5-hexanedione, 5-hydroxy-2-hexanone, 2,5 hexanediol, methyl n-butyl 
ketone, and 2-hexanol. n-Hexane was not neurotoxic under the conditions of 
this experiment.
Saida et al [73] have shown that methyl ethyl ketone increased the 
toxicity of methyl n-butyl ketone, whereas methyl ethyl ketone alone at
1,125 ppm was not neurotoxic in cats [73,74]. Rats continuously exposed to 
methyl n-butyl ketone at 225 ppm developed paralysis in 66 days. Animals 
exposed to a combination of methyl n-butyl ketone at 225 ppm and methyl 
ethyl ketone at 1,125 ppm developed paralysis after 25 days of exposure.
Spencer and Schaumburg [92] have shown that 2,5-hexanedione 
(previously shown by other investigators [83,91] to be a metabolite of
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methyl n-butyl ketone) produced a pattern and distribution of peripheral 
and CNS degeneration similar to that produced by methyl n-butyl ketone 
itself. They suggested that the CNS degeneration might not be reversible 
[78]. However, Abdel-Rahman et al [91] found that phenobarbital 
pretreatment protected against the neurotoxic effects of methyl n-butyl 
ketone. They suggested that protection might have resulted from an 
increased rate of excretion of 2,5-hexanedione.
In a later study, DiVincenzo and colleagues [85] demonstrated that 
respiratory carbon dioxide was the major excretory product of methyl n- 
butyl ketone.
The vapor pressure and thus the volatility of the homologous ketones 
is inversely proportional to the number of carbon atoms (see Tables XI-1 
and XI-2). Therefore, although the higher ketones are more toxic, exposure
by inhalation would tend to be less as the number of carbons increases,
thus reducing the relative hazard of the ketones. Because lipid solubility 
is directly proportional to the number of carbon atoms, the hazard
associated with skin absorption would be expected to be greater with the 
higher ketones because the affinity of the higher ketones for dermal lipids 
would increase. These factors are important considerations in developing a 
hygiene program for the ketones.
Carcinogenicity. Mutagenicity, Teratogenicity, and Effects on Reproduction
No reports that Implicated ketones as carcinogens or mutagens were 
found; some negative results were found for acetone [93-96] and for
cyclohexanone (G Taylor, written communication, March 1978).
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Schwetz et al [97] exposed pregnant rats to methyl ethyl ketone vapor 
and found some evidence of teratogenicity; however, because of the lack of 
a dose-response relationship in some of the effects, this evidence of 
teratogenicity should not be extrapolated to human effects until the 
effects on rats are confirmed or clarified. Griggs et al [98] demonstrated 
that embryos exposed to cyclohexanone produced chicks that could not stand 
and that exhibited spastic motions. In the absence of such information as 
data on placental transfer of ketones or their metabolites, whether these 
data from nonplacental embryos apply to human embryonic development is not 
evident.
Summary Tables of Exposure and Effect
Tables of selected effects of the ketones are presented below. 
Tables III-7 and III-8 show the irritative and systemic effects of the 
ketones, respectively, on humans. Table III-9 summarizes effects of the 
ketones on animals. Lastly, the effects on animals from inhaling methyl n- 
butyl ketone are given in Table 111-10.
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TABLE II 1-7
IRRITATION PRODUCED BY SOME KETONES IN HUMANS*




000-1,000 ppn/8 hr 
5 00 ppm/"6 hr
500 ppm/?-M hr 




Sl i gh t -m ode rat e eye irrita tio n
Irritat ion  to eyes, nose, throat, and 
trachea
No r.ymj' • oms
Int ole rab le eye and nose irr it at io n
Mo derate eye and nose ir rit ati on
Slight eye and throat irritation, 
slight headache









«See alijo Table 1II-1
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TABLE I 11-6 
SYSTEMIC EFFECTS OF KETONES ON HUMANS
Ketone Concentration/Duration ET fect a Refi rene:
Acetone Unknown Vomiting, narcosis 23
n Greater than
12,000 ppm/?
Throat and eye irritation, dizziness, 
weakness
25
n Greater than 
12,0 00 ppm/2 roln
Dizziness and weakness 25
n 1000 ppo/3 hr/d, 
7-15 yr
Inflammation of respiratory tract, 







Eye irritations, gastrointestinal 
disturbances, headache, and narcosis
33
Methyl ethyl ketone 
(possibly methanol)
Unknown Retrobulbar neuritis 35
Methyl ethyl ketone 300-600 ppro Dermatitis of the face, numbness of 
fingers and legs
33
Methyl ethyl ketone 
and tetrahydrofuran
Unknown Peripheral neuropathy 36
Methyl n-butyl ketone 




H 37 ,38 
■*7
Methyl n-butyl ketone Unknown II :9 ,** 1
Methyl Isobutyl 
ketone
80-500 ppm/20-30 min/d Weakness, loss of appetite, headache, 
eye irritation, stomach ache, nausea, 
vomiting, and sore throat
30
'
50-105 ppm/15-30 min/d CNS and gastrointestinal disturbances 




EFFECTS OF KETONES ON ANIMALS*
Ketone Concentration/Duration Animal Ef fect 3 Reference
Acetone 0.5 ral on the skin, 0.05 ml 
sc/3 times/wk, 3 wk
Guinea pigs Cataracts 66
Methyl ethyl 
ketone
33,000-100,000 ppra/200 rain n Gasping death, emphysema, alight 
congestion of brain, marked conges­
tion of aystemic organs especially 
the lungs, and corneal opacities
19
M 3,300 ppm/810 min * No abnormal signs 19
n 1,125 ppm/24 hr/3, 55 d Rats No evidence of peripheral neuropathy 74
n 1 , 1 2 6  or 2,618 ppra/7 hr/d 
on d 6-15 of gestation
Pregnant 
rat s





50,000 ppra/50 min Guinea pigs Death, slight congestion of brain
and marked congestion of systemic organs
52
- 1,500 ppm/810 min n No abnormal signs 52
Methyl r. - a m y 1 
k et one
1,025 ppra/6 hr/d for 2 wk Rats and 
monkey 3
No evidence of peripheral neuropathy 82
Methyl isobutyl 
k et one
200 ppm/24 hr/d for 2 wk Mice, rats, 
dogs, and 
monkeys
Heavier liver and kidneys in rats 53
n 100 ppm/24 hr/d for 2 wk " Heavier kidneys in rats 53
n 100 ppm at 258 mm Hg/24 hr/d 
90 d
Monkey 3 , 
dog s , rats
Inflammation of kidneys in 1 monkey, 
hyaline droplet degeneration of proximal 
tubules in all rats, normal clinic p. 1 and 
hematologic measurements
53
n 150 mg/kg/twice/d , 5 d/wk 
8.5 mo
Cats No evidence of peripheral neuropathy 74
Diisobutyl
ketone
1,650 ppm/7/hr/d, 5 d/wk for 
6 wk
Rats Higher kidney and liver weights, death, 
no microscopic changes except cloudy 
swelling of the liver and moderate lung 
congestion
20
Cyclohexanone 608 pprc/300 hr Monkey Extensive injury to heart muscle, lungs, 
liver, and kidneys
54
" 190 ppra/300 hr Rabbits Slight degenerative changes in liver 
and kidney s
54
" 0.5 ml on the skin, 0.05 ml 
sc/3 times/wk, 3 wk
Guinea pigs Cataracts 66
- Unknown/3-12 hr Chick eggs Embryotoxi c 98
Mesityl oxide 1 3 , 0 0 0  ppm/30 min/d 
6 d
Mice Necrotic spots in liver, lung hemor­
rhage, alimentary tract distension, 
and death
55




Congested livers and lungs, dilatated 
Bowman's capsules and swollen 
convoluted tubular epithelium
21
laophorone 500 ppm/8 hr/d, 5 d/wk 
6 wk
" Severely injured kidneys and/or lungs, 
and death
21
•All of the ketones produced some Irritation and narcosis.
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TABLE III-10
EFFECTS ON ANIMALS EXPOSED 
TO METHYL n-BUTYL KETONE BY INHALATION
Species Concentration
(ppm)
Duration Observed Effects Reference
Rats 1,300-2,000* 3-4 wk Hindlimb footdrop 71
If 1,050* 5 wk Peripheral neuropathy 77
Rats and 
monkeys
976* 25 wk Hindlimb dragging 80
Rats 400 - 600** 5-8 wk ft 70
ft 400** 42 d Paralysis 73
If 330* 30 wk Peripheral neuropathy 3
fl 225** 66 d Paralysis 73
tl 100* 72 wk No evidence of neuro­
pathy
76
II 100* 4 wk II 77
II 60* 6 wk If 77
Cats 400 - 600** 11-12 wk Limb dragging 70
If 330* 4.5 wk Minimal microscopic 
changes
72
ft 100* 4.5 mo No evidence of neuro­
pathy
72
Chickens 100 - 200** 4-5 wk Unable to stand 70
Monkeys 97* 9 mo Decreased motor con­
duction velocity
80





A variety of common methods have been used over the years to sample
airborne ketones in the workplace. These have included the use of
impingers, bubblers, gas bags, and silica gel tubes. Currently, most 
ketone collection is done with charcoal tubes.
Impingers or bubblers containing absorbing liquids were the most 
common early methods used to collect ketone vapor. Smith and Wood [100] 
determined that a single absorber with water as the absorbent was 70 to 
100% efficient in collecting acetone, methyl ethyl ketone, methyl isobutyl 
ketone, diacetone alcohol, mesityl oxide, and cyclohexanone in small air 
samples (125-1,625 ml). Kacy and Cope [101] recommended a fritted-glass 
bubbler for collecting airborne isophorone. Glacial acetic acid was the 
absorbent, and a sampling rate of 1 liter/minute for 5 minutes was used. 
No data on collection efficiency were presented. Andrew and Wood [102] 
used water as an absorbent in an impinger for isophorone sampling. Smith
and Wood [99] used sodium nitroprusside and ammonium acetate in a bubbler
to absorb acetone. A color complex was formed on the addition of ammonium 
solution, and the concentration was determined rapidly by visual comparison 
with standards. No efficiency data were presented. Acetone has also been 
collected in a series of two fritted bubblers with water as the absorbent
[103].
Ketones have also been collected by the grab sample method using gas 
bags [104] or sample or prescription bottles [104,105]. Van Houten and Lee 
[105] found that the recovery of methyl isobutyl ketone was 95% after 30
days of storage in sample bottles and was 94% when samples were subjected 
to one week's storage over a temperature range of 0-175 F. The 1-week 
storage was used to simulate shipment by aircraft. Maykoski and Jacks
[104] found recoveries of 91, 84, and 91% for collection of methyl ethyl 
ketone with a Scotchpac bag, Tedlar bag, and prescription bottle, 
respectively.
Using impingers, bubblers, and grab sample methods can be efficient 
ways to collect ketones, but such methods are undesirable for personal 
monitoring. Grab samples generally limit sample size; therefore, 
collection time is short. Impingers, bubblers, and other collection 
devices containing liquids may hamper the free movement of the worker. 
Spillproof impingers are commercially available, but these still have the 
problem of absorbent losses through evaporation and interference with 
movement.
More recently, solid sorbents in tubes, including silica gel, 
activated charcoal, and some chromatographic column packings have been used 
to collect ketones. The advantages of collection with a solid sorbent 
include the ability to collect samples over a wide range of sampling times, 
ease of transportation over that of air bags and impingers, minimal 
restriction on workers' movements, and collection efficiency. Some 
disadvantages are loss of the sample if the concentration of the ketone 
exceeds the adsorption capacity of the sorbent, the decrease in adsorption 
capacity with increasing humidity, and the need to determine or predict 
desorption efficiency.
Erley [106] reported 100% recovery of acetone from silica gel using 
thermal desorption at 400 C. A sampling rate of 1-3 liters/minute was
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used. Buchwald [107] has stated that acetone can be removed from silica 
gel by desorbing with 1 N sodium hydroxide. In a review, Buchwald [108] 
recommended 20/40 mesh silica gel and stated, without providing data, that 
variations in humidity did not interfere with the sampling. Feldstein et
al [109] used silica gel to collect methyl ethyl ketone and methyl isobutyl
ketone.
In 1976, Parkes et al [110] reported results showing 96-99% primary 
tube collection efficiency on preconditioned 80/100 mesh Chromosorb 101 for 
a variety of ketones such as acetone, methyl ethyl ketone, methyl isobutyl 
ketone, methyl n-amyl ketone, and cyclohexanone when they were removed from 
the sorbent by thermal desorption.
Activated charcoal is the most widely used and tested of the solid
sorbents. Fraust and Hermann [111] determined that 0.7 g of 10/30 mesh
charcoal and a sampling rate of 100-200 ml/minute were most efficient for 
sampling methyl ethyl ketone. The volume of air sampled did not affect 
efficiency except in the case of methyl ethyl ketone, but efficiency 
decreased as the contaminant concentration in the air increased. Charcoal 
tubes also have good storage characteristics when stored at or below room 
temperatures. Sadenwasser [112] found no loss of acetone (472 ppm) or
methyl ethyl ketone (189 ppm) when the substances were stored for 6 days on 
a 2-inch section of 10/20 mesh charcoal. When White et al [113] used a 1-
inch section of charcoal for collection and carbon disulfide for
desorption, methyl ethyl ketone recoveries were over 90%, even when 13
other solvents were simultaneously collected.
NIOSH has investigated and validated charcoal tube sampling for many 
ketones [114,115]. Experimental results on breakthrough for these ketones
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are presented in Table IX-2. These data show that the efficiency of 
charcoal tube collection is adequate at the recommended concentration 
limits. For the selected ketones in this document, breakthrough from 
overloading the charcoal should not be a problem except at unusually high 
ketone concentrations, and it can be avoided by decreasing the sample 
volume.
Charcoal tube collection has many advantages. The tubes are 
inexpensive and readily available. They do not interfere with the workers' 
movements, and methods including charcoal tube collection have been 
validated; however, the sample volume is limited by the amount of the 
ketone which can be adsorbed on a given amount of charcoal, and there is 
the possibility of breakthrough. For these reasons, charcoal sampling is 
recommended for these ketones; details of the recommended sampling method 
are given in Appendix I. The presence of ketone aerosols does not seem 
likely because of the volatility of these substances. However, should such 
aerosol formation occur, it will probably be sorbed on charcoal if the 
airborne concentration is not too high. If any such aerosols are formed, 
possible breakthrough should be investigated.
The pump used to pull air through the collecting device should be a 
personal sampling pump capable of maintaining a constant flowrate of about 
0.2 liters/minute (within 5%) across the pressure drop of the charcoal 
tube. Because the ketones exhibit various degrees of flammability, only 
pumps that are certified explosion-proof should be used, especially where 
the concentrations of airborne ketones are suspected or known to be high.
The recommended sampling method, as well as other methods discussed 
above, does not allow for continuous 10-hour sampling. Therefore, several
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samples may be required to accurately determine the TWA exposure of any 
given employee. For a discussion of the estimation and calculation of TWA 
exposure concentrations from less than full-shift samples, refer to the 
NIOSH report, Occupational Exposure Sampling Strategy Manual [116].
Analysis
There are many methods available for the analysis of ketones in 
environmental samples. Colorimetry using detector tubes, gas-liquid 
chromatography, titration of iodoform, and ultraviolet absorption 
spectroscopy are the most common analytical methods.
Methyl ketones have been analyzed for many years by the iodoform test
[103,117,118]. In this test, iodine in the presence of a base, which is 
often the sampling medium, reacts with the methyl group of the ketone to 
yield iodoform. Excess iodine is determined by titration with an 
indicator, such as thiosulfate, and the concentration of ketone is then 
calculated. This method can be used to measure ketones at low 
concentrations. For example, acetone can be measured at a concentration of 
10 ppm in a 1-cu ft air sample, approximately 23.7 mg/cu m, [103], and 1 mg 
of mesityl oxide [119] and 0.73 mg of methyl ethyl ketone [120] can be 
measured in a 25-liter sample. However, any compound that reacts with 
iodine to form iodoform, eg, many alcohols, aldehydes, and other ketones, 
will interfere.
The formation of colored complexes has also been used to analyze
ketones. In a field test method, Smith and Wood [100] collected acetone,
methyl ethyl ketone, methyl iso-butyl ketone, diacetone alcohol, and 
mesityl oxide in water and reacted them with 2,4-dinitrophenylhydrazine.
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When potassium hydroxide in methanol was added, a red color developed, 
which was compared visually to standards, allowing a rough determination to 
the nearest 500 ppm. Haidle and Knight [121] reported that methyl n-amyl 
ketone could be measured by the 2,4-dinitrophenylhydrazine method over the 
range of 0.25-3.0 junol when a spectrophotometer was used rather than visual 
comparison to standards. Isophorone has been measured colorimetrically by 
its reaction with phosphomolybdic acid in glacial acetic acid. Over the 
range of 12-93 /ug, isophorone was measured with a standard deviation of 40 
jug. Andrew and Wood [102] used dodecamolybdophosphoric acid with 
perchloric acid to analyze isophorone in a range-finding field test method. 
Concentrations were determined to the nearest 35 mg/cu m over the range of 
0-140 mg/cu m. When they are performed carefully, most colorimetric 
methods can provide accurate and precise results. Field test methods are 
also available for range-finding purposes. However, these rapid methods 
tend to be inaccurate. Accurate results are time consuming, and quick 
tests are usually not accurate [100,102].
Ultraviolet spectrophotometry has also been used to measure ketones. 
Isophorone in isopropanol absorbs ultraviolet light at 235 nm, and 
concentrations down to about 14 jug of isophorone can be detected in a 25- 
liter air sample by this method [122], Acetone concentrations of about 4.5 
mg in a 25-liter sample can also be measured [103]. Interference can occur 
whenever two or more compounds are present, including aromatic and 
unsaturated compounds that absorb ultraviolet light at similar wavelengths.
Direct reading instrumentation is available for real time and 
continuous monitoring of the ketones. Infrared spectrophotometers, 
equipped with adjustable, long pathlength gas cells, can be used and
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provide quick, accurate measurement of the workplace concentrations. 
Analytical wavelengths of 8.2 (m (acetone), 8.3 /um (cyclohexanone), 8.5 nm 
(methyl ethyl ketone, methyl isobutyl ketone, and diacetone alcohol), and
8.6 jim (methyl isoamyl ketone, diisobutyl ketone, methyl n-butyl ketone, 
and methyl n-amyl ketone) have been used and have a minimum detectable 
concentration with a 20-meter cell of less than 1 ppm for each ketone 
[123]. The ketone wavelengths overlap and, therefore, where more than one 
ketone is present, the result may indicate the total amount present without 
allowing for separate determinations for each ketone. Combustible-gas 
meters and hydrocarbon meters are also available and, although nonspecific, 
can be useful for leak determinations.
Detector tubes or indicator tubes are being used more frequently 
since personnel require little specialized training to use them; they are 
inexpensive; and they give rapid estimations of exposure concentration. 
Indicator tubes are available for acetone (Draeger 100B, MSA 460423, and 
Kitagawa 102A) and methyl ethyl ketone (Kitagawa 139 B) according to a 
study of a working group of the British Occupational Hygiene Society [124]. 
Only the MSA acetone tube had been certified by NIOSH as of June 1976. The 
certified range of use was 500-5,000 ppm.
Gas-liquid chromatography (GLC) is widely applicable to the analysis 
of ketones. NIOSH has validated a GLC method for 11 of the 12 ketones, and 
the 12th, methyl isoamyl ketone, should be readily adaptable to this method 
[114,115]. In April 1977, documentation of the various validation tests of 
many of the methods was published by NIOSH [125]. Other investigators have 
also tested GLC methods for many of the ketones. McDonald et al [126] 
noted a retention time for acetone with a Porapak Q column of 0.88 minute
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and 0.65 minute relative to n-propanol. Cooper et al [127] were able to 
detect as little as 2.6 ng of methyl ethyl ketone in a 10-liter air sample 
when the GLC method was used with a mass spectrophotometric detector. The 
limits of detection achievable with a mass spectrophotometer are not 
necessary for routine industrial hygiene monitoring; sufficient results are 
attainable with a flame-ionization detector. White et al [113] reported 
measuring methyl ethyl ketone by means of GLC analysis in the presence of 
13 other solvents.
For these reasons, GLC is recommended for quantitation of these 
ketones; details of the analysis and a general method applicable to all 12 
ketones are given in Appendix I. Methods for many of the individual 
ketones have been published in the latest edition of the NIOSH Manual of 
Analytical Methods [114,115]. The GLC operating conditions, validated 
ranges, coefficients of variation, and standard deviations have been 
determined and are listed in Tables IX-1 and IX-3.
An important step in the use of GLC for ketone analysis is the 
desorption of the compound(s) from the solid sorbent used to collect the 
ketones from the sampled air. Charcoal or silica gel tubes are the most 
commonly used collection methods, and the validated charcoal tube procedure 
has been recommended as described in Appendix I. Feldstein et al [109] 
used dimethyl sulfoxide, carbon disulfide, and a carbon disulfide-water 
mixture as a solvent to desorb methyl ethyl ketone or methyl isobutyl 
ketone from silica gel. Carbon disulfide and the carbon disulfide-water 
mixture gave unacceptable recoveries of 4-75%; dimethyl sulfoxide 
desorption was 97-98% efficient. NIOSH [114,115,125] has tested and 
validated the use of carbon disulfide as the desorbing solvent for use with
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ketones collected on charcoal tubes. Regardless of the solid sorbent and 
desorbing solvent used, it is necessary to determine the desorption 
efficiency for each batch of analyses. Directions for this determination 
are included in Appendix I.
Environmental Data
Data on current and past occupational exposures to the ketones in 
this document are found only infrequently. Acetone and methyl ethyl ketone 
have been the most frequently monitored ketones.
Many NIOSH reports of health hazard evaluations [128-136] contain 
data on exposures to ketones in many different industries, but sampling of 
airborne ketones was performed primarily where the ketones have been used 
as solvents. The NIOSH method validated for the particular compound was 
used to obtain the data. Data from many such reports are briefly 
summarized in Table IV-1.
Data on methyl n-butyl ketone exposures during its manufacture have 
been reported to NIOSH [145]. Monitoring was performed during the summer 
of 1977. Operator breathing zone samples, collected during process 
sampling and laboratory analysis, averaged 41 mg/cu m with a range of from 
less than 0.01 up to 746 mg/cu m for 28 samples. Three samples taken in 
the operators' breathing zone during rail tank car loading were reported as 
containing a high of 187 mg/cu m and a low of 8 mg/cu m. Six samples taken 
during drum loading had methyl n-butyl ketone concentrations ranging from 
less than 4 to 27 mg/cu m.
Results from recent (April 1977) monitoring at the coated-fabric 
plant in Ohio have shown a reduction in environmental concentrations of
148
ENVIRONMENTAL DATA FROM HEALTH HAZARD EVALUATION REPORTS
TABLE XV-1
Compound
Use or Concentrations 
Operation Mean Range of 





Acetone Aeryloid 620 - 1 129
11 Injection molding <2 - - 130
fl Plastics cleaning - <118-493 5 131
tl Solvent 17 5-40 8 132
11 Fiberglass plant 76 15-324 26 133







»1 Vinyl installation 185 128-216 3 136
II Spray painting 40 - - 136
Methyl ethyl 
ketone
Label printing <1 - 8 135
II Baseball bat 
manufacturing
9 3-15 11 137
11 Painting 4 ND-35 11 138
11 Parts cleaning 196 44-413 7 138












If Painting 6 ND-21 - 140
It Cementing 26 6-68 8 132
tl Spray painting <30 - - 136
11 Reinforced plastics 
plant
0.8 ND-33 47 141
II Gasket cleaning 339 233-395 3 142
II Paint plant 182 38-1441 21 143
Methyl butyl 
ketone





4 <4-45 30 128
II Spray painting <40 - - 136





114 18.5-265 30 144
*ND-non-detected
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ketones from those present when cases of peripheral neuropathy were found 
in 1973 [146]. Methyl n-butyl ketone concentrations (84 samples) were all 
below the detection limit (0.01 mg/cu m) of the analytical method. Methyl 
ethyl ketone concentrations averaged 99 mg/cu m for 84 samples with a range 
from 7 to 388 mg/cu m. Methyl isobutyl ketone concentrations averaged 18 
mg/cu m for 84 samples with a range of less than 0.01 mg/cu m to 108 mg/cu 
m. Methyl n-butyl ketone use had been discontinued following the episode 
of peripheral neuropathy, and methyl ethyl and methyl isobutyl ketones were 
substituted. All methyl ethyl ketone and methyl isobutyl ketone 
concentrations reported in April 1977 were below 388 and 108 mg/cu m, 
respectively.
Engineering Controls
Engineering controls should be designed to keep airborne ketones at 
concentrations at or below the permissible exposure limits. Closed 
systems, preferably under lower pressure than uncontaminated areas and 
properly operated and maintained, should be used wherever appropriate, for 
example, in the manufacture of the ketones and in their use as intermediate 
chemicals. Frequent tests must be conducted for leaks in such a closed 
system. Where closed systems are not feasible, well-designed local exhaust 
ventilation systems should be used. Guidance for design of ventilation 
systems can be found in Industrial Ventilation— A Manual of Recommended 
Practice [147] and in Fundamentals Governing the Design and Operation of 
Local Exhaust Systems, ANSI Z9.2-1971 [148]. Continuous local exhaust
ventilation or some means of ketone containment (such as cooling coils)
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should be used when ketones are used in open tanks and during their 
charging or discharging.
Ventilation systems require regular inspection to provide the 
necessary level of employee protection. Airflow should be measured on a 
frequent, regular basis, at least every 3 months. Continuous monitoring 
can be provided by the installation of oil or water manometers. The 
desired airflow can be indicated on the manometer to provide ready 
reference for a quick determination of optimum performance.
Electrical systems used in processes in which ketones are used, 
handled, or processed should conform to the National Electrical Code [149]. 
Motors used for ventilation systems or material transfer must be explosion- 
proof when ketones classified as flammable liquids (mesityl oxide, acetone, 
methyl n-butyl ketone, methyl ethyl ketone, methyl isobutyl ketone, and 
methyl n-propyl ketone) are present. Explosion-proof motors should also be 
used with the other ketones, which are all classified as combustible 
liquids. Concentrations of ketones in the exhaust system must be kept 
below the lower flammable limit for the particular ketone. Airmovers in 
exhaust systems where ketone concentrations may exceed one fourth of the 
lower explosive limit must be of sparkproof construction. Data on 
flashpoints and lower explosive limits are included in Table Xl-2.
Storage facilities for the ketones must conform to the requirements 
for storing flammable and combustible liquids as stated in 29 CFR 1910.106. 
Many of the lower boiling ketones form flammable air-vapor mixtures in the 
spaces of a storage tank at normal temperatures unless air is excluded. 
Inert gas can be used to exclude air. If air is not excluded, a flame 
arrestor should be installed on the tank vent [150]. Storage tanks should
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be electrically bonded and grounded and should be diked to contain leaks. 
Diked areas should be equipped with a sump pump (non-sparking) to remove 
any spilled ketone. Steel piping and tanks are adequate for storing most 
ketones up to 2 months and when product quality is not unusually critical. 
For longer storage or critical purity, a steel tank may have to be lined, 
eg, with an inorganic zinc silicate coating [150].
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V. WORK PRACTICES
The 12 ketones included in this document present different 
toxicologic problems; however, they also have many common properties that 
require similar work practices. Although all 12 ketones are liquids at 
room temperature (Table XI-2), some have high vapor pressure, and, 
therefore, employees may contact ketones by inhaling vapor or mist as well 
as by having their skin or eyes come in contact with the liquid. There is 
some evidence that skin absorption, at least of some ketones, may also 
occur [43,45]. All ketones are good lipid solvents and thus cause 
dermatitis whether or not they can penetrate the skin. Engineering 
controls and work practices should be designed and implemented to maintain 
concentrations of airborne ketones at or below permissible exposure limits, 
minimize excursions, prevent skin and eye contact, and reduce fire and 
explosion hazards.
The ketones have been shown to be a significant fire hazard. All of 
them have flashpoints below 200 F (Table XI-2) and are therefore classified 
as combustible or flammable liquids of Classes IA, IB, IC, II, and IIIA 
according to the criteria in 29 CFR 1910.106a. Boiling points and 
flashpoints for the 12 ketones are listed in Table XI-2.
A flammable liquid has a flashpoint below 100 F (37.8 C). The 
classes of flammable liquids are IA, liquids with a flashpoint below 73 F 
(22.8 C) and boiling point below 100 F; IB those with a flashpoint below 73 
F and boiling point at or above 100 F; and IC, those with a flashpoint at 
or above 73 F (22.8 C) and below 100 F (37.8 C). Combustible liquids have 
flashpoints above 100 F and are divided into two classes. Those in Class
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II have a flashpoint at or above 100 F and below 140 F, and those in Class
III have a flashpoint above 140 F. Combustible liquids in Class IIIA have 
flashpoints at or above 140 F and below 200 F, and those in IIIB have 
flashpoints at or above 200 F. If ventilation is adequate to maintain the 
concentrations of ketones at or near their permissible exposure limits, 
which are based on toxicologic considerations, the potential for fire and 
explosion will be eliminated. However, elevated concentrations can be 
caused by vapor accumulation above a liquid surface, in depressions, at 
container openings, and at vent openings. The employer should be familiar 
with the particular properties of the ketone in use and should provide 
instructions for safely handling that ketone. All ignition sources, such 
as fire, sparks, and smoking, must be prohibited when and where ketones are 
handled, used, or stored. The National Fire Protection Association (NFPA) 
Standard #77, "Static Electricity," lists precautions to be taken to 
prevent the accumulation of static electricity which may be a source of 
ignition. Precautions include bonding, grounding, and humidity control.
Equipment for handling ketones should be properly bonded, grounded, 
and installed according to local and state building codes. Only sparkproof 
tools may be used with the ketones that are classified as flammable 
liquids, and it is a good practice to use them with all ketones. Outside 
storage areas are preferred to inside areas, but storage containers should 
always be protected from direct sunlight and from other sources of heat. 
Only containers and tanks designed to contain flammable or combustible 
liquids should be used for transporting or storing large amounts of 
ketones.
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Detailed regulations for handling flammable and combustible liquids 
are found in 29 CFR 1910.106. These rules have been adapted from the NFPA. 
Areas covered include tank storage; piping, valves, and fittings; 
containers and portable tank storage; and industrial uses.
When fighting fires involving ketones, personnel must use protective 
equipment similar to that worn whenever there may be the danger of 
breathing hazardous products of combustion. Carbon dioxide or dry chemical 
extinguishers are most effective for extinguishing ketone fires. Water 
spray may also be used, but a water hose stream which can scatter the 
burning liquid should not. Larger spills or tank fires are best controlled 
with "alcohol type" foam [151,152]. When entering an area for 
firefighting, personnel should wear a self-contained breathing apparatus 
operated in the positive-pressure mode.
Closed system operations, when compatible with the use of the ketone, 
present the best means of protecting the worker from ketone exposure. When 
workers carefully observe good, preventive maintenance and frequently 
inspect systems for leaks, spills, and worn parts, closed systems are 
effective in minimizing exposure to ketones. When leaks do occur, they 
must promptly be repaired by trained workers wearing the appropriate 
protective clothing and respiratory protection.
Ketones are powerful degreasing agents and are capable of causing or 
aggravating skin irritation after prolonged or repeated exposure. Although 
the use of personal protective equipment is not an adequate substitute for 
good work practices and ventilation, in some cases it is necessary. 
Resistant gloves and clothing, safety goggles (with 20-cm minimum face 
shields if full-face protection is necessary), aprons, coats, and boots
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should be worn when needed to prevent prolonged or repeated skin contact 
with ketones. If clothing becomes soaked with a ketone, it is important 
that the clothing be removed immediately and not be reused until it is free 
of contamination. The prompt removal of clothing will not only lessen the 
chance for skin irritation but will also minimize the risk of burns, since 
clothing contaminated with ketones is readily flammable. Clothing may be 
decontaminated by laundering or by allowing the clothing to dry. (Clothing 
must be dried in a suitably ventilated area.) Laundry personnel must also 
be informed of any hazards to them and must be protected from ketone 
exposure. Foot burns may result if some ketones (acetone, for example 
[151]) with high vapor pressures are spilled into shoes and the shoes are 
not thoroughly cleaned and ventilated after contamination.
The employer should be aware that not all rubber or plasticized 
gloves are adequate protection from ketones. McFee [153] and Sansone and 
Tewari [154] have investigated gloves' resistance to acetone and methyl 
ethyl ketone penetration. The data, as shown in Table V-l, indicate that 
only milled butyl gloves offer protection for long periods and several 
(neoprene, polyvinyl chloride, and nitrile) may not be adequate even for 
short, half-hour usage. Employers must determine that gloves supplied for 
skin protection are adequate and provide the necessary protection for the 
particular ketone.
Although engineering controls are required to prevent or contain 
major spills, minor spills may also present a hazard and should be promptly 
cleaned up by personnel properly protected against the inhalation of and 
prolonged skin contact with ketones. These precautions will minimize the 
risk of fire and also reduce the spread of vapors into confined spaces or
156
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Acetone
Natural 0.4 0.1-1 1-10 154
rubber 0. 18 - - 41 153
Neop rene 0. 4 1-10 > 1 0 154




0.5 0. 1-1 1-10 - 154
neoprene 0. 30 - - 50 153
Polyvinyl 0. 2 >10 > 1 0 _ 154
chloride 0.51-0.69 - - 90 153
Polyvinyl 0. 4 <0. 1 <0. 1 _ 154
alcohol 0.7^ “ - 3.6 153
N i t ri 1 e 0.4 > 1 0 > 1 0 - 154
Milled
butyl
0. 48 - - <0.3 153
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into those located below ground level. Rags, mops, and other materials 
contaminated with a ketone or used to clean up a spill must be stored in a 
closed metal container until they can be removed from the work area and 
properly cleaned or disposed of.
Ketones and materials contaminated with ketones must be disposed of 
according to applicable Federal, state, and local regulations. The 
preferred method is to recover and reuse the ketone if possible. 
Incineration or burial in a proper land fill are other methods of disposal. 
Ketone disposal in sewers should be prohibited since vapors may still be 
ignited.
Under some conditions, ketones may collect in low and confined 
spaces. Confined-space entry procedures must be developed and enforced to 
prevent exposure from exceeding the permissible exposure limit in an 
enclosed or confined space. The atmosphere should be checked for the 
presence of ketones, sufficient oxygen, and toxic materials as may be 
necessary. Where ketones are present or where their absence cannot be 
assured, workers should wear proper equipment when entering an enclosed or 
confined space. The following protective measures are also required: use
of a lifeline and harness, communication with an observer properly equipped 
to rescue, and the presence of a third party ready to lend assistance. 
Before entering a tank or confined space, every worker must obtain a permit 
signed by an authorized person stating that the atmosphere has been checked 
and found safe or stating that all necessary safety precautions have been 
observed.
Employees should never use ketones to remove grease and dirt from 
their hands. Employers should provide washrooms and showers where mild
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soap can be used to remove dirt and grease. If soap and water are not 
effective, the employer should provide an alternative means of removal, 
such as a waterless cleanser. The employees should also wash their hands 
following contact with any ketone; this procedure will minimize the risk of 
irritation. The requirements for sanitation facilities are listed in 29 
CFR 1910.141.
Eyewash fountains and emergency showers must be provided for 
immediate emergency use in work areas where employees may come in contact 
with ketones at excessive concentrations. The requirements for emergency 
eyewash fountains and showers, as well as for medical and first aid, are 
detailed in 29 CFR 1910.151. Emergency equipment must be useable and 
sanitary at all times.
Engineering controls are the first choice in reducing exposure to 
ketone vapors. Work practices, such as those discussed in this chapter, 
may also significantly reduce exposure. Respirators are the least 
satisfactory means of preventing inhalation exposure to ketones, but there 
are situations, such as during the installation or testing of new exhaust 
systems, during performance of nonroutine maintenance or repair, during 
single operations, or during emergencies, when they represent the only 
feasible and adequate source of protection. When respirators are required, 
the employer should ensure that only respirators approved by NIOSH or MSHA 
are used. Respirator selection should follow the guidelines indicated in 
Table 1-2. Respirators certified for use at higher concentrations may 
always be used at lower concentrations. Dust respirators are not suitable 
for protection against ketone vapors and offer only poor protection. 
Compressed oxygen should not be used when there is danger of contact with
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flammable liquids, vapors, or sources of ignition, especially in confined 
spaces [151].
Since some ketones can cause eye irritation, the use of half-mask 
facepiece respirators has been restricted. Data presented in Tables III-l 
and III-8 suggest that eye irritation will occur at concentrations less 
than 10 times the proposed limit of each ketone except methyl n-butyl 
ketone and isophorone.
Evidence to support the use of air purifying (cartridge or canister) 
respirators was not found. Air purifying respirators can only be safely 
used when knowledge of the absorbent's capacity for the ketone is available 
and where an indication of breakthrough (end-of-service-life indicators or 
smell and taste properties) is available at non-hazardous concentrations. 
Nelson and Harder [155] have conducted respirator cartridge efficiency 
studies. The test concentration was 1,000 ppm, the flowrate 53.3 
liters/minute, humidity 50%, and the temperature 20-22 C. These data show 
that the useful life of cartridges is limited to 1-2 hours, and they 
highlight the need to get more definitive data for breakthrough at other 
concentrations. End-of-service-life indicators for cartridges do not yet 
exist for the ketones, and, therefore, warnings of breakthrough are 
dependent on odor or taste. Odor threshold values, to provide an adequate 
margin of safety, must be no more than three times the recommended 
environmental limit. It seems probable that the odor of some of these 
ketones can be detected at such concentrations, but the reliability of 
detection, the rapidity of odor fatigue, and the variation in the 
population are not known.
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In all workplaces where ketones or ketone-containing substances must 
be handled, written instructions informing employees of the particular 
hazards involved, the method of handling, procedures for cleaning up 
spilled material, personal protective equipment to be worn, and procedures 
for emergencies must be posted, on file, and available to employees. The 
employer must establish a program of instruction that will ensure that all 
potentially exposed employees are familiar with the procedures. The 
Material Safety Data Sheet described in Appendix II may be used as a guide 
for employers in providing the necessary information. The duties of 
employees involved in maintenance and repair activities pose special 
problems of potential contact and exposure, especially in work on enclosed 
systems or in operations involving ventilation-system repair and 
maintenance. The nature of this type of work increases the potential for 
exposure. Maintenance employees may not be sufficiently familiar with the 
hazardous materials with which they are involved. Therefore, special 
supervisory control and work practice precautions are required to prevent 
exposure of these employees.
161
VI. DEVELOPMENT OF STANDARD
Basis for Previous Standards
(a) Acetone
In 1945, Cook [156] compiled a list of maximum allowable 
concentrations (MAC's) for industrial atmospheric contaminants. He noted 
that the California Industrial Accident Commission, the Oregon State Board 
of Health, and the Massachusetts Department of Labor and Industries 
recommended a 500-ppm (1,180 mg/cu m) MAC for exposure to acetone, while
the Utah Department of Health used a 200-ppm (474 mg/cu m) MAC and the New 
York State Department of Labor used a 1,000-pptn (2,370 mg/cu m) MAC as the 
guidelines for exposure to acetone. Cook recommended 1,000 mg/cu m as a 
tentative limit for occupational exposure to acetone. This recommendation 
was based on the findings of Nelson and coworkers [15], who reported that,
at a concentration of 500 ppm (1,180 mg/cu m), acetone caused eye, nose,
and throat irritation in humans exposed for 3-5 minutes.
In 1946, the Subcommittee on Threshold Limits of the American 
Conference of Governmental Industrial Hygienists (ACGIH) [157] adopted a 
list entitled "Maximum Allowable Concentrations of Air Contaminants for 
1946," which included a 500-ppm (1,180-mg/cu m) MAC for acetone as noted by 
Cook [156].
In 1948, the designation of the environmental limit was changed from 
an MAC to a TLV (Threshold Limit Value), but the value remained at 500 ppm 
(1,180 mg/cu m) for acetone [158], In 1953, the ACGIH [159] defined a TLV
as the "maximum average atmospheric concentration of contaminants to which
workers may be exposed for an eight-hour working day without injury to
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health," and it adopted a TLV of 1,000 ppm (2,370 mg/cu m) for acetone. No 
justification for the change in the limit was reported at that time, but 
the basis for the change was presented in the 1962 ACGIH Documentation of 
Threshold Limit Values [160], which cited reports by Nelson et al [15], 
Lehmann and Flury [57], and Vigliani and Zurlo [28]. Nelson et al [15] 
stated that, although acetone caused slight irritation at 300 ppm (711 
mg/cu m), most humans tolerated exposure at 500 ppm (1,180 mg/cu m). 
Lehmann and Flury [57] noted a fatal acetone poisoning in a 12-year-old 
child who wore a damp acetone dressing. Vigliani and Zurlo [28] found 
chronic inflammation of the respiratory tract in workers exposed to acetone 
at 1,000 ppm (2,370 mg/cu m) for 3 hours daily for 7-15 years, and 
complaints of dizziness were reported. Since 1958, the 2,400 mg/cu m TLV 
was referred to as a time-weighted average (TWA) concentration for a normal 
workday [161].
In 1966, the ACGIH Committee on Threshold Limit Values [162] 
questioned whether the exposure of workers to acetone reported by Vigliani 
and Zurlo [28] was "pure." The level has remained at 2,400 mg/cu m since 
1953 [163]. Review of the more detailed study [27] of the workers, 
however, does not confirm the suspicion that exposures were mixed.
In 1976, the ACGIH [164] proposed a Threshold Limit Value-Short Term 
Exposure Level (TLV-STEL) for acetone of 3,000 mg/cu m. The ACGIH defined 
the TLV-STEL as the "maximal concentration to which workers can be exposed 
for a period up to 15 minutes continuously without suffering from 1) 
intolerable irritation, 2) chronic or irreversible tissue change, or 3) 
narcosis of sufficient degree to increase accident proneness, impair self­
rescue, or materially reduce work efficiency, provided that no more than
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four excursions per day are permitted, with at least 60 minutes between 
exposure periods, and provided that the daily TLV-TWA also is not 
exceeded."
Occupational exposure limits to ketones in other countries are listed 
in Table VI-1 [165] .
The current US Federal standard for occupational exposure to acetone 
is 2,400 mg/cu m (1,000 ppm) as an 8-hour TWA concentration limit (29 CFR
1910.1000). This standard was based on the TLV adopted by ACGIH in 1968 
[166] .
(b) Methyl Ethyl Ketone
In 1945, Cook [156] noted that a limit for methyl ethyl ketone 
exposure in workplaces of 500 ppm (1,470 mg/cu m) was recommended by the 
California Industrial Accident Commission and a 300-ppm (882 mg/cu m) limit 
was used as a guideline by the Massachusetts Department of Labor and 
Industries. Cook recommended 500 mg/cu m as a tentative limit, because of 
the nose and throat irritation experienced by humans exposed at 350 ppm 
(1,032 mg/cu m) [15]. He also cited the work of Patty et al [19] that 
showed no "serious disturbance" in guinea pigs exposed to methyl ethyl 
ketone at 0.3% by volume for a few hours.
In 1946, the ACGIH [157] adopted a 200-ppm (588 mg/cu m) MAC for 
methyl ethyl ketone. In 1948, the ACGIH [158] adopted a 250-ppm (735 mg/cu 
m) limit for methyl ethyl ketone when the designation was changed from an 
MAC to a TLV. No justification for this change was reported at that time. 
This TLV was retained until 1961, when the ACGIH [167] lowered the TLV as a 
TWA concentration to 590 mg/cu m. The basis for this recommendation was 
provided in the 1962 ACGIH documentation [160], which included the reports
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Au d t r a i1d 2,400 590 700 410 465 410 475 150 200 100 240 140
BeIgium 2,;oo 590 700 410 - 410 475 150 200 100 240 25
Bulgaria - 200 200 - - - - 10
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2,400 590 700 410 400 “ 290 200 100 24D 2d
Hungary 200 200 - - - - - - - - - -
Italy 1,000 400 - - - 300 - 150 200 - - -
Japan 480 590 - - - 410 - - 100 - -
Netherlands 2,400 590 700 100 - 410 475 150 200 100 240 25
Poland 200 200 100 200 - 200 - - 20 20 - 5
Romania 1,000 200 250 200 - 200 - 150 100 100 150 50
Sweden 1,200 440 - - - 210 - - - - - -
Switzerland 2,400 590 700 410 - 410 475 150 200 100 240 25*
USSR 200 200 200 - - - - - 10 l ** - -
Yugoslavla 800 200 700 410 465 410 - 290 200 100 240 140
United Stated
1978 Federal Standards (29 CFR 1910. 1000)
2,-00 590 700 410 465 410 - 290 200 100 24Ü 140
SIOSH Reccr̂ ner.ded Exposure Limits
590 590 530 4 465 200 230 140 100 40 240 23
•Ceiling value 
**Sk.ln irritant
Adapted from reference 165
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of Patty et al [19] and Nelson et al [ 1 5 ] ,  cited earlier. In addition, 
Smith and Mayers [33] found that dermatitis and numbness in the arms 
occurred in humans exposed to methyl ethyl ketone vapor at 300-600  ppm 
( 8 8 2 - 1 , 7 6 0  mg/cu m).
The TLV has remained the same since 1961 [163]. In 1976, the ACGIH [164] 
proposed, in addition to the existing TLV-TWA, a TLV-STEL of 885 mg/cu m.
The current US Federal standard for occupational exposure to methyl 
ethyl ketone is 590 mg/cu m as an 8-hour TWA concentration limit (29 CFR
1910.1000). This standard is based on the TLV of 1968 adopted by ACGIH 
[166].
(c) Methyl n-Propyl Ketone
In 1945, in his list of MAC's for atmospheric contaminants, Cook 
[156] noted that the California Industrial Accident Commission recommended 
a 500-ppm (1,760 mg/cu m) MAC for exposure to methyl n-propyl ketone in the 
workplace and the Utah Department of Health recommended a 1,500-ppm (5,280
mg/cu m) MAC. Cook [156] considered 1,000 mg/cu m to be a tentative 
concentration limit for occupational exposure to methyl n-propyl ketone. 
This conclusion was based on the results of an inhalation study with guinea 
pigs by Yant and associates [52], who reported that guinea pigs exposed at
0.15 vol% for 810 minutes exhibited little or no effects and that short 
exposures to methyl n-propyl ketone at 0.15% by volume were irritating to 
humans.
In 1946, the Subcommittee on Threshold Limits of the ACGIH [157] 
adopted a 200-ppm (704 mg/cu m) MAC for methyl n-propyl ketone. No 
justification for this level was reported. In 1948, the designation of the
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limit was changed from an MAC to a TLV, but the value remained at 200 ppm 
(704 mg/cu m) [158].
In the 1962 documentation [160], the ACGIH presented the basis for 
their TLV as a TWA concentration of 700 mg/cu m. It referred to the 
inhalation study by Yant et al [52] on guinea pigs exposed to methyl n- 
propyl ketone at 0.15% by volume for several hours. The guinea pigs showed 
little or no effect from the exposure. In 1966, the ACGIH [162] still 
considered the 700 mg/cu m TLV "low enough to prevent onset of narcosis and 
irritation."
The ACGIH, in the 1974 documentation [168], cited the findings of 
Specht et al [34] and of Yant and associates [52] . Specht et al reported 
that, when exposed to methyl n-propyl ketone at 0.25% by volume, guinea 
pigs exhibited irritation and weakness, and coma resulted in animals 
exposed at 0.50% by volume.
The current US Federal standard for occupational exposure to methyl 
n-propyl ketone is 700 mg/cu m as an 8-hour TWA concentration limit (29 CFR
1910.1000). This standard is based on the TLV adopted by the ACGIH in 1968 
[166] .
(d) Methyl n-Butyl Ketone
In 1945, Cook [156] recommended 500 mg/cu m as a tentative MAC for 
exposure to methyl n-butyl ketone in the workplace. This recommendation 
was based on findings by Schrenk et al [169] about the responses of guinea 
pigs and humans to methyl n-butyl ketone vapor. The guinea pigs had no 
abnormal signs during or after an exposure to methyl n-butyl ketone at 0.1% 
by volume for 810 minutes. However, humans exposed at that concentration 
for a few minutes noted a strong odor and developed eye and nose
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irritation. Cook [156] derived the 500 mg/cu m limit for prolonged 
exposure by arbitrarily making it one-fourth of the concentration at which 
there was irritation.
In 1946, the Subcommittee on Threshold Limits [157] adopted the 200- 
ppm (820 mg/cu m) MAC for methyl n-butyl ketone recommended by Cook [156]. 
In 1947, the MAC was reduced to 100 ppm (410 mg/cu m), but no reason was 
given [170]. In 1948, when the designation of an MAC was changed to a TLV, 
the limit remained at 100 ppm (410 mg/cu m) [158], In the 1962 
documentation [160], ACGIH cited the study of guinea pig and human 
responses conducted by Schrenk et al [169] to justify setting the TLV as a 
TWA concentration at 410 mg/cu m.
In 1966, the ACGIH [162] once again recommended the TLV as a TWA 
concentration of 410 mg/cu m for exposure to methyl n-butyl ketone and 
cited the study of Specht et al [34] in the 1966 ACGIH documentation. 
Specht and his coworkers found that guinea pigs developed progressive 
narcosis leading to coma and death when they were exposed to methyl n-butyl 
ketone at concentrations of 0.13, 0.6, and 1.2% by volume for 12, 7, and 4 
hours, respectively. The ACGIH considered the TLV of 410 mg/cu m 
sufficient to "provide protection against irritation and, by a large 
margin, against initiation of narcosis." The same information was reported 
in the 1974 ACGIH documentation [168]. In 1976, the ACGIH [164] adopted a 
TLV-TWA of 100 mg/cu m with a proposed TLV-STEL of 150 mg/cu m.
The current US Federal standard for occupational exposure to methyl 
n-butyl ketone is 410 mg/cu m as an 8-hour TWA concentration limit (29 CFR
1910.1000). This standard is based on the ACGIH's TLV set in 1968 [166],
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(e) Methyl n-Amyl Ketone
In 1971, the ACGIH [171] adopted a TLV of 465 mg/cu m as a TWA 
concentration for methyl n-amyl ketone, stating that the limit "should be 
low enough to prevent onset of narcosis and to serve as a guide for 
practical control." The level was based on a recommendation by Rowe and 
Wolf [9], who had reviewed the data from an inhalation exposure study on 
guinea pigs by Specht et al [34]. Mucous membrane irritation occurred at a 
concentration of 0.15% by volume, narcotic effects were apparent at 0.20% 
by volume, and, at 0.48% by volume, narcosis and death resulted in guinea 
pigs exposed for 4-8 hours. In 1976, the ACGIH [164] proposed a 710 mg/cu 
m TLV-STEL in addition to the TLV-TWA.
The current US Federal standard for occupational exposure to methyl 
n-amyl ketone is 465 mg/cu m (100 ppm) as an 8-hour TWA concentration limit 
(29 CFR 1910.1000).
(f) Methyl Isobutyl Ketone
In 1945, Cook [156] recommended an MAC of 200 ppm as a tentative 
concentration limit for exposure to methyl isobutyl ketone in workplaces. 
This recommendation was based on Specht's [59] inhalation study of guinea 
pigs which showed that, at a concentration of 0.1% by volume, methyl 
isobutyl ketone caused nose and eye irritation in a man but was well 
tolerated by the guinea pigs.
In 1946, the Subcommittee on Threshold Limits of the ACGIH [157] 
adopted the 200-ppm (820 mg/cu m) MAC for methyl isobutyl ketone
recommended by Cook [156]. In 1948, the designation of the limit was 
changed from an MAC to a TLV, and the ACGIH [158] lowered the limit to 100 
ppm (410 mg/cu m). The justification for this reduction was not reported
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at the time. In addition to citing Specht's findings [59], the ACGIH in 
their 1962 documentation mentioned the report of Silverman and coworkers 
[16] as justification for the TLV of 410 mg/cu m. Silverman et al [16] 
found that most people exposed to methyl isobutyl ketone at 200 ppm (820 
mg/cu m) experienced eye irritation. They concluded that 100 ppm (410 
mg/cu m) was a sensory response limit and that most people experimentally 
exposed to 100 ppm found this limit acceptable for an 8-hour exposure. In 
1966, the ACGIH [162] stated that the TLV as a TWA concentration of 410 
mg/cu m "should be sufficiently low to permit exposures without eye 
irritation during the working day." This statement was based on the 
previously mentioned studies. [59,16].
The ACGIH has retained the TLV-TWA of 410 mg/cu m [164]. In 1976, 
the ACGIH [164] proposed a 510 mg/cu m TLV-STEL in addition to the TLV-TWA.
The current US Federal standard for occupational exposure to methyl 
isobutyl ketone is 410 mg/cu m as an 8-hour TWA concentration limit (29 CFR
1910.1000). This standard is based on the ACGIH's 1968 TLV for methyl 
isobutyl ketone [166].
(g) Methyl Isoamyl ketone
In 1971, the Committee on Threshold Limit Values of the ACGIH [171] 
adopted a TLV of 460 mg/cu m for methyl isoamyl ketone. The Committee 
assumed that the toxicities of methyl isoamyl ketone and methyl isobutyl 
ketone would be similar because their structures are similar. In the 19.71 
documentation [171], the ACGIH recommended a TLV of 460 mg/cu m as a TWA 
concentration to protect against eye irritation to methyl isoamyl ketone in 
the workplace. The limit was based on information from Rowe and Wolf [9],
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who stated that 100 ppm (466 mg/cu m) was well below the concentration at 
which methyl isobutyl ketone produced narcotic effects.
At present, there is no Federal standard for occupational exposure tb 
methyl isoamyl ketone in the United States.
(h) Diisobutyl Ketone
In 1956, the ACGIH [172] recommended a TLV of 50 ppm (290 mg/cu m) 
for occupational exposure to diisobutyl ketone. The basis for this 
recommendation was not published at that time. A study by Carpenter et al
[20] on animals' responses to exposure of diisobutyl ketone was cited in
1962 documentation [160] by ACGIH. Carpenter and colleagues [20] found 
that at 125 ppm (726 mg/cu m) the vapor had no adverse physiologic effects 
on rats and guinea pigs exposed for 7 hours/day for 30 days. However, the 
guinea pigs exposed at 250 ppm (1,450 mg/cu m) for the same duration had a 
decrease in liver weight. According to Carpenter et al, humans considered 
exposure at 50 ppm (290 mg/cu m) for 8 hours to be "satisfactory." The TLV 
of 290 mg/cu m was designated as a TWA concentration.
In the 1971 documentation [171], the ACGIH included a study by 
Silverman and associates [16], describing the sensory response to 
industrial solvent vapors, to substantiate the recommendation that 290 
mg/cu m was a concentration at which "no toxic effects will occur and
irritation should be minimal." Silverman et al reported that humans 
exposed to diisobutyl ketone above 50 ppm (290 mg/cu m) experienced eye 
irritation and an unpleasant odor.
In 1973, the ACGIH [173] recommended a lower TLV as a TWA
concentration, 150 mg/cu m, for exposure to diisobutyl ketone. In the 1974 
documentation [168], the ACGIH again cited the studies of Carpenter et al
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[20] and Silverman et al [16] to justify the recommended TLV as one that 
should prevent eye irritation from exposure to diisobutyl ketone.
The current US Federal standard for occupational exposure to 
disobutyl ketone is 290 mg/cu m as an 8-hour TWA concentration limit (29 
CFR 1910.1000). This standard is based on the TLV adopted by ACGIH in 1968 
[166].
(i) Cyclohexanone
In 1945, Cook [156] recommended a tentative MAC of 400 mg/cu m for 
exposure to cyclohexanone in workplaces. This tentative value was based on 
the experimental human exposure study by Nelson and his associates [15] and 
the exposure study of rabbits by Treon et al [54]. At a concentration of
75 ppm (301 mg/cu m), Nelson et al [15] noted that cyclohexanone caused
eye, nose, and throat irritation in humans exposed for 3-5 minutes. Treon 
et al [54] found that, at a concentration of 0.75 mg/liter (750 mg/cu m) in 
air, cyclohexanone induced degenerative changes in the liver and kidneys of 
rabbits exposed for fifty 6-hour periods.
In 1946, the Subcommittee on Threshold Limits of the ACGIH [157]
adopted the 100-ppm (401 mg/cu m) MAC for cyclohexanone recommended by Cook 
[156].
In 1948, the designation of the limit was changed from an MAC to a
TLV [158], but the level remained at 100 ppm (401 mg/cu m) for 
cyclohexanone through 1960 [174]. In 1961, the ACGIH [167] recommended a 
lower TLV of 200 mg/cu m as a TWA concentration. The justification was 
included in the 1962 documentation [160], in which the ACGIH referred to a 
report by Treon et al [54] stating that 0.75 mg/liters (750 mg/cu m) was 
just above the maximal safe level for rabbits. Nelson and associates [15]
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reported that throat irritation was the most marked effect on humans 
exposed to cyclohexanone at 50 ppm (200 mg/cu m) for 3-5 minutes. Most 
subjects in their study were able to tolerate exposure to cyclohexanone at 
25 ppm (100 mg/cu m) .
The TLV of 200 mg/cu m as a TWA concentration remained unchanged
[163,166,175]. However, the ACGIH, in 1974 documentation [168], stated
that, although 200 mg/cu m "is recommended as the TLV, some complaints of 
irritation may be raised by some unaccustomed individuals at this level. 
It should provide a good margin of safety against systemic effects because 
concentrations that might be harmful are not likely to be tolerated."
In 1976, the ACGIH [164] proposed a TLV-STEL of 200 mg/cu m in 
addition to the TLV-TWA.
The current US Federal standard for occupational exposure to 
cyclohexanone is 200 mg/cu m as an 8-hour TWA concentration limit (29 CFR
1910.1000). This standard is based on the TLV adopted by the ACGIH in 1968 
[166].
(j) Mesityl Oxide
In 1942, Smyth and coworkers [21] reported that no adverse effects 
occurred in animals exposed to mesityl oxide vapor at 50 ppm (201 mg/cu m) 
for thirty 8-hour exposures. They found that mesityl oxide at 250-500 ppm 
(1,000-2,010 mg/cu m) had primarily narcotic effects on guinea pigs and 
rats, and they concluded that it might cause damage to the lungs, liver, 
and kidneys [21]. In 1945, Cook [156] recommended an MAC value of 200 
mg/cu m as a tentative limit for exposure to mesityl oxide in the
workplace. He used the report of Smyth et al [21] to substantiate his
recommendation. The ACGIH Committee on Threshold Limits [157] adopted 50
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ppm (201 mg/cu m) as the recommended environmental limit in 1946, as 
proposed by Cook.
In 1948, the ACGIH [158] recommended a limit of 50 ppm (201 mg/cu m), 
although the designation was changed from an MAC to a TLV. The TLV value 
remained at 50 ppm (201 mg/cu m) until 1958, when the ACGIH [16] lowered it 
to 100 mg/cu m. No reason for this change was given at that time. The 
ACGIH, in the 1962 documentation [160], cited a study of human sensory 
response conducted by Silverman et al [16] showing eye irritation at 25 ppm 
(100 mg/cu m) and nose irritation at 50 ppm (200 mg/cu m), to justify the 
TLV as a TWA concentration of 100 mg/cu m for mesityl oxide. Some subjects 
found that the odor was objectionable at 50 ppm (201 mg/cu m) and that they 
had a persistent, unpleasant taste that remained for 3-6 hours after the 
exposure [16]. The level has remained at 100 mg/cu m for mesityl oxide 
since 1972 [164]. In 1976, the ACGIH [164] proposed a TLV-STEL of 100 
mg/cu m.
The current US Federal standard for occupational exposure to mesityl 
oxide is 100 mg/cu m as an 8-hour TWA concentration limit (2 i CFR
1910.1000). This standard was based on the 1968 TLV adopted by the ACGIH 
[166] .
(k) Diacetone Alcohol
In 1955, the ACGIH [176] established a tentative TLV of 50 ppm (237 
mg/cu m) for occupational exposure to diacetone alcohol. No basis for 
recommending this level was reported at that time. The ACGIH later 
provided the justification for this level in the 1962 documentation [160], 
where the studies of Silverman et al [16] and Von Oettingen [177] were 
discussed. Silverman and associates [16] reported that, at a concentration
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of 100 ppm (474 mg/cu m), the vapor of diacetone alcohol caused eye, nose, 
and throat irritation in humans. They concluded that 50 ppm (237 mg/cu m) 
was a "more reliable limit." Von Oettingen [177] reported that 
restlessness, irritation of the mucous membranes, and excitement followed 
by drowsiness were observed in mice, rats, rabbits, and cats exposed to 
diacetone alcohol vapor at 2,100 ppm (10,000 mg/cu m). The ACGIH [160] 
concluded: "In view of eye, nose and throat irritation occurring in persons 
exposed to 100 parts per million, a value of 50 parts per million is 
suggested." The TLV of 239 mg/cu m as a TWA concentration has not been 
changed by the ACGIH [162,163,168].
The current US Federal standard for occupational exposure to 
diacetone alcohol is 240 mg/cu m as an 8-hour TWA concentration limit (29 
CFR 1910.1000). This standard is based on the TLV adopted by the ACGIH in 
1968 [166].
(1) Isophorone
In 1945, Cook [156] recommended a tentative value of 100 mg/cu m as 
an MAC for exposure to isophorone in the workplace. This tentative value 
was based on an inhalation study with guinea pigs and rats by Smyth and 
coworkers [21]. The animals were exposed to isophorone vapor for thirty 8- 
hour exposures at concentrations of 25-500 ppm (140-2,800 mg/cu m) [21]. 
The exposures at 25 ppm (140 mg/cu m) had no adverse effects on rats and 
guinea pigs.
In 1946, the ACGIH [157] recommended an MAC of 25 ppm (140 mg/cu m) 
which was based on the recommendation by Cook [156]. In 1948, the 
designation of the limit changed from an MAC to a TLV, and the 25-ppm (140 
mg/cu m) limit was again recommended by the ACGIH [158]. The ACGIH, in the
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1962 documentation [160], cited a report by Smyth et al [58] of the warning 
properties of isophorone vapor in humans exposed for a few minutes at 
concentrations of 40-400 ppm (230-2,300 mg/cu m). Eye, nose, and throat 
irritation was reported at all concentrations, and nausea, headache, 
dizziness, faintness, intoxication, and a feeling of suffocation occurred 
in a few subjects at concentrations of 200 ppm (1,130 mg/cu m) and 400 ppm 
(2,300 mg/cu m). The ACGIH [162] established a TLV of 140 mg/cu m to 
prevent irritative and narcotic effects, stating that the level was well 
below the concentration at which systemic effects might occur.
The ACGIH cited a study by Silverman and coworkers [16] on human 
sensory response to isophorone in the 1966 documentation [162]. Eye, nose, 
and throat irritation was experienced by subjects exposed to isophorone 
vapor at 25 ppm (140 mg/cu m). However, the TLV as a TWA concentration was 
not changed from 140 mg/cu m [162].
In the 1971 documentation [171], the ACGIH included the comments by 
Rowe and Wolf [9] that impure commercial products containing appreciable 
amounts of material more volatile than isophorone were used in the studies 
by Smyth and coworkers [21] and Smyth and Seaton [58] and, therefore, that 
the results should not be considered in evaluating the hazards of exposure 
to isophorone. Rowe and Wolf [9] recommended a lower TLV of 10 ppm (56 
mg/cu m).
In 1972, the ACGIH [178] recommended that the TLV for isophorone be 
lowered. A ceiling TLV of 28 mg/cu m was recommended and documented in 
1974 documentation [168]. GD Ware (written communication, June 1973) 
reported to the ACGIH that fatigue and malaise were experienced by 
employees exposed to isophorone at 5-8 ppm (28-45 mg/cu m) for 1 month.
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This study found that, when the concentrations were lowered to 1-4 ppm CG­
IS mg/cu m) with exhaust ventilation, complaints about such effects were no 
longer made.
The current US Federal standard for occupational exposure to 
isophorone is 140 mg/cu m as an 8-hour TWA concentration limit (2 ± CFR
1910.1000). This standard is based on the TLV adopted by the ACGIH in 1968 
[166] .
Basis for the Recommended Standard
Many workers are exposed to small amounts of airborne ketones or have 
negligible contact with these compounds. Under these conditions, many 
provisions of the recommended standard need not be complied with since they 
are intended to protect workers' health under hazardous circumstances. 
Concern for workers' health requires that protective measures be instituted 
below the enforceable limit to ensure that exposures stay below that limit, 
so NIOSH has defined the action level as one-half of the recommended 
environmental limit. Occupational exposure is defined as exposure above 
the action level. This definition delineates those work situations that do 
not require the expenditure of health resources for environmental and 
medical monitoring and associated recordkeeping. The action level has been 
chosen on the basis of professional judgment rather than on quantitative 
data that delineate nonhazardous areas from potentially hazardous areas.
(a) Permissible Exposure Limits
Because all of these ketones are CNS depressants, exposure to several 
of them, even at or below the recommended workplace environmental 
concentration, might produce additive effects. Employers should consider
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these additive effects when simultaneous exposures to several ketones, or 
to ketones and other CNS depressants, occur. The following formula can be 
used to determine compliance with the recommended TWA environmental limits 
when such additive effects may occur:
Cl + C2 + C3 + . .. + Cn <1
PEL1 PEL2 PEL3 ... PELn ~
where:
C = the concentration of a substance
PEL = the permissible exposure limit of that substance
Peripheral neuropathy caused by methyl n-butyl ketone is the most 
serious known form of occupational illness from these ketones. Although 
narcosis may result from exposure to all of these ketones at high 
concentrations, irritation of the eyes, nose, and throat occurs first and 
should act as a warning property.
Studies have indicated that the high molecular weight ketones in a 
homologous series are more irritating and have a stronger narcotic action. 
Therefore, the higher molecular weight ketones of a homologous series 
should have exposure limits that are less than those of the low molecular 
weight ketones when toxicity is based solely on irritation.
(1) Acetone (1 ppm = 2.37 mg/cu m)
Eight workers exposed to acetone at concentrations above 
12,000 ppm had throat and eye irritation, weakness in the legs, and 
headache [25]. One worker fainted; several felt dizzy and lightheaded. 
The symptoms and urinary acetone levels indicate that even a short exposure 
to acetone at concentrations above 12,000 ppm is hazardous.
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Six studies have reported possible adverse effects on humans from 
acetone at concentrations at and below 1,000 ppm. In one study [17], 
exposure at an average concentration of 1,000 ppm for 8 hours resulted in 
headaches and lightheadedness in some workers. A second study [28] 
indicated that exposure to acetone at 1,000 ppm for 3 hours/day for 7-15 
years and at 700 ppm for an unreported length of time resulted in 
inflammation of the respiratory tract, stomach, and duodenum, occasional 
dizziness, and loss of strength. In a third study [27], which may have 
been the basis for part of the data in the second study, employees exposed 
to acetone at 307-918 ppm (730-2,180 mg/cu m) had irritation of the eyes, 
nose, throat, and lungs and CNS disturbances. In addition, these 
investigators presented evidence that daily 6-hour exposures to acetone at 
833 ppm (2,000 mg/cu m) did lead to an accumulation in the body, which 
persisted into the next workday. A fourth report [18] revealed that 
several subjects experienced irritation of the eyes, nose, and throat, 
tension, general weakness, heavy eyes, or lack of energy the morning after 
6 hours of exposure to acetone at 1,000 ppm. This study also found the 
same complaints in those exposed at 500 ppm for 6 hours and the same but 
fewer complaints in those exposed at 250 ppm for 6 hours. These results 
are consistent with those in a fifth report [15] in which acetone at 350 
ppm for 3-5 minutes caused irritation of the eyes, nose, and throat in a 
majority of 10 subjects exposed to it. In this report it was also noted 
that at 300 ppm there was slight irritation and that most of the 10 
volunteers estimated 200 ppm was the highest concentration that would be 
satisfactory for an 8-hour exposure. A sixth study [42] indicated that 
employee volunteers who were exposed to acetone for 2 or 4 hours, with
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exercise in some cases, suffered no untoward effects and had no symptoms 
after exposure at 100 ppm, a finding consonant with that in another paper 
[18] in which none of five young men exposed for 6 hours at 100 ppm in an 
unstressed situation complained of any adverse reaction.
From the above six studies, it is apparent that untoward effects have 
occurred at 1,000 ppm and have become decreasingly severe as the 
concentration decreases. As the concentrations of acetone have decreased 
below 200 ppm, few or no complaints of adverse reactions have occurred.
One report [42], in which an unreported number of men (probably four 
or less) were unaffected by acetone at 500 ppm for between 2 and 4 hours, 
seems to be inconsistent with the trend indicated by the results of other 
exposures. It is unclear whether a longer exposure, such as that during a 
normal 8-hour workday, would have resulted in adverse reactions similar to 
those seen in the other five studies; however, it is clear from this report 
that acetone did accumulate in the body and that some of it would probably 
remain to the next workday.
The preponderance of exposure data at concentrations of 1,000 ppm and 
less leads to the conclusion that some untoward effects will occur in those 
exposed to acetone at concentrations below 500 ppm. Furthermore, the 
available evidence indicates that occupational exposure to acetone may lead 
to its accumulation in the body. It seems reasonable to conclude that a 
workplace environmental limit of about 250 ppm (590 mg/cu m) should be 
established. Therefore, it is recommended that acetone concentrations in 
the workplace air not exceed 250 ppm (590 mg/cu m) as a TWA concentration 
limit for up to a 10-hour workshift in a 40-hour workweek.
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(2) Methyl Ethyl Ketone (1 ppm = 2.95 mg/cu m)
Nelson et al [15] reported that most volunteers exposed to 
methyl ethyl ketone estimated that 200 ppm (590 mg/cu m) would be 
satisfactory for an 8-hour exposure. However, at 100 ppm, slight nasal 
irritation and throat irritation were produced, while at 200 ppm it caused 
mild eye irritation in some subjects. At 350 ppm (1,030 mg/cu m), methyl 
ethyl ketone irritated the eyes, nose, and throat of most subjects.
Patty et al [19] detected no serious disturbances in guinea pigs 
exposed to methyl ethyl ketone at 3,000 ppm (8,850 mg/cu m) for a few 
hours. In animals, methyl ethyl ketone did not produce any signs of 
peripheral neuropathy [73,74,77]. However, animals exposed to a 
combination of methyl n-butyl ketone and methyl ethyl ketone developed 
paralysis in a much shorter period of time than did animals exposed to only 
methyl n-butyl ketone [73]. Couri et al [87] presented evidence that 
methyl ethyl ketone may potentiate the toxicity of methyl n-butyl ketone by 
stimulating the metabolic activation of the latter ketone.
Schwetz et al [97] found some evidence of teratogenicity when 
pregnant rats were exposed to methyl ethyl ketone at 1,126 and 2,618 ppm 
(3,320 and 7,720 mg/cu m). However, as discussed in Chapter III, it is not 
clear that this evidence can be reliably extrapolated to humans. In 
addition, the possible potentiation of neurotoxicity induced by methyl n- 
butyl ketone should be handled by stringent control of methyl n-butyl 
ketone rather than by regulating methyl ethyl ketone for possible effects. 
A review of the available data provides no basis for a change in the 
present Federal workplace environmental limit of 200 ppm (590 mg/cu m). 
Therefore, it is recommended that methyl ethyl ketone concentrations in the
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workplace air not exceed 200 ppm (590 mg/cu m) as a TWA concentration for 
up to a 10-hour workshift in a 40-hour workweek.
(3) Methyl n-Propyl Ketone (1 ppm = 3.52 mg/cu m)
Specht et al [34] found that methyl n-propyl ketone was 
considerably less toxic than methyl n-butyl ketone but more toxic than 
methyl ethyl ketone in guinea pigs. Narcosis was produced in guinea pigs 
exposed at 5,000 ppm (17,600 mg/cu m). Interpretation of the data of 
Specht et al suggests that methyl n-propyl ketone might be more irritating 
to the eyes, nose, and throat than was either acetone or methyl ethyl 
ketone.
It is believed that an extrapolation from the data of Specht et al 
[34] to the findings of Nelson et al [15] is appropriate. Nelson et al
reported that 100 ppm (350 mg/cu m) of methyl ethyl ketone produced slight 
irritation in volunteers. Interpretation of the data of Specht et al [34], 
as mentioned before, suggests that methyl n-propyl ketone is at least as 
irritating as methyl ethyl ketone. Thus, it is believed that a slight
reduction in the current Federal standard of 700 mg/cu m (200 ppm) is 
warranted to protect employees from irritation to the eyes, nose, and 
throat. Therefore, an exposure limit for methyl n-propyl ketone of 150 ppm 
(530 mg/cu m) for up to a 10-hour TWA concentration in a 40-hour workweek 
is recommended.
(4) Methyl n-Butyl Ketone (1 ppm »4.10 mg/cu m)
Allen et al [37] found 81 cases of peripheral neuropathy, 11
of which were diagnosed as moderate to severe, in a coated-fabric plant 
where methyl n-butyl ketone and methyl ethyl ketone were used. Employees 
who worked at or near the print machines, where both ketones were used as
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solvents, had a significantly higher incidence of neuropathy than did 
employees who worked in other departments. Analysis of the areas around 
the print machine showed methyl n-butyl ketone at 9.2-36 ppm (38-148 mg/cu 
m) and methyl ethyl ketone at 331-516 ppm (1,360-2,115 mg/cu m) when 9 of 
17 machines were in operation. No neuropathy was found in a similar plant 
that used methyl ethyl ketone without methyl n-butyl ketone.
In 1976, Mallov [39] investigated peripheral neuropathy in three 
spray painters. The onset of neuropathy correlated with the substitution 
of methyl n-butyl ketone in a paint formulation for methyl isobutyl ketone 
and methyl isoamyl ketone. Although no environmental sampling or analysis 
was reported, Mallov stated that the three workers had ample opportunity 
for exposure to methyl n-butyl ketone by inhalation and skin absorption.
Studies on a variety of animals have conclusively demonstrated that 
repeated exposure to methyl n-butyl ketone produced peripheral neuropathy 
[70,71,73,179]. A comparison of data indicated that the no effect 
concentration for methyl n-butyl ketone in animals was probably less than 
100 ppm [76,77,80].
Exposure concentrations at the coated-fabric plant varied over a 
considerable range, so it is difficult to interpret which concentrations 
were safe and which were not. While methyl n-butyl ketone at higher 
concentrations probably caused the neuropathy, a review of the data of 
Billmaier et al [38] indicates that apparently 2.3 ppm (9.4 mg/cu m) cannot 
be ruled out. Because of the severity of the toxic effects and the 
incomplete reversibility of the lesions in these fabric workers, a cautious 
approach which views the lowest concentration as a possible toxic 
concentration is needed and a recommendation for a very low environmental
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limit seems appropriate. Thus, a limit at least as low as 1 ppm (4 mg/cu 
m) is recommended, pending the development of suitable data that will allow 
a more rigorous development of a permissible limit.
Inasmuch as methyl n-butyl ketone penetrates skin, it might be 
interpreted that percutaneous absorption played a significant, conceivably 
even the predominant, part in the development of neuropathy in the fabric 
workers. This interpretation is supported by evidence that the workers 
washed their hands in the ketone solution. However, a study of the 
relevant data does not support this interpretation. Calculations based on 
quantitative data on percutaneous absorption [45] and some assumptions 
about likely immersion times (see Chapter III, Correlation of Exposure and 
Effect for an example of these calculations) suggest that percutaneous 
absorption was less important than inhalation in what was undoubtedly a 
dose-related neuropathogenesis. However, the ability of this ketone to 
penetrate skin as well as to cause local skin effects is sufficiently 
evident to warrant work practices to prevent skin contact. It is 
recommended, therefore, that methyl n-butyl ketone concentrations in 
workplace air not exceed 1 ppm (4 mg/cu m) as a 10-hour TWA concentration.
(5) Methyl n-Amyl Ketone (1 ppm = 4.67 mg/cu m)
Specht et al [34] found that methyl n-amyl ketone at 1,500 ppm 
(7,000 mg/cu m) produced irritation of the mucous membranes of guinea pigs. 
At 2,000 ppm, it was strongly narcotic, and 4-8 hours of exposure at 4,800 
ppm (22,400 mg/cu m) produced narcosis and death. Because repeated 
exposure of rats and monkeys to methyl n-amyl ketone did not produce any 
evidence of peripheral neuropathy, it is believed that the standard for 
this ketone should be based on its irritating properties.
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As was the case for methyl n-propyl ketone, methyl n-amyl ketone was 
also more irritating than acetone and methyl ethyl ketone [34]. Because 
methyl n-amyl ketone was at least as irritating to animals as methyl n- 
propyl ketone [34], the recommended exposure limit should be at least as 
low as that for methyl n-propyl ketone. However, the concentration at 
which methyl n-amyl ketone does not produce irritation in humans was not 
found. Therefore, there is no basis for a change in the present Federal 
workplace environmental limit of 100 ppm (465 mg/cu m). It is therefore 
recommended that the concentration of methyl n-amyl ketone in workplace air 
not exceed 100 ppm (465 mg/cu m) as a TWA concentration for up to a 10-hour 
workshift in a 40-hour workweek. It seems probable that this exposure 
limit should prevent most irritation in workers exposed to methyl n-amyl 
ketone.
(6) Methyl Isobutyl Ketone (1 ppm = 4.10 mg/cu m)
Silverman et al [16] reported that 100 ppm was the highest 
concentration that most volunteers estimated to be satisfactory for an 8- 
hour exposure. At 200 ppm, the eyes of most persons were irritated.
Specht [59] reported that methyl isobutyl ketone at 1,000 ppm (4,100 mg/cu
m) was exceedingly irritating to the eyes and nose of the investigator
during an experiment in which guinea pigs showed little disturbance. 
Linari et al [30] reported that methyl isobutyl ketone at 80-500 ppm
produced weakness, loss of appetite, headache, eye irritation, sore throat, 
stomach ache, nausea, and vomiting in exposed workers. In a followup 
study, Armeli et al [31] reported that these signs were reduced to the 
point of disappearing in workers exposed to methyl isobutyl ketone at 50- 
105 ppm (205-430 mg/cu m); however, a few workers still had CNS and
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gastrointestinal disorders. It seems probable that the effects noted in 
these few workers resulted from exposures at the higher concentrations.
Spencer et al [71] reported that rats exposed to methyl isobutyl 
ketone at 1,500 ppm for 5 months developed minimal neuropathologic changes 
in the most distal portions of the tibial and ulnar nerves. The authors 
related these findings to the presence of 3% methyl n-butyl ketone as a 
contaminant of the methyl isobutyl ketone. In a later study, Spencer et al 
[74] reported that purified methyl isobutyl ketone (9 % purity) did not 
cause peripheral neuropathy in animals.
Because of the studies of Silverman et al [16], Linari et al [30], 
and Armeli et al [31], it is believed that the current Federal standard for 
methyl isobutyl ketone of 410 mg/cu m (100 ppm) is not adequate to protect 
employees from adverse effects, but the concentration at which methyl 
isobutyl ketone will produce no adverse effects is not known. The study of 
Armeli et al [31] indicated that the adverse effects were virtually 
eliminated when the concentration of airborne methyl isobutyl ketone was 
reduced to 50-105 ppm. Thus, it is recommended that the concentration of 
methyl isobutyl ketone in the workplace air not exceed 50 ppm (200 mg/cu m) 
as a TWA concentration for up to a 10-hour workshift in a 40-hour workweek.
(7) Methyl Isoamyl Ketone (1 ppm = 4.67 mg/cu m)
Currently, there is no information to firmly support a limit 
for methyl isoamyl ketone. Because methyl isoamyl ketone contains one more 
carbon atom than does methyl isobutyl ketone, methyl isobutyl ketone might 
produce irritation and narcosis at concentrations at least as low as those 
at which methyl isobutyl ketone produces these effects. Therefore, a limit 
of 50 ppm (230 mg/cu m), corresponding to that of methyl isobutyl ketone,
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is proposed for up to a 10-hour TWA concentration in a 40-hour workweek.
(8) Diisobutyl ketone (1 ppm = 5.82 mg/cu m)
Two volunteers had slight irritation of the eyes and nose when 
exposed to diisobutyl ketone at 100 ppm (582 mg/cu m) [20]. Another person 
had slight tearing and two others had headaches at the same concentration. 
Two of the subjects exposed at 50 ppm (290 mg/cu m) experierHed transitory, 
slight irritation of the eyes and nose at the beginning of the exposure. 
However, Carpenter et al [20] stated that the vapor could be smelled and 
tasted throughout the exposure period. All three subjects exposed at 100 
ppm estimated that a workplace atmosphere of 100 ppm would be 
unsatisfactory for continuous exposure. Silverman et al [16] reported that 
25 ppm (145 mg/cu m) was the highest concentration that most subjects 
considered satisfactory for an 8-hour exposure to diisobutyl ketone. 
Because of these findings, it is recommended that to reduce eye irritation, 
the concentration of diisobutyl ketone in workplace air not exceed 25 ppm
(140 mg/cu m) for up to a 10-hour TWA concentration in a 40-hour workweek.
(9) Cyclohexanone (1 ppm = 4.01 mg/cu m)
Nelson et al [15] reported that 25 ppm (100 mg/cu m) was the 
highest concentration that most subjects considered satisfactory for an 8- 
hour exposure to cyclohexanone. At 50 ppm, throat irritation was reported, 
while, at 75 ppm (300 mg/cu m), most subjects had irritation of the eyes, 
nose, and throat.
Cyclohexanone at 190 ppm (762 mg/cu m) for fifty 6-hour exposures
produced liver and kidney damage in rabbits [54] . Cutaneous or 
subcutaneous application of cyclohexanone produced cataracts in guinea pigs 
[66]. In some cases, lens damage was reversed within 3 months after
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exposure. No such findings in humans have been reported (see discussion in 
paragraph (c) of this section). Because of the findings of Nelson et al 
[15], and because of the ability of cyclohexanone to produce liver and 
kidney damage at relatively low concentrations in rabbits, it is 
recommended that the exposure limit for cyclohexanone be set at 25 ppm (100 
mg/cu m) as #  TWA concentration for up to a 10-hour workshift in a 40-hour 
workweek.
(10) Mesityl Oxide (1 ppm = 4.01 mg/cu m)
Silverman et al [16] reported that the majority of volunteers 
exposed to mesityl oxide for 15 minutes had eye irritation at 25 ppm and 
nose irritation at 50 ppm (200 mg/cu m). Smyth et al [21] reported that 
mesityl oxide at 50 ppm had no adverse affects on rats and guinea pigs 
exposed for thirty 8-hour periods. An extrapolation of the data of Smyth 
et al to humans might indicate that repeated exposures to mesityl oxide at 
50 ppm would be safe. However, eye irritation was reported at 25 ppm (100 
mg/cu m), and there is reason to believe that eye irritation by mesityl 
oxide is more serious than that produced by the lower ketones. (See
Correlation of Exposure and Effect.) In addition, systemic effects (liver
and kidney changes) occurred in animals exposed (at higher concentrations) 
to mesityl oxide. Thus, it is recommended that the concentration of 
mesityl oxide in workplace air not exceed 10 ppm (40 mg/cu m) as a TWA 
concentration for up to a 10-hour workshift in a 40-hour workweek.
(11) Diacetone Alcohol (1 ppm = 4.75 mg/cu m)
Silverman et al [16] reported that most subjects had eye
irritation and all subjects had nose and throat irritation when exposed to
diacetone alcohol at 100 ppm (475 mg/cu m) [16]. The highest concentration
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of diacetone alcohol judged to be satisfactory for an 8-hour exposure was 
50 ppm. Lehmann and Flury [57] found irritation of mucous membranes and 
somnolence in a variety of experimental animals exposed to diacetone 
alcohol at 2,100 ppm (9,975 mg/cu m). Kidney injury was also reported in 
rabbits at that concentration. To prevent eye irritation, an exposure 
limit for diacetone alcohol of 50 ppm (240 mg/cu m) for up to a 10-hour TWA 
concentration in a 40-hour workweek is recommended. This is identical to 
the present Federal standard.
(12) Isophorone (1 ppm = 5.65 mg/cu m)
Silverman et al [16] reported that 10 ppm was the highest 
concentration that most volunteers considered satisfactory for an 8-hour 
exposure. They noted that irritation of the eyes, nose, and throat was 
produced in the majority of persons exposed at 25 ppm.
Smyth et al [21] exposed animals to isophorone for 8 hours/day, 5 
days/week, for 6 weeks. They reported that isophorone at 25 ppm produced 
no adverse effects. In six animals exposed at 50 ppm, the liver of one and 
the kidneys of four were affected; the nature of these changes was not 
described. All of 20 animals survived exposures at 50 ppm, but 2 of 16 
died after exposure at 100 ppm.
GD Ware (written communication, June 1973) of Western Electric 
Company reported to the TLV Committee of the ACGIH that workers suffered 
fatigue and malaise after exposure to isophorone at 5-8 ppm. When air 
levels were reduced to 1-4 ppm, no further complaints were received. (A 
copy of this letter to the TLV Committee has been furnished to NIOSH.) 
Based on this information, a permissible exposure limit of 4 ppm (23
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mg/cu m) as a TWA concentration for up to a 10-hour workshift, 40-hour 
workweek is recommended.
(b) Sampling and Analysis
The recommended sampling method, reviewed in more detail in Chapter 
IV, involves collecting airborne ketones in charcoal-filled tubes, followed 
by desorption with carbon disulfide. Gas-liquid chromatography is the 
recommended analytic procedure. The sampling method was chosen because it 
has been validated for 11 of the ketones and because it is expected to 
provide adequate collection efficiency for airborne ketones. The gas- 
chromatographic method of analysis was selected because it is sensitive and 
relatively simple to use, although it is not entirely specific for ketones. 
Other compounds having the same retention time as the ketone being analyzed 
will interfere with the analysis; however, mass spectrometry can be used to 
identify some of the eluted compounds.
(c) Medical Surveillance
Because repeated exposure to methyl n-butyl ketone can produce 
peripheral neuropathy [37,39,70-72,74], electrodiagnostic examinations 
including electromyography and nerve conduction and velocity measurements 
must be made available to workers exposed to this ketone. These types of 
electrodiagnostic studies are objective tests which are the most sensitive 
indicators of early peripheral neuropathy. Employees' weight should also 
be monitored, since unexpected weight loss may be an advanced indicator of 
peripheral neuropathy. Exposure to the 12 ketones can also irritate the 
eyes, nose, and throat. These effects should be considered in medical 
examinations of exposed employees. Furthermore, because acetone and 
cyclohexane have produced cataracts in experimental animals, particular
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attention should be given to the eyes where exposure to these substances 
may occur [66]. Although the evidence of kidney and liver damage 
[30,54,55,57] was developed from exposures at high concentrations or, in 
the case of animal studies, at high doses, and thus not weighed heavily in 
developing environmental limits, workers' kidney and probably liver 
functions should be monitored. Therefore, periodic urinalysis is proposed 
as a requirement, and periodic monitoring of liver enzymes is proposed as 
an additional recommendation.
(d) Personal Protective Equipment and Clothing
Because these ketones are defatting agents that can cause skin 
irritation and dermatitis, workers who are likely to have skin contact with 
the liquid ketones must wear protective gloves. The use of safety goggles 
or face shields (20-cm minimum) is recommended to prevent eye irritation 
when contact of ketones with the eyes is likely. Other personal protective 
equipment should include respirators when necessary, and appropriate 
protective clothing. The types of respiratory protective devices described 
in Tables 1-2 should be those approved under the provisions of 30 CFR 11.
(e) Informing Employees of Hazards
Personnel in areas where a ketone is present must be advised of the 
adverse effects of exposure and informed of the signs and symptoms of the 
disorders. Employees exposed to methyl n-butyl ketone should be warned 
that the neurotoxic symptoms of this ketone may have an insidious onset. A 
continuing education program is an important part of a preventive hygiene 
program for employees occupationally exposed to ketones. Properly trained 
persons should periodically inform employees about the dangers of improper 
work practices, such as washing their hands with ketones, and of exposure
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by other routes, such as inhalation and ingestion. Additionally, employees 
should be informed of engineering controls and work practices used to limit 
exposure and of the environmental and medical monitoring practices for 
checking control procedures and determining the health status of employees.
(f) Work Practices
Procedures that minimize the volatilization of ketones and workers'
contact with ketones should be used for the cleanup of spills, waste 
disposal, general housekeeping, and storage of ketones. Personal hygienic 
measures should be adopted to prevent ingestion of ketones and to further 
reduce the probability of skin contact. Work practices that will prevent 
ingestion and limit inhalation or skin contact with ketones must be 
implemented. Smoking, eating, and food preparation should be prohibited in 
areas where ketones are present. Spilled ketones must be cleaned up 
promptly by trained personnel wearing adequate protective equipment and 
clothing. Employees must be prohibited from washing their hands with 
ketones, and handwashing facilities must be provided. If contamination of 
clothing with ketones is likely, employees should wear protective outer 
garments. Because of the adverse effects associated with exposure to 
ketones, entry into areas where there is occupational exposure to ketones 
should be restricted to authorized persons.
(g) Monitoring and Recordkeeping
Industrial hygiene surveys should be made to determine in which areas 
there may be occupational exposure to ketones. Thereafter, where there is 
occupational exposure to ketones, the exposure of each employee should be
determined, and the workplace air in the breathing zones of employees in 
every operation should be sampled and analyzed at least every 3 months.
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Changes in production or process necessitate additional monitoring to 
detect any changes in the concentrations of airborne ketones.
The Toxic Substances Control Act of 1976 requires that "Records 
of...adverse reactions to the health of employees shall be retained for 
thirty years from the date such reactions were first reported to or known 
by the person maintaining such records...." Because medical examinations 
will often provide the first recognized evidence of an adverse reaction, 
whether at the time of the examination or retrospectively, it appears 
consonant with the Toxic Substances Control Act to require medical records 
on ketone workers to be maintained for 30 years. Furthermore, records of 
environmental exposures should be kept for the same period, to allow 
correlation of a ketone worker's exposure with his or her health.
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VII. RESEARCH NEEDS
No detailed epidemiologic studies of the effects of occupational 
exposure to ketones other than methyl n-butyl ketone have been found in the 
literature. Such studies are needed to determine chronic effects of ketone 
exposure on humans and safe levels of such exposures.
An investigation of potential neurotoxic effects of ketones other 
than methyl n-butyl ketone is needed. Such studies are needed to determine 
if any other ketones can produce peripheral neuropathy in exposed workers. 
Studies are also necessary to gather information on the toxicity of 
metabolites and on relevant toxic interactions with other chemicals. In 
this connection, NIOSH is currently (1978) investigating evidence of 
peripheral neuropathy in an operation involving exposure to methyl ethyl 
ketone and toluene. Studies in animal models are needed to examine 
possible neurotoxic effects from mixed exposures. Also, since methyl ethyl 
ketone has been shown to enhance the toxicity of methyl n-butyl ketone, the 
possibility of a toxic interaction between methyl ethyl ketone and other 
chemicals should be explored.
Further studies are needed to discover whether these ketones have
carcinogenic, mutagenic, or teratogenic effects.
Preliminary conclusions regarding the potential of acetone and 
cyclohexanone to cause cataracts have been made based on animal data. 
Retrospective morbidity studies of workers exposed to ketones should be 
performed to determine the cataract-causing potential in humans.
Although studies on the concentrations of ketones that produced
irritation of the eyes, nose, and throat were found, not all of the ketones
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were tested. Research is required to determine the concentrations of 
ketones that produce irritation. Investigations should also be conducted 
to determine the concentrations of ketones that can produce impaired 
judgment.
Information concerning the resistance to ketone penetration of 
personal protective devices, such as gloves and clothing, is needed.
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IX. APPENDIX I
SAMPLING AND ANALYSIS FOR SELECTED KETONES
The following method for 12 selected ketones is adapted from NIOSH 
methods validated for 11 of the compounds [114,115]. Mention of company 
name or product does not constitute endorsement by NIOSH.
Principle of the Method
(a) A known volume of air is drawn through a charcoal tube to trap
the organic vapors present.
(b) The charcoal in the tube is transferred to a small, stoppered
glass sample container and desorbed with carbon disulfide.
(c) An aliquot of the desorbed sample is injected into a gas
chromatograph.
(d) The area of the resulting peak is determined and compared with
areas obtained from the injection of standards.
Range and Sensitivity
(a) This method was validated for the individual ketones over the
range presented in Table IX-1. An atmospheric temperature and pressure of 
approximately 25 C and 761 mmHg and a sample size of 10-12 liters were 
used. The method is capable of measuring much lower concentrations, but 
they have not been validated. Methyl n-butyl ketone, for example, is
measurable at a concentration of 4 mg/cu m provided desorbing efficiency is
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t a b u :  ìx-i
RANGE, COEFFICIENTS OF VARIATIONS, AND STANDARD DEVIATION OF THE RECOMMENDED SAMPLING AND
















Acetone 1, 200-4,500 350-5,000 0.082 4.12** -22 114
Methyl ethyl 
ketone




395-1,570 70-2,100 0.063 21 mg/cu m -1.3 2 114
Methyl n-butyl 
ketone
lbb-790 40-1,200 0.053 22 mg/cu m -0.5% 115
Methyl n-anyl 
ketone











145-582 30-1,000 0.070 20.3 mg/cu m -1 .42 115
Cyclohexanone 98-392 10-500 0.062 7.4 mg/cu m -6.32 114
Mesityl oxide 45-210 10-300 0.0708 7 .8 mg/cu a +72 114
Diacetone
alcohol
140-510 24-750 0.104 24.1 ng/cu TTl -11 .92 114
Isophorone 68-283 2-400 0.058 8 mg/cu m +52 115
*At current Federal standard 
♦♦Relative standard deviation
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adequate since the lower limit of detection for the NIOSH validated method 
has been stated as 0.01 mg/cu m [146]. Desorption efficiency must be 
determined over the actual range of the samples.
(b) The useful range of the sampling method depends largely on the 
adsorptive capacity of the charcoal tube. The total amount of ketone 
collected will vary with the sampling rate and with the concentrations of 
ketones and other substances, particularly water vapor, in the air. 
Experimental results on breakthrough are listed in Table IX-2 and were 
determined with a relative humidity of less than 15% and at normal 
conditions. If a particular atmosphere is suspected of containing a large 
amount of ketone, a smaller sample volume should be collected.
Interference
(a) When the amount of water in the air is so great that 
condensation actually occurs in the charcoal tube, ketone vapors will not 
be trapped efficiently.
(b) When two or more compounds are known or suspected to be 
present in the air, such information, including their suspected identities, 
should be transmitted with the sample.
(c) It must be emphasized that any compound that has the same 
retention time as the ketone at the operating conditions described in this 
method will interfere. Hence, retention time data on a single column, or 




(d) If interference is known to occur with the analysis in 
question, separation conditions (column packing, temperature, etc) must be 
changed to circumvent the problem.
Precision and Accuracy
The coefficients of variation, standard deviations, and deviations 
from "true" values for the combined sampling and analytical method are 
listed in Table IX-1. The standard deviation at the present Federal 
standard is also reported. The data in Table IX-1 for mesityl oxide, 
methyl n-butyl ketone, methyl n-amyl ketone, and diacetone alcohol are 
based on experiments using an internal standard.
Advantages and Disadvantages of the Method
(a) The sampling device is small and portable and involves no 
liquids. Analytical interferences are usually minimal, and most of those 
that do occur can be eliminated by altering the chromatographic conditions. 
The tubes are analyzed by means of a quick, instrumental method. In some 
cases, by adjusting chromatographic conditions, the method can also be used 
for the simultaneous analysis of two or more substances suspected to be 
present in the same sample, provided that each substance can be efficiently 
desorbed with the same desorbing medium.
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TABLE IX-2

















Acetone 18 4,300 0.195 2 2 114
Methyl ethyl 
ketone
19 1,260 0.17 8 6 114
Methyl n-propyl 
ketone
27 1,450 0.19 1 0 0 114
Methyl n-butyl 
ketone
35 790 0.187 240** 115
Methyl n-amyl 
ketone
15 925 0 . 2 >180** 114
Methyl isobutyl 
ketone
2 0 1,145 0.19 91.7 114
Diisobutyl
ketone
25 582 0 . 2 0 219 115
Cyclohexanone 26*** - - - 114
Mesityl oxide 9.6 2 1 0 0 . 2 240 114
Diacetone
alcohol
24 507 0 . 2 >240** 114
Isophorone 13 283 0.19 >240** 115
*When concentration of ketone in effluent reaches 5% of that in influent
**No breakthrough in stated time
***In 1 st section when breakthrough occurred
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(b) One disadvantage of the method is that the amount of sample
that can be taken is limited by the mass of ketone that the tube will hold
before overloading. This sample size is dependent on the types and 
concentrations of the contaminants in the workplace air. When the sample 
value obtained for the backup section of the charcoal trap exceeds 25% of 
that found on the front section, sample loss must be suspected.
(c) The precision of the method is limited by the reproducibility
of the pressure drop across the tubes. If the pump is calibrated for one 
tube only, variations in pressure drop from tube to tube will result in 
different flowrates and cause volumes to be imprecise.
Apparatus
(a) An approved and calibrated personal sampling pump with a flow 
that can be determined to within 5% at the recommended flowrate.
(b) Charcoal tubes: glass tube with both ends flame-sealed, 7 cm 
long with a 6 -mm outer diameter and a 4-mm inner diameter, containing two 
sections of 20/40 mesh activated charcoal separated by a 2-mm portion of 
urethane foam. The activated charcoal is prepared from coconut shells and 
is fired at 600 C prior to packing. The absorbing front section contains 
100 mg of charcoal, the backup section 50 mg. A 3-mm portion of urethane 
foam is placed between the outlet end of the tube and the backup section. 
A plug of silylated glass wool is placed in the front of the tube. The 
pressure drop across the tube must be less than 1 inch of mercury at a 
flowrate of 1 liter/ minute.
(c) Gas chromatograph equipped with a flame-ionization detector.
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(d) Chromatographic column:
(1 ) 2 0 -feet x 1 /8 -inch stainless steel, packed with 1 0 %
FFAP on 80/100 mesh Chromosorb W AW-DMCS (acid-washed 
dimethylchlorosilated) for methyl n-butyl ketone.
(2) 4-feet x 1/4-inch stainless steel, packed with 50/80
mesh Porapak, Type Q, for acetone.
(3) 10-feet x 1/8-inch stainless steel, packed with 10%
FFAP on 80/100 mesh Chromosorb W DMCS, for the other 10 ketones.
(e) An electronic integrator or some other suitable method for
measuring peak areas . *
(f) One-milliliter glass sample containers with glass stoppers or
Teflon-lined caps.
(g) Microliter syringes: 10-jul and other convenient sizes for
making standards.
(h) Pipets: 0.5-ml delivery pipets or 1.0-ml type graduated in
0 .1 -ml increments.
(i) Volumetric flasks: 10-ml or convenient sizes for making
standard solutions.
Reagents
(a) Chromatographic quality carbon disulfide (containing 5% 2-
propanol for diacetone alcohol analysis).
(b) Ketone, reagent grade.
(c) Purified nitrogen.
(d) Prepurified hydrogen.
(e) Filtered compressed air.
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(f) n-Tridecane (99+%) for use as internal standard.
(g) n-Heptane, reagent grade.
Procedure
(a) Cleaning of Equipment. Detergent wash all glassware used for 
the laboratory analysis and rinse thoroughly with tapwater and distilled 
water.
(b) Calibration of Personal Pumps. Calibrate each personal pump
with a representative charcoal tube in line as shown in Figure XI-1. This 
will minimize errors associated with uncertainties in the sample volume 
collected.
(c) Collection and Shipping of Samples
(1) Immediately before sampling, break the ends of the tube
to provide an opening at least one-half the internal diameter of the tube 
( 2 mm).
(2) Use the smaller section of charcoal as a backup and
position it nearest the sampling pump.
(3) Place the charcoal tube in a vertical direction during 
sampling to minimize channeling through the charcoal.
(4) Do not pass air being sampled through any hose or
tubing before entering the charcoal tube.
(5) A maximum sample size of 10-12 liters is recommended.
This size can be attained by sampling at a rate of 0.20 liter/minute. The
flowrate should be known with an accuracy of at least 5%.
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(6 ) Record the temperature and pressure of the atmosphere 
being sampled.
(7) Cap the charcoal tubes with the supplied plastic caps 
immediately after sampling. Under no circumstances should rubber caps be 
used.
(8 ) Handle at least one tube in the same manner as the 
sample tube (break, seal, and transport), but do not draw air through this 
tube. Label this tube as a blank.
(9) Pack capped tubes tightly before they are shipped to 
minimize tube breakage during shipping.
(10) Submit a sample of the bulk material to the laboratory 
in a glass container with a Teflon-lined cap. Do not transport this sample 
in the same container as the charcoal tubes.
(d) Analysis of Samples
(1) Preparation of Samples. Sample tubes will be received 
opened but protected by plastic caps. Remove the plastic cap from the 
front section, discard the glass wool in front of the charcoal, and 
transfer the charcoal in the first (larger) section to a 1 -ml stoppered 
sample container. Remove and discard the separating section of foam; 
transfer the second section to another stoppered container. Analyze these 
two sections separately.
(2) Desorption of Samples. Prior to analysis, pipet 0.5 ml
of carbon disulfide (1 . 0  ml for mesityl oxide, methyl n-butyl ketone, 
diacetone alcohol, and methyl n-amyl ketone analysis) into each sample 
container. For the internal standard method, use a 0.1% solution of the
internal standard in the eluent. Tests have indicated that desorption is
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complete in 30 minutes if the sample is stirred occasionally during this 
period. If an automatic sample injector is used, cap the sample vials as 
soon as the solvent is added to minimize volatilization.
EXTREME CAUTION MUST BE EXERCIZED AT ALL TIMES WHEN USING 
CARBON-DISULFIDE BECAUSE OF ITS HIGH TOXICITY AND FIRE AND 
EXPLOSION HAZARDS. IT CAN BE IGNITED BY HOT STEAM PIPES. ALL 
WORK WITH CARBON DISULFIDE MUST BE PERFORMED UNDER AN EXHAUST 
HOOD.
(3) Chromatograph Conditions. The typical operating 
conditions for the gas chromatograph for each ketone are listed in Table 
IX-3.
(4) Injection. The first step in the analysis is the 
injection of the sample into the gas chromatograph. To eliminate 
difficulties arising from blow back or distillation within the syringe 
needle, one should employ the solvent flush injection technique, possibly 
using a syringe guide for ease of performance. First flush the 10-/il 
syringe with solvent several times to wet the barrel and plunger. Draw 3 
/nl of solvent into the syringe to increase the accuracy and reproducibility 
of the injected sample volume. Remove the needle from the solvent, and 
pull the plunger back about 0 . 2  jul to separate the solvent flush from the 
sample with a pocket of air to be used as a marker. Immerse the needle in 
the sample, and withdraw a 5-jul aliquot, taking into consideration the 
volume of the needle, since the sample in the needle will be completely
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TABLE IX-3
TYPICAL CHROMATOGRAPH CONDITIONS FOR KETONES









Acetone 50 at 60 
psig




175 2 0 0 125 114
Methyl ethyl 
ketone
fl If fl 1 0 0 2 0 0 50 114
Methyl n-propyl 
ketone
If ff II 190 250 60 114
Methyl n-butyl 
ketone
30 at 60 
psig




225 250 80 115
Methyl n-amyl 
ketone
30 at 80 
psig




2 0 0 300 1 2 0 114
Methyl isobutyl 
ketone
50 at 60 
psig




260 193 65 114
Methyl isoamyl 
ketone
ff ff f 1 2 0 0 300 1 2 0 114
Diisobutyl
ketone
50 at 60 
psig




230 241 71 115
Cyclohexanone If fl II 2 2 0 255 1 1 0 114
Mesityl oxide 30 at 80 
psig




2 0 0 300 1 2 0 114
Diacetone
alcohol
II If II 2 0 0 300 1 2 0 114
Isophorone 50 at 60 
psig




255 250 167 115
*Flow to detector
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injected. After removing the needle from the sample and prior to 
injection, pull the plunger back 1 . 2  /al to minimize evaporation of the 
sample from the tip of the needle. Observe that the sample occupies 4.9- 
5.0 nl in the barrel of the syringe. Make duplicate injections of each 
sample and standard. No more than a 3% difference in area is to be 
expected.
An automatic sample injector can be used if it is shown to give 
reproducibility at least as good as the solvent flush technique. In this 
case, 2 -/il injections are satisfactory.
(5) Measurement of Area. Measure the area of the sample
peak with an electronic integrator or some other suitable form of area 
measurement and read preliminary results from a standard curve prepared as 
discussed below.
(e) Determination of Desorption Efficiency
(1) Importance of Determination. The desorption efficiency 
of a particular compound can vary from one laboratory to another and also 
from one batch of charcoal to another. Thus, it is necessary to determine 
at least once the percentage of the specific compound that is removed in 
the desorption process for a given compound, provided the same batch of 
charcoal is used.
(2) Effect of Time. The amount of cyclohexanone found on
the charcoal tubes decreased with time. The storage stability of the other 
ketones was not tested. Therefore, in determining desorption efficiency 
for field samples, the spiked tubes should be stored under the same 
conditions as the field samples (for example, time and temperature of 
storage should be the same).
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(3) Procedure for Determining Desorption Efficiency. 
Measure an amount of activated charcoal equivalent to the amount in the
first section of the sampling tube (100 mg) into a 7-cm, 4-mm inner 
diameter glass tube, flame-sealed at one end. This charcoal must be from 
the batch used in obtaining the samples, and it can be obtained from unused 
charcoal tubes. Cap the open end with Parafilm. Inject a known amount of
the ketone directly into the activated charcoal with a microliter syringe,
and cap the tube with more Parafilm. For mesityl oxide analysis, inject an 
8% stock solution of mesityl oxide in n-heptane in the desired amount. For 
diacetone alcohol, use a 600 mg/ml stock solution of the analyte in n- 
heptane. In experiments conducted to validate the method, the amount
injected was approximately equivalent to that present in a 1 0 - or 1 2 -liter
sample at the selected level.
Prepare six tubes, each containing an amount of ketone that would be 
expected in a 10- to 12-liter sample of air at 0.5X, 1.0X, and 2.OX the
recommended workplace environmental limit specified for the ketone of 
interest in Chapter I. Allow these tubes to stand at least overnight to 
assure complete sorption of the analyte onto the charcoal. These tubes are 
referred to as the samples. Treat a parallel blank tube in the same manner
but add no ketone to it. Desorb and analyze the sample and blank tubes in
exactly the same manner as the sampling tube.
Prepare two or three standards by injecting the same volume of 
compound into 0.5 ml (or 1.0 ml) of carbon disulfide. Analyze these 
standards with the samples.
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The desorption efficiency equals the average weight in milligrams
recovered from the tube divided by the weight in milligrams added to the 
tube, or
Desorption Efficiency = average weight (mg) recovered
weight (mg) added
The desorption efficiency is dependent on the amount of analyte
collected on the charcoal. Plot the desorption efficiency versus weight of 
analyte found. Use this curve to correct for adsorption losses.
Calibration and Standards
It is convenient to express concentration of standards in terms of
mg/0.5 ml (or mg/1.0 ml as appropriate) of carbon disulfide, because
samples are desorbed in this amount of carbon disulfide. The density of
the ketone is used to convert mg into jul for easy measurement with a
microliter syringe. When using an internal standard, prepare a final
concentration of 0.1% standard in the desorbent. Prepare a series of
standards, varying in concentration over the range of interest, and analyze
them under the same gas-chromatographic conditions and during the same time
period as the unknown samples. Curves are established by plotting
concentration in mg/0.5 ml versus peak area; a linear response is expected
with the ketones.
Note: If an internal standard is not used in the method,
standard solutions must be analyzed at the same time that the 
sample analysis is done. This will minimize the effect of 
. known day-to-day variations and variations during the same day 
of the flame-ionization detector response. In the case of the 
internal standard method, plot concentration versus the ratio 
of peak area of ketone to peak area of the internal standard.
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Calculations
(a) Read the weight, in mg, corresponding to each peak area from 
the standard curve. No volume corrections are needed, because the standard 
curve is based on mg/0.5 ml (or mg/1.0 ml) of carbon disulfide and the 
volume of sample injected is identical to the volume of the standards 
injected.
(b) Corrections for the blank must be made for each sample:
mg = mg sample - mg blank
where:
mg sample * mg found in front section of sample tube 
mg blank = mg found in front section of blank tube
Use a similar procedure for the backup sections.
(c) Add the weights found in the front and backup sections to get
the total weight in the sample.
(d) Read the desorption efficiency from the curve for the amount
found in the front section. Divide the total weight by this desorption 
efficiency to obtain the total mg/sample:
corrected mg/sample = total weight_____
desorption efficiency
(e) The concentration of the ketone in the sampled air can be
expressed in mg/cu m:
mg/cu m = total mg x 1 , 0 0 0  (liters/cu m) 
air volume sampled (liters)
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(f) Another method of expressing concentration is ppm:
ppm = mg/cu m x 24.45 x 760 x T + 273 
FW P 298
where:
P = pressure (mmHg) of air sampled
T = temperature (C) of air sampled
24.45 = molar volume (liters/mole) at 25 C and 760 mmHg
FW = formula weight
760 = standard pressure (mmHg)
298 = standard temperature (K)
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X. APPENDIX II 
MATERIAL SAFETY DATA SHEET
The following items of information which are applicable to a specific 
product or material shall be provided in the appropriate block of the 
Material Safety Data Sheet (MSDS).
The product designation is inserted in the block in the upper left 
corner of the first page to facilitate filing and retrieval. Print in 
upper case letters as large as possible. It should be printed to read 
upright with the sheet turned sideways. The product designation is that 
name or code designation which appears on the label, or by which the 
product is sold or known by employees. The relative numerical hazard 
ratings and key statements are those determined by the rules in Chapter V, 
Part B, of the NIOSH publication, An Identification System for 
Occupationally Hazardous Materials. The company identification may be 
printed in the upper right corner if desired.
(a) Section I. Product Identification
The manufacturer's name, address, and regular and emergency telephone 
numbers (including area code) are inserted in the appropriate blocks of 
Section I. The company listed should be a source of detailed backup 
information on the hazards of the material(s) covered by the MSDS. The 
listing of suppliers or wholesale distributors is discouraged. The trade 
name should be the product designation or common name associated with the 
material. The synonyms are those commonly used for the product, especially 
formal chemical nomenclature. Every known chemical designation or
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competitor's trade name need not be listed.
(b) Section II. Hazardous Ingredients
The "materials" listed in Section II shall be those substances which 
are part of the hazardous product covered by the MSDS and individually meet 
any of the criteria defining a hazardous material. Thus, one component of 
a multicomponent product might be listed because of its toxicity, another 
component because of its flammability, while a third component could be 
included both for its toxicity and its reactivity. Note that a MSDS for a
single component product must have the name of the material repeated in
this section to avoid giving the impression that there are no hazardous 
ingredients.
Chemical substances should be listed according to their complete name 
derived from a recognized system of nomenclature. Where possible, avoid 
using common names and general class names such as "aromatic amine," 
"safety solvent," or "aliphatic hydrocarbon" when the specific name is 
known.
The "%" may be the approximate percentage by weight or volume 
(indicate basis) which each hazardous ingredient of the mixture bears to 
the whole mixture. This may be indicated as a range or maximum amount, ie, 
"10-40% vol" or "1 0 % max wt" to avoid disclosure of trade secrets.
Toxic hazard data shall be stated in terms of concentration, mode of 
exposure or test, and animal used, eg, "100 ppm LC50-rat," "25 mg/kg LD50-
skin-rabbit," "75 ppm LC man," or "permissible exposure from 29 CFR
1910.1000," or, if not available, from other sources of publications such 
as the American Conference of Governmental Industrial Hygienists or the 
American National Standards Institute Inc. Flashpoint, shock sensitivity,
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or similar descriptive data may be used to indicate flammability, 
reactivity, or similar hazardous properties of the material.
(c) Section III. Physical Data
The data in Section III should be for the total mixture and should 
include the boiling point and melting point in degrees Fahrenheit (Celsius 
in parentheses); vapor pressure, in conventional millimeters of mercury 
(mmHg); vapor density of gas or vapor (air = 1); solubility in water, in 
parts/hundred parts of water by weight; specific gravity (water = 1 ); 
percent volatiles (indicated if by weight or volume) at 70 F (21.1 C); 
evaporation rate for liquids or sublimable solids, relative to butyl 
acetate; and appearance and odor. These data are useful for the control of 
toxic substances. Boiling point, vapor density, percent volatiles, vapor 
pressure, and evaporation are useful for designing proper ventilation 
equipment. This information is also useful for design and deployment of 
adequate fire and spill containment equipment. The appearance and odor may 
facilitate identification of substances stored in improperly marked 
containers, or when spilled.
(d) Section IV. Fire and Explosion Data
Section IV should contain complete fire and explosion data for the 
product, including flashpoint and autoignition temperature in degrees 
Fahrenheit (Celsius in parentheses); flammable limits, in percent by volume 
in air; suitable extinguishing media or materials; special firefighting 
procedures; and unusual fire and explosion hazard -information. If the 
product presents no fire hazard, insert "NO FIRE HAZARD" on the line 
labeled "Extinguishing Media."
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(e) Section V. Health Hazard Information
The "Health Hazard Data" should be a combined estimate of the hazard 
of the total product. This can be expressed as a TWA concentration, as a 
permissible exposure, or by some other indication of an acceptable 
standard. Other data are acceptable, such as lowest LD50 if multiple 
components are involved.
Under "Routes of Exposure," comments in each category should reflect
the potential hazard from absorption by the route in question. Comments
should indicate the severity of the effect and the basis for the statement
if possible. The basis might be animal studies, analogy with similar 
products, or human experiences. Comments such as "yes" or "possible" are 
not helpful. Typical comments might be:
Skin Contact— single short contact, no adverse effects likely;
prolonged or repeated contact, possibly mild irritation.
Eye Contact— some pain and mild transient irritation; no corneal
scarring.
"Emergency and First Aid Procedures" should be written in lay 
language and should primarily represent first-aid treatment that could be 
provided by paramedical personnel or individuals trained in first aid.
Information in the "Notes to Physician" section should include any 
special medical information which would be of assistance to an attending 
physician including required or recommended preplacement and periodic 
medical examinations, diagnostic procedures, and medical management of 
overexposed employees.
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(f) Section VI. Reactivity Data
The comments in Section VI relate to safe storage and handling of 
hazardous, unstable substances. It is particularly important to highlight 
instability or incompatibility to common substances or circumstances, such 
as water, direct sunlight, steel or copper piping, acids, alkalies, etc. 
"Hazardous Decomposition Products" shall include those products released 
under fire conditions. It must also include dangerous products produced by 
aging, such as peroxides in the case of some ethers. Where applicable, 
shelf life should also be indicated.
(g) Section VII. Spill or Leak Procedures
Detailed procedures for cleanup and disposal should be listed with 
emphasis on precautions to be taken to protect employees assigned to 
cleanup detail. Specific neutralizing chemicals or procedures should be 
described in detail. Disposal methods should be explicit including proper 
labeling of containers holding residues and ultimate disposal methods such 
as "sanitary landfill" or "incineration." Warnings such as "comply with 
local, state, and Federal antipollution ordinances" are proper but not 
sufficient. Specific procedures shall be identified.
(h) Section VIII. Special Protection Information
Section VIII requires specific information. Statements such as 
"Yes," "No," or "If necessary" are not informative. Ventilation 
requirements should be specific as to type and preferred methods. 
Respirators shall be specified as to type and NIOSH or Mine Safety and 
Health Administration approval class, ie, "Supplied air," "Organic vapor 
canister," etc. Protective equipment must be specified as to type and 
materials of construction.
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(i) Section IX. Special Precautions
"Precautionary Statements" shall consist of the label statements 
selected for use on the container or placard. Additional information on 
any aspect of safety or health not covered in other sections should be 
inserted in Section IX. The lower block can contain references to 
published guides or in-house procedures for handling and storage. 
Department of Transportation markings and classifications and other 
freight, handling, or storage requirements and environmental controls can 
be noted.
(j) Signature and Filing
Finally, the name and address of the responsible person who completed 
the MSDS and the date of completion are entered. This will facilitate 
correction of errors and identify a source of additional information.
The MSDS shall be filed in a location readily accessible to employees 
exposed to the hazardous substance. The MSDS can be used as a training aid 
and basis for discussion during safety meetings and training of new 
employees. It should assist management by directing attention to the need 
for specific control engineering, work practices, and protective measures 
to ensure safe handling and use of the material. It will aid the safety 
and health staff in planning a safe and healthful work environment and in 
suggesting appropriate emergency procedures and sources of help in the 
event of harmful exposure of employees.
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MATERIAL SAFETY DATA SHEET
1 PRODUCT IDENTIFICATION
M A N U F A C T U R E R  S N A M E
R E G U L A R  T E L E P H O N E  N O  
E M E R G E N C Y  T E L E P H O N E  N O




M A T E R I A L  O R  C O M P O N E N T % H A Z A R D  D A T A
III PH YSICA L DATA
B O I L I N G  P O I N T  760  M M  H.G M E L T I N G  P O IN T
S P E C IF IC  G R A V I T Y  ( H p O M ) V A P O R  P RE SS U R E
V A P O R  D E N S I T Y  ( A l R O ) S O L U B I L I T Y  IN  h 20  % B Y W T
% V O L A T  1 L E S BY V O L E V A P O R A T I O N  R A T E  ( B U T Y i  A C E T A T E  \)
A P P E A R A N C E  A N D  G O O R
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IV FIRE AND EXPLOSION DATA
f l a s h  p o i n t  
(TE S T  M E T H O D )
A U T O I G N I T I O N
T E M P E R A T U R E
F L A M M A B L E  L I M I T S  IN  A I R ,  % B Y  V O L . L O W E R UP P ER
E X T I N G U I S H I N G
M E D I A
S P E C IA L  F IR E
F I G H T I N G
P R O C E D U R E S
U N U S U A L  F IR E  
A N D  E X P L O S I O N  
H A Z A R D
V HEALTH HAZARD INFORMATION
H E A L T H  H A Z A R D  D A T A
R O U T E S  OF E X P O S U R E  
I N H A L A T I O N
S K I N  C O N T A C T
S K I N  A B S O R P T I O N
£ Y E  C O N T A C T
I N G E S T I O N
E F F E C T S  OF O V E R E X P O S U R E  
A C U T E  O V E R E X P O S U R E
C H R O N I C  O V E R E X P O S U R E
E M E R G E N C Y  A N D  F I R S T  A I D  P R O C E D U R E S  
E Y E S
S K I N
t N H A L  A T I O N
I N G E S T I O N
N O T E S  TO  P H Y S I C I A N
235
VI REACTIVITY DATA
C O N D I T I O N S  C O N T R I B U T I N G  T O  I N S T A B I L I T Y
IN C O M P A 1  i B I L I T Y
H A Z A R D O U S  D E C O M P O S I T I O N  P H O O U C T S
C O N D I T I O N S  C O N T R I B U T I N G  T O  H A Z A R D O U S  P O L Y M E R I Z A T I O N
VII SPILL OR LEAK PRO CEDURES
S TEPS TO  BE T A K E N  IE M A T E R I A L  IS R E L E A S E D  O R S P t L L E D  
N E U T R A L I Z I N G  C H E M I C A L S
W A S T E  D I S P O S A L  M E T H O D
VIII SP EC IA L PROTECTION INFORMATION
V E N T I L A T I O N  R E Q U I R E M E N T S
S P E C IF IC  P E R S O N A L  P R O T E C T I V E  E Q U I P M E N T  
R E S P I R A T O R Y  (S P E C IF Y  IN  D E T A I L )
E Y E
G L O V E S
O T H E R  C L O T H I N G  A N D  E Q U I P M E N T
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P R E C A U T I O N A R Y
S T A T E M E N T S
IX S P EC IA L PRECAUTIONS
O T H E R  H A N D L I N G  A N D  
S T O R A G E  R E Q U I R E M E N T S
P R E P A R E D  B Y
A D D R E S S
D A T E
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XI. TABLES AND FIGURE
TABLE XI-1




































c = 0 
I
c h 3






















SYNONYMS AND STRUCTURAL FORMULAS FOR THE KETONES
Ketone Name Structural
and Formula Synonyms Formula
Methyl n-butyl ketone 2-Hexanone
CgHioO n-Butyl methyl ketone . 3
MBK '
Methyl butyl ketone 9*"*2
MNBK '
Methyl 2-butyl ketone . 2
Methyl butanone I,.OMo
I


















SYNONYMS AND STRUCTURAL FORMULAS FOR THE KETONES
Ketone Name Structural
and Formula Synonyms Formula
Methyl isobutyl ketone 





Isobutyl methyl ketone 
Methyl-isobutyl-cetone (French) 











c = o 
I
CHo
Methyl isoamyl ketone 
CHßCOCgHi'i
5-Methyl-2-hexanone 
Isoamyl methyl ketone 



























































Isobutenyl methyl ketone 
Mesityloxid (German) 
Mesityloxyde (Dutch)
Ossido di mesitile (Italian) 







































C = 0 
I
CHo
Adapted from references 9,11,100,157,158,162,165,180-183
241
242
T A B L E  X1-  2
CHEMICAL AND PHYSICAL PROPERTIES OF KETONES
C onpoun d
Air Evapor*
Formula Boiling Melting Specific Refractive Vapor Satura- atlon Flash- Flara/nable Water C o n v e r s l c*
Weight Point Point Gravity Index Pressure tion Rate point* Limits Solubility Factors
(C) (C) (20/20 C) (20 C) (mmHg 
at 25 C)
(Ï) (ethe r = 1 ) (* v/v) (mg/cu a
S 1 ppm)
58.08 36 .  1
Methyl ethyl 72.11 79.6
ket one
Methyl 86. 1 1 102.2
n-p r opy1 
ketone
Methyl 1 00. 16 127.5
n-bu t y1 
ketone
Methyl n-amyl 114.16 150.6ketone




1 1 M . 18 1 4 4
Di 1sobu ty 1 
ketone
142.24 168. 1
Cyclohexanone 9 8 . I1! 155.6
Mesityl oxide 98.1*1 129.55
1 16. 16 169.2Diacetone
alcohol
Is opho rone 1 3 8.2 1 215.2
-95.6 0.7911 1.3589
-86.6 0.8072 1 .38 1 4




(25/4 C) (17.4 C)
- 2 6 . 9  0 . 8 1 6 6  1 . 4 0 7 3
- 8 3 - 5  0 . 8 0 2 0  1 . 3 9 5 9





















2.4 0. 32 30.8
4.5 0.60 40.6
9.5 1 - 25 8.4
1.2 0 . 1 6  60
0.44 0.06 200
0 2. 15-13
22 1 . 8 -1 2 . 0
( 2 0 )




61 1 . 3 5 - 7 . 6
( 7 * 0
(1 1 0)
3 0 . 8  
( 1 2 0 )
1443 1 . 1
( 1 1 6 ) (l o w e r )
90 1 . 3 - 8 .
( 8 U )
1 . 8 - 6.9( 1 U2)






0 .  H3
1.9 1

















44 . 0 1 
44.75 
5.65
•Flashpoint, Tag closed cup value (F) with open cup value (F) in parentheses. 
••All of the ketones are soluble in inorganic solvents.
•••Butyl acetate=1
TABLE XI-3
OCCUPATIONS WITH POTENTIAL EXPOSURE TO KETONES
Acetic acid makers 
Acetic anhydride makers 
Acetone workers 
Acetylene cylinder fillers 
Adhesive makers 





Cellulose acetate makers 
Cellulose cementmakers 
Chloroform makers 
Cleaning compound makers 
Colorless synthetic resin makers 
Cosmetic makers 
Dewaxers















Adapted from references 181,186
Leather workers, artificial 
Lubricating oil dewaxer 
Mesityl oxide makers 
Metal cleaners
Methyl isobutyl ketone makers 











































CALIBRATION SETUP FOR PERSONAL SAMPLING PUMP WITH CHARCOAL TUBE
D E P A R T M E N T  O F  
H E A L T H .  E D U C A T I O N ,  A N D  W E L F A R E
P U B L I C  H E A L T H  S E R V I C E  
C E N T E R  F O R  D I S E A S E  C O N T R O L  
N A T I O N A L  I N S T I T U T E  F O R  O C C U P A T I O N A L  S A F E T Y  A N D  H E A L T H  
R O B E R T  A  T A F T  L A B O R A T O R I E S  
4 6 7 6  C O L U M B I A  P A R K W A Y .  C I N C I N N A T I .  O H I O  4 5 2 2 6
O F F I C I A L  B U S I N E S S  
P E N A L T Y  F O R  P R I V A T E  U S E .  $ 3 0 0
r  — \
U.S. MAIL
P O S T A G E  A N D  F E E S  
U S.  D E P A R T M E N T  O F  H 
N E W  3 9 6
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